Master Reference List
REFERENCES EXAMINED -
CONTINUING
(MJS < 18 May 2004)
Abbott CM et al 1988 LANCET
Apr 2: 1(8588): 763-4
Abu-Hadid MM et al MOL
IMMUNOL. Aug: 25(8): 739-49
Ahrens P et al 1987
HUM GENET Jun: 76(2): 127-8
Akeson AL et al J BIOL CHEM.
Nov 5: 263(31): 16291-6
Allen
RC et al 1989 BIOTECHNIQUES Jul-Aug: 7(7): 736-44
Amselem S et al 1988 AM J HUM GENET. Jul: 43(1): 95-100
Angelini G et al. 1986 PROC NATL ACAD SCI U.S.A Jun: 83(12): 4489-93
Antonarakis SE et al 1982 PROC NATL ACAD SCI U S A. Jan: 79(1): 137-41
Antonarakis SE et al 1982 J PEDIATR Jun: 100(6): 845-56
Antonarakis SE et al 1982 PROC NATL ACAD SCI U S A Nov: 79(21): 6608-11
Antonarakis SE et al 1985 PROC NATL ACAD SCI U S A May: 82(10): 3360-4
Antonarakis SE et al 1985 LANCET Jun 22: 1(8443): 1407-9
Antonarakis SE et al 1985 N ENGL J MED Oct 3: 313(14): 842-848
Antonarakis SE et al. 1988 HUM GENET. Nov; 80(3); 265-73
Antonarakis SE et al 1988 BR J HAEMATOL Nov: 70(3): 357-61
Arai K
et al 1989 PROC NATL ACAD SCI U S A Aug: 86(16): 6092-6
Arnheim
N et al 1985 PROC NATL ACAD SCI U S A Oct: 82(20): 6970-74
Arpaia E
et al NATURE 1988 May 5: 333(6168): 85-6
Bahnak
BR et al 1988 THROMB HAEMOST Oct 31: 60(2): 178-81
Baxter-Lowe LA et al. 1989 J CLIN INVEST Aug: 84(2): 613-8
Beaudet
AL et al 1988 N ENGL J MED Jan 7: 318(1): 50-1
Bellis M
et al 1987 MOL BIOL EVOL Jul: 4(4): 351-63
Bidwell
JL et al. 1988 TRANSPLANTATION Mar: 45(3): 640-6
Boehm CD 1989 CLIN CHEM Sep: 35(9): 1843-8
Boehnke M et al 1989 AM J HUM GENET Jul: 45(1): 21-32
Botstein
D et al. 1980 AM J HUM GENET May: 32(3): 314-331
Bouhassira EE et al 1989 J CLIN INVEST Jun: 83(6): 2070-3
Brink PA et al 1987 HUM GENET Sep: 77(1): 32-5
Brinster RL et al 1988 PROC NATL ACAD SCI U S A Feb: 85(3): 836-849
Brocker-Vriends AH et al 1987 THROMB HAEMOST Apr 7: 57(2): 131-6
Buchman VL et al 1988
GENE Oct 30: 70(2): 245-52
Bufton L et al
1986 AM J HUM GENET Apr: 38(4): 447-60
Bugawan TL et al
1988 J IMMUNOL Dec 1: 141(11): 4024-30
Cai SP et al 1989 BLOOD Feb: 73: 372-4
Camerino G et al 1984 PROC NATL ACAD SCI U S A Jan: 81(2): 498-502
Camerino G et al 1985 HUM GENET 71(1): 79-81
Cavalli-Sforza L 1990 AM J HUM GENET Apr: 46(4): 649-51
Chamberlain JS
et al 1988 NUCLEIC ACIDS RES Dec 9: 16(23): 11141-56
Chao S et al
1989 THEOR APPL GENET 78(4): 495-504
Chebloune Y et
al 1988 PROC NATL ACAD SCI U S A Jun; 85(12): 4431-5
Chehab FF et al
1987 NATURE Oct 22-28: 329(6141): 293-4
Chelly J et al
1989 PROC NATL ACAD SCI U S A Apr: 86(8): 2617-21
Chow CM
et al 1989 MOL CELL BIOL Nov: 9(11): 4631-44
Clark AG 1990
MOL BIOL EVOL Mar: 7(2): 111-122
Claustres M et
al 1989 J GENET HUM Sep: 37(3): 243-9
Cohen JB, Levinson AD 1988
NATURE Jul 14:
334(6178): 119-24
Coleman RT et al 1986 MOL BIOL MED Jun: 3(3): 213-8
Coleman RT et al
1988 NUCLEIC ACIDS RES Feb
11: 16(3): 1221
Cooper DN et al 1984 HUM GENET 66(1): 1-16
Cooper DN et al 1985 J HUM GENET 69(3): 201-5
Cox DW et al
1987 AM J HUM GENET Nov: 41(5): 891-906
Cremer T et al 1988 HUM GENET Nov: 80(3): 235-246
Davies KE et al 1983 NUCLEIC ACIDS RES Apr 25: 11(8): 2303-2312
Delpech M et al
1986 HUM GENET. Nov: 74(3): 316-7
de Preval C et
al. 1987 IMMUNOGENETICS 26(4-5): 249-57
Deng GR NUCLEIC ACIDS RESEARCH Jul 11: 16(13): 6231
Deng TL et al
1989 NUCLEIC ACIDS RES Jan 25: 17(2): 645-58
Denton PH et al 1988 BLOOD Oct: 72(4): 1407-11
Dennis ES et al 1988
NUCLEIC ACIDS RESEARCH May 11: 16(9): 3815-28
Detera-Wadleigh
SD et al 1989 NUCLEIC ACIDS RES Aug 11: 17(15): 6432
Dicker AP et al
1989 BIOTECHNIQUES Sep: 7(8): 830-7
DiLella AG et al
1986 NATURE Aug 28-Sep 3: 322(6082): 799-803
DiLella AG et al
1988 LANCET March 5: 1(8584): 497-499
Di Marzo R et al 1988 BR J HAEMATOL Jul: 69(3): 393-7
Din et al 1985 LANCET Jun 22: 1(8443): 1446-7
Dorsett D et al 1989
GENES
DEV Apr: 3(4): 454-68
Drayna D et al 1984 PROC NATL ACAD SCI U S A May: 81(9): 2836-9
Driscoll MC et al 1988 BLOOD Jul: 72(1): 61-5
Duceman BW et al
1986 IMMUNOGENETICS 23(2): 90-9
Duyk GM et al 1990 PROC NATL ACAD SCI U S A Nov: 87(22): 8995-99
Embury SH et al 1987 N ENGL J MED Mar 12: 316(11): 656-61
Emrie PA et al
1988 SOMAT CELL MOL GENET Jan: 14(1): 105-10
Erlich HA et al.
1990 J FORENSIC SCI. Sep; 35(5): 1017-19
Estivill X et al
1987 GENOMICS Nov; 1(3): 257-63
Farrall M et al
1986 LANCET 2: 1402-4
Feener CA et al
1989 NATURE Apr 6: 338(6215): 509-11
Feldman GL et al
1988 LANCET Jun 21: 2(8495): 102
Ferns GA, Galton
DJ 1986 HUM GENET July: 73(3): 245-9
Fey MF et al
1990 HUM GENET Apr: 84(5): 471-2
Fojo SS et al J
CLIN INVEST. Nov: 82(5): 1489-94
Forrest D et al 1987
VIROLOGY May: 158(1): 194-205
Fournier D et al
1989 J MOL BIOL Nov 5: 210(1): 15-22
Freedenberg DL et al 1987 HUM GENET Jul:
76(3): 262-4
Frossard PM
et al 1987
NUCLEIC ACIDS
RES Jan 12: 15(1): 381
Fugger L et al.
1989 IMMUNOGENETICS 30(3): 208-13
Fujisaku A et al 1989
J BIOL
CHEM Feb 5: 264(4): 2118-25
Funke H et al 1987 J CLIN CHEM CLIN BIOCHEM Mar: 25(3): 131-4
Gaitskhoki VS et al 1993 BIOCHEM MED METAB BIOL Oct: 50(2): 186-9.
Gatti RA et al
1987 AM J HUM GENET Oct: 41(4): 654-67
Geisel J et al 1988 J. CLIN CHEM CLIN BIOCHEM Jul: 26(7): 429‑434
Giannelli F et al 1984 LANCET Feb 4: 1(8371): 239-241
Gibbs RA
et al 1989 PROC NATL ACAD SCI U S A Mar: 86(6): 1919-23
Gibson J B, Wilks A V 1989
BIOCHEM GENET
Dec: 27(11-12): 679-88
Gitschier J et al 1985 NATURE Apr 25-May 1: 314(6013): 738-40
Gitchhier J et
al 1988 BLOOD Sep: 72(3): 1022-8.
Gotoda T et al
1989 BIOCHEM BIOPHYS RES COMMUN Nov 15: 164(3): 1391-6
Graham JB et al 1989 BLOOD Jun; 73(8): 2104-7
Grandchamp B et
al 1989 PROC NATL ACAD SCI U S A Jan: 86(2): 661-4
Greenberg A et
al 1989 INT J CANCER Jan
15: 43(1): 87-92
Griffiths LR et
al 1988 AM J HUM GENET May: 42(5): 756-771
Gusella JF et al
1982 PROC NATL ACAD SCI U S A Dec: 79(24): 7804-8
Gusella JF et al 1983 NATURE Nov 17-23: 306(5940): 234-8
Gyllensten UB, Erlich HA 1988 PROC NATL ACAD SCI U S A Oct: 85(20) 7652-6
Gyllensten U et al 1989 PROC NATL ACAD SCI U S A Dec: 86(24): 9986-9990
Haber DA et al
1990 CELL Jun 29: 61(7): 1257-69
Hamada H 1982
PROC NATL ACAD SCI U.S.A. 79(19): 5901-5905
Harper JF, Madges W 1988 MOL
GEN GENET Aug: 213(2-3): 315-24
Hastbacka J et al
1992 NAT
GENET Nov: 2(3): 204-11
Haugen A et al
1989 MOL CARCINOG 2(2): 68-71
Hay CW et al 1986 BLOOD May: 67(5): 1508-11
Hejtmanick JF et al 1989 PRENAT DIAGNOSIS Mar: 9(3): 177-86
Helentjaris
T,
Gesteland R 1983 J MOL APPL GENET 2(3):
237-247
Helmuth R et al 1990 AM J HUM GENET Sep: 47(3): 515-523
Herbert
CJ et al 1988 MOL
GEN GENET Aug: 213(2-3): 297-309.
Higuchi R et al 1988 NATURE Apr 7: 332(6164): 543-6
Hill AV et al
1988 BLOOD Jul: 72(1): 9-14
Hixson JE et al 1988 GENOMICS May:
2(4):
315-23
Ho CK,
Abelson J 1988
J MOL BIOL Aug 5: 202(3): 667-72
Ho
CK et al 1990 EMBO J Apr:
9(4): 1245-52
Hodges PE, Rosenberg LE 1989
PROC NATL ACAD SCI U S A Jun: 86(11): 4142-6
Houwen RH et al 1994 NAT
GENET Dec: 8(4): 380-6
Hsia YE et al 1989 LANCET May
6: 1(8645): 988-90
Huang LS et al 1989
J BIOL CHEM Jul 5: 264(19): 11394-400
Huang LS et al 1990 J LIPID
RESEARCH Jan: 31(1): 71-7
Janco RL et al 1987 BLOOD May: 69(5): 1539-41
Jeffreys AJ 1979
CELL Sep: 18(1): 1-10
Jeffreys AJ et
al 1985 NATURE Mar 7-13: 314(6006): 67-73
Jeffreys AJ et al 1988 NUCLEIC ACIDS RES Dec 9: 16(23): 10953-71
Jenkins RN et al
1990 J BIOL CHEM Nov 15: 265(32): 19624-31
Jinks DC et al 1989 HUMAN GENET Mar: 81(4): 363-6
Kagnoff MF et al 1989 PROC NATL ACAD SCI U S A Aug: 86(16): 6274-8
Kan YW, Dozy AM
1978 LANCET Oct 28: 2(8096): 910-2
Kan YW, Dozy AM
1978 PROC NATL ACAD SCI U S A Nov: 75(11): 5631-5
Kan YW et al 1980 N ENGL J MED Jan 24: 302(4): 185-8
Keim P et al
1990 GENETICS Nov: 126(3): 735-742
Kelly
DP et al 1990
PROC NATL ACAD SCI U S
A Dec: 87(23): 9236-40
Kerem B et al 1989 SCIENCE Sep 8: 245(4922): 1073-80
Knoll
BJ et al 1988 J BIOL
CHEM Aug 25: 263(24): 12020-7
Kogan SC et al
1987 N ENGL J MED Oct; 317(16): 985-90
Kogan S,
Gitschier J 1990 PROC NAT ACAD SCI U S A Mar: 87(6): 2092-6
Krawczak M et al
1988 HUM GENET Sep: 80(1): 78-80
Krawczak M 1988
PROC NATL ACAD SCI U S A Oct: 85(19): 7298-301
Kulozik AE et al 1988 BR J HAEMATOL Dec: 70(4): 455-8
Labouesse M et al 1987
EMBO J Mar: 6(3): 713-21
Lander ES, Botstein D 1987 SCIENCE Jun 19: 236(4808): 1567-70
Landsman
D et al 1989 NUCLEIC ACIDS RES Mar 25: 17(6): 2301-14
Lazzeroni LC 2001 STAT METH MED RES Feb: 10(1): 57-76
Leitersdorf E et al 1989 AM J
HUM GENET Mar: 44(3): 409-21
Lemaire HG et al 1989 NUCLEIC
ACIDS RES. Jan 25: 17(2): 517-22
Lewis RA et al
1990 GENOMICS Jun: 7(2): 250-6
Li HH et al 1988
NATURE Sep 29: 335(6189): 414-417
Lifton RP et al
1990 GENOMICS May: 7(1): 131-5
Limm TM et al
1993 HUM IMMUNOL Sep: 38(1): 57-68
Litt M, Luty JA
1989 AM J HUM GENET Mar: 44(3): 397-401
Little PF et al
1980 NATURE May 15: 285(5761): 144-7
Love JM et al
1990 NUCLEIC ACIDS RES 18: 14, 4123-4130
Lubahn DB et al
1989 PROC NATL ACAD SCI
U S A Dec: 86(23): 9534-8
Luty JA et al
1990 AM J HUM GENET Apr: 46(4): 776‑83
Lyonnet S et al
1989 AM J HUM GENET Apr: 44(4): 511-7
Ma YH et al 1988
ARTERIOSCLEROSIS Sep-Oct: 8(5): 521-4
Macek M et al
1990 ACTA UNI CAROL [MED] (PRAHA) 36(1-4): 108-111
Magdolen V et al 1988
MOL CELL BIOL Dec: 8(12): 5108-15
Mages W et al 1988
MOL GEN GENET Aug: 213(2-3): 449-58
Maggio A et al
1986 HUM GENET Mar: 72(3): 229-30
Mardis ER et al
1989 BIOTECHNIQUES Sep: 7(8): 840-50
Marx J 1990
SCIENCE Mar 30: 247(4950): 1540-42
Martiniuk F et
al 1990 DNA CELL BIOL Mar: 9(2): 85-94
Masson P et al
1989 CELL Aug 25: 58)4): 755-65
Mathison L et al
1989 MOL CELL BIOL Oct: 9(10): 4220-8
Matoskova B et al 1989 MOL
CELL BIOL. Jul: 9(7): 3148-50
Mattick JS. 1994 CURR OPIN
GENET DEV. Dec: 4(6): 823-31
McGee TL
et al 1989 GENE Aug 1: 80(1): 119-28
McIntosh I et al 1989 AM J MED GENET Feb: 32(2): 274-6
Metherall JE et
al 1986 EMBO J Oct: 5(10): 2551-7
Miura O et al 1989
BIOCHEM Jun 13:
28(12): 4934-8
Moller
DE et al 1989 MOL ENDOCRINOL. Aug: 3(8): 1263-9
Monteiro MJ, Cox RA 1987
J MOL BIOL Feb 5: 193(3):
427-38
Moschonas et al 1982 NUCLEIC ACIDS RES Mar 25: 10(6): 2109-20
Murray JC et al 1987 AM J HUM
GENET Apr: 40(4): 338-50
Nafa K et al 1990
HUM GENET Apr: 84(5): 401-5
Nakamura Y et al 1987 SCIENCE Mar 27: 235(4796): 1616-1622
Nakamura Y et al 1988 GENOMICS May: 2(4): 302-9
Nakamura Y et al
1988 AM J HUM GENET Dec: 43(6): 854-859
Nakamura Y et al
1989 AM J HEMATOL Sep: 32(1): 24-9
Nakano T, Suzuki K 1989 J
BIOL CHEM Mar
25: 264(9): 5155-8
Nam HG et al
1989 PLANT CELL Jul: 1(7): 699-705
Newgard CB et al
1987 AM J HUM GENET Apr: 40(4): 351-64
Newton CR et al
1989 LANCET Dec 23-30: 2(8678-9): 1481-3
Nottenburg C et
al 1987 J IMMUNOL Sep 1: 139(5): 1718-26.
Nozari G et al
1988 ANAL BIOCHEM Jul: 172(1): 180-4
Ochman H et al
1988 GENETICS Nov: 120(3): 621-623
O'Hara PJ, Grant FJ 1988 GENE
Jun 15: 66(1): 147-58
Ohno K, Suzuki K 1988
BIOCHEM BIOPHYS RES COMM May 31: 153(1):
463-9
Old JM et al
1986 J MED GENET Feb: 23(1): 14-18
Olson M et al 1989 SCIENCE Sep 29: 245(4925): 1434-1435
Orkin SH et al
1982 NATURE Apr 15: 296(5858): 627-31
Orkin SH et al
1982 NATURE Dec 23: 300(5894): 768-9
Orkin SH et al
1985 EMBO J Feb: 4(2): 453-6
Palsdottir A et
al 1987 IMMUNOGENETICS 25(5): 299-304
Paolella G et al 1987 HUM GENET Oct: 77(2): 115-7
Parker R et al 1987
CELL Apr 24: 49(2): 229-39
Patterson M et
al 1989 AM J HUM GENET May: 44(5):
679-85
Paul H et al 1987 HUMAN GENET Mar: 75(3): 264-8
Peake IR
et al 1990
BLOOD Aug 1: 76(3): 555-61
Petersen MB et
al 1990 GENOMICS May: 7(1): 136-8
Philipsen JN et
al 1989 J MOL EVOL
Mar: 28(3): 185-90
Phillips JA 3rd
et al 1980 PROC NATL ACAD SCI U S A May: 77(5): 2853-6
Pietu G et al 1988 THROMB HAEMOST Aug 30: 60(1): 102-6
Poncz M et al 1983 J BIOL CHEM Oct 19: 258(19): 11599-11609
Potter
H, Dressler D 1986 GENE 48(2-3): 229-39
Quirk SM et al 1989
CELL
Feb 10: 56(3): 455-65
Quirk
SM et al 1989 NUCLEIC ACIDS RES Jan 11: 17(1): 301-15
Ragusa A et al
1989 AM J HUM GENET Jul: 45(1): 106-111
Rathbun GA et al
1988 IMMUNOGENETICS 27(2): 121-6
Raulf F et al
1989 J NEUROSCI RES. Sep: 24(1): 81-8
Rees A et al 1986 HUM GENET Feb: 72(2): 168-71
Riess O et al
1990 IMMUNOGENETICS 32(2): 110-6
Riordan JR et al 1989 SCIENCE Sep 29: 245(4925): 1066-73
Rommens JM et al 1989 SCIENCE Sep 8: 245(4922): 1059-65
Rouabhi
F et al 1988 HUM GENET Aug: 79(4): 373-6
Ruano G, Kidd KK
1989 NUCLEIC ACID RES Oct 25: 17(20): 8392
Saha BK et al
1986 J IMMUNOL Dec 15: 137(12): 4004-9
Saiki RK et al 1985 SCIENCE Dec: 230: 1350-4
Saiki RK et al
1986 NATURE Nov 13-19: 324(6093): 163-6
Saiki RK et al
1988 N ENGL J MED Sep 1: 319(9): 537-541
Saiki RK et al
1989 PROC NATL ACAD SCI U S A Aug: 86(16): 6230-6234
Sattaur O 1988
NEW SCIENTIST Dec 3: 120(1641): S1-S4
Scharf SJ et al 1988 HUM IMMUNOL May: 22(1): 61-9
Scharf SJ et al 1988 PROC NATL ACAD SCI U S A May: 85(10): 3504-8
Scharf SJ et al 1989 PROC NATL ACAD SCI U S A Aug: 86(16): 6215-9
Scambler PJ et
al 1987 NUCLEIC ACIDS RES May 11: 15(9): 3639-52
Searles LL et al 1990
MOL CELL BIOL Apr:
10(4): 1423-31
Seino
S, Bell GI 1989 BIOCHEM BIOPHYS RES COMMUN. Feb 28: 159(1): 312
Semenza GL et al 1989 NUCLEIC ACIDS RES Mar 25: 17(6): 2376
Servenius B et al 1987
J
BIOL CHEM Jun 25: 262(18): 8759-66
Sheehy MJ et al
1989 J CLIN INVEST Mar: 83(3): 830-835
Shtivelman E, Bishop JM 1989
MOL CELL BIOL
Mar: 9(3): 1148-54
Simons MJ et al 1993 HUM IMMUNOL Sep; 38(1): 69-74
Sinha AA et al 1988 SCIENCE Feb 26: 239(4843): 1026-9
Sinnett D et al
1990 GENOMICS Jul: 7(3): 331-4
Skolnick MH,
Wallace RB 1988 GENOMICS May; 2(4): 273-9.
Smeaton I et al
1987 IMMUNOGENETICS 25(3): 179-83
Snyder LC et al
1988 J Biol Chem. Nov 15: 263(32): 17150-8
Stephens JC et
al 1990 AM J HUM GENET Jun: 46(6): 1149-55
Stevanovic M et
al 1989 GENE Jun 30: 79(1): 139-50
Strobel MC,
Abelson J 1986 MOL CELL BIOL Jul: 6(7):
2663-73
Strobel MC,
Abelson J 1986 MOL CELL BIOL Jul: 6(7):
2674-83
Sutton M et al 1989 AM J HEMATOL Sep: 32: 66-69
Symons
DB et al 1987 J IMMUNOGENET. Dec: 14(6): 273-83
Takahashi H et al 1988
J
BIOL CHEM Oct 25: 263(30): 15528-34
Tanksley SD et
al 1989 BIO/TECHNOLOGY Mar: 7(3): 257-264
Tautz D 1989
NUCLEIC ACIDS RES Aug 25: 17(16): 6463-6471
Tautz D, Renz M
1984 NUCLEIC ACIDS RES May 25: 12(10): 4127-4138
Taylor R et al 1989 J MED GENET Aug: 26(8): 494-8
Thein SL
et al 1988 BR J HAEMATOL Oct: 70(2): 225-31
Theophilus B et
al 1989 AM J HUM GENET Aug: 45(2): 212-25
Tiercy JM et al
1988 PROC NATL ACAD SCI U S A Jan: 85(1): 198-202
Todd JA et al
1987 NATURE Oct 15-21: 329(6140): 599-604
Traver CN et al 1989 PROC NATL ACAD SCI U S A Aug: 86(15): 5898-5902
Tsang TC et al 1989 THROMB HAEMOST Jun 30: 61(3): 343-7
Tsavaler L et al 1988 PROC NATL ACAD SCI U S A Oct: 85(20): 7680-4
Tsui LC
et al 1986 AM J HUM GENET Dec: 39(6): 720-8
Tuan D et al 1979 NUCLEIC ACIDS RES Jun 11: 6(7): 2519-44
Udey JA, Blomberg BB 1988
NUCLEIC ACIDS RES Apr 11: 16(7): 2959-69
Vance JM 1989
EXP NEUROL May: 104(2): 186-189
van Kuppevelt TH
et al 1989 PROC NATL ACAD SCI U S A Jul: 86(14): 5415-8
Vidaud M et al
1989 PROC NATL ACAD SCI U S A Feb: 86(3): 1041-5
Vijayraghavan U
et al 1989 GENES DEVEL Aug: 3(8): 1206-16
Vrieling H et al 1988 MUTAT RES. Mar: 198(1): 107-13
Wainscoat et al 1986 NATURE Feb 6-12: 319(6053): 491-3
Weber JL, May PE 1989 AM J MED GENET Mar: 44(3): 388-396
Weber JL 1990
GENOMICS Aug: 7(4): 524-530 (corresponding to US Patent 5,075,217)
Weber JL 1990
CURR OPIN BIOTECHNOL Dec: 1(2) 166-47
Wehnert M et al
1989 DISEASE MARKERS Apr-Jun: 7(2): 113-7
White R et al
1985 NATURE Jan 10-18: 313(5998): 101-105
Williams C et al
1988 LANCET Jul 9: 2(8602): 102-3
Winey M et al 1989
GENE Mar 15: 76(1): 89-97
Winship PR et al 1984 NUCLEIC ACIDS RES Dec 11: 12(23): 8861-8872
Winship PR et al
1989 LANCET Mar 25: 1(8639): 631-634
Wion KL et al 1986 NUCLEIC ACIDS RES Jun 11: 14(11): 4535-42
Wong C et al 1987 NATURE Nov 26–Dec 2: 330(6146): 384-6
Wong WW et al 1989
J
EXP MED Mar 1: 169(3): 847-63
Wu DY et al 1989 PROC NATL ACAD SCI U S A Apr: 86(8): 2757-60
Wyman AR, White R 1980 PROC NATL ACAD SCI U S A Nov: 77(11): 6754-8
Ye RD et al 1989
J BIOL CHEM Apr 5: 264(10): 5495-502
Young LJ et al
1988 HUM GENET Jun: 79(2): 137-41
Yu CY, Campbell
RD 1987 IMMUNOGENETICS 25(6): 383-90
Zhang K et al
1987 GENE 57(1): 27-36
Zhu H et al 1989
MOL CELL BIOL Apr: 9(4):
1507-12
Zimmer M et al 1987
CURRENT GENETICS
12(5): 329-36
Master
Reference Abstracts
Abbott CM, McMahon CJ, Whitehouse
DB, Povey S.
Prenatal diagnosis of
alpha-1-antitrypsin deficiency using polymerase chain reaction.
Lancet 1988 Apr 2: 1(8588): 763-4.
------------------------------------------------------------------------------------------------------------------------------------
Abu-Hadid MM, Fuji H, Sood AK.
Department of Molecular
Immunology, Roswell Park Memorial Institute, Buffalo, NY 14263.
Identification of an alternatively
spliced Kd and the Qa-6d mRNAs by using amplified cDNA.
Mol Immunol. 1988 Aug: 25(8): 739-49.
We have employed the primer chain reaction method for direct sequencing of H-2
mRNAs. This approach is highly sensitive and permits quantitation and sequencing
of the canonical as well as alternatively spliced mRNAs that may be expressed at
5-10% level in comparison to the major H-2 species. Using this technique, we
have identified a novel species of alternatively spliced Kd mRNA expressed in
L1210 lymphoma and in the spleen and liver of DBA/2 mice. Similarly, we found a
previously described alternatively spliced species of H-2Dd mRNA to be expressed
in L1210 lymphoma and have determined the sequence of the cytoplasmic domain of
Ld mRNA. In addition, we have identified a Class I MHC transcript presumably
encoded by a gene allelic to Q6 gene of BALB/c mice.
------------------------------------------------------------------------------------------------------------------------------------------------
Ahrens P, Kruse TA, Schwartz M,
Rasmussen PB, Din N.
A new HindIII restriction
fragment length polymorphism in the hemophilia A locus.
Hum Genet. 1987 Jun: 76(2): 127-8.
Using a fragment of the cDNA for human coagulation factor VIII as a
hybridization probe, we have detected a new polymorphic HindIII site in intron
19 of the factor VIII gene. The frequency of the minor allele is 0.30. This
polymorphism shows strong linkage disequilibrium with a previously described
BclI polymorphism in intron 18.
------------------------------------------------------------------------------------------------------------------------------------
Akeson AL, Wiginton DA, Dusing MR,
States JC, Hutton JJ.
Children's Hospital Research Foundation, Cincinnati, Ohio.
Mutant human adenosine deaminase
alleles and their expression by transfection into fibroblasts.
J Biol Chem. 1988 Nov 5: 263(31): 16291-6.
Adenosine deaminase (ADA) deficiency in humans is one cause of severe combined
immunodeficiency disease. Single base mutations affecting the ADA protein have
been identified for both alleles of the ADA-deficient cell line GM2606 and for
one allele of the ADA-deficient cell line GM2825A. One allele of GM2606 has a
mutation altering amino acid 101 from Arg to Trp, and the other allele has a
mutation altering amino acid 211 from Arg to His. As previously reported, one
ADA allele of GM2825A has a single base mutation changing Ala-329 to Val-329,
and the other allele has a mutation which eliminates exon 4 from the mature
mRNA. Sequence analysis of polymerase chain reaction-amplified GM2825A DNA
showed a single base change of A to G within the invariant bases of the 3'
splice site of intron 3 that can account for the mis-splicing of exon 4. To test
the effect on ADA catalytic activity of these mutations and the mutations
previously found in the ADA-deficient line GM2756, expression vectors containing
normal and mutant ADA-coding sequences under transcriptional regulation of the
Rous sarcoma virus long terminal repeat were constructed and transfected into
human fibroblasts. All transfected cells had levels of ADA mRNA 15-25 times
higher than the endogenous ADA message. Yet, cells transfected with the normal
ADA-coding sequences had ADA enzymatic levels 40 times higher than cells
transfected with any of the mutant ADA sequences. This analysis demonstrates
that while the mutant ADA-coding sequences are transcribed, they do not encode a
functional ADA protein.
------------------------------------------------------------------------------------------------------------------------------------------------
Allen RC, Graves G, Budowle B.
Dept. of Pathology and
Laboratory Medicine, Medical University of South Carolina, Children's Hospital,
Charleston 29425.
Polymerase chain reaction
amplification products separated on rehydratable polyacrylamide gels and stained
with silver.
Biotechniques. 1989 Jul-Aug: 7(7): 736-44.
Separation of polymerase chain reaction (PCR) amplification of specific fragment
length polymorphisms was carried out on rehydratable polyacrylamide gels on a
horizontal flat slab system. A discontinuous sulfate-borate buffer system was
employed on 5-8% T gels crosslinked with 3.5% C. Samples were diluted in leading
sulfate ion buffer at 1/10 the ionic strength of the separating gel buffer and
placed directly onto the surface of the rehydrated gels in 0.5-10 microliters
volumes. The trailing ion and counterion were contained in a gel plug and placed
directly onto the anodal and cathodal ends of the gel, and the electrodes placed
directly onto the surface of the gel plugs. Filter paper wicks, soaked in
diluted leading ion buffer, were placed along each side to lower the ionic
strength of the edges, thereby increasing mobility at the edge and thus
preventing smile effects. The gel-gel contact of the plug and separating gel
prevent the production of a junction potential which occurs between dissimilar
materials such as a paper wick and the gel. Ten- to 20-cm separations were
carried out from 2-5 h, respectively, and resolution in the 20 cm system was
1.6-4 bp (base pairs) between 100 and 500 bp, 4-7 bp between 500 and 1000 bp,
12-20 bp between 1000 and 2000 bp and about 50 bp between 2000 and 3000 bp.
Between 3000 and 4000 bp, resolution fell off to +/- 100 bp. Sensitivity, using
a silver stain, indicated that one could readily distinguish less than 10 pg of
DNA per mm width on the gels.
------------------------------------------------------------------------------------------------------------------------------------------------
Amselem S, Nunes V, Vidaud M,
Estivill X, Wong C, d'Auriol L, Vidaud D, Galibert F, Baiget M, Goossens M.
INSERM U.91 Hopital Henri
Mondor, Creteil, France.
Determination of the
spectrum of beta-thalassemia genes in Spain by use of dot-blot analysis of
amplified beta-globin DNA.
Am J Hum Genet. 1988 Jul: 43(1): 95-100.
We have delineated the molecular lesions causing beta-thalassemia in Spain, a
country that has witnessed the passage of different Mediterranean populations
over the centuries, in order to evaluate the extent of heterogeneity of these
mutations and to make possible simplified prenatal diagnosis of the disorder in
that country. The use of the polymerase chain-reaction (PCR) technique to
preferentially amplify beta-globin DNA sequences that contain the most frequent
beta-thalassemia mutations in Mediterraneans enabled us to rapidly analyze 58
beta-thalassemia alleles in a dot-blot format either by hybridization with
allele-specific radiolabeled oligonucleotide probes or by direct sequence
analysis of the amplification product. The Spanish population carries seven
different beta-thalassemia mutations; the nonsense codon 39 is predominant
(64%), whereas the IVS1 position 110 mutation, the most common cause of beta-thalassemia
in the eastern part of the Mediterranean basin, is underrepresented (8.5%). The
IVS1 mutation at position 6 accounts for 15% of the defects and leads to a more
severe form of beta+-thalassemia than originally described in most of the
patients we studied. In this study, we demonstrate further the usefulness of the
dot-blot hybridization of PCR-amplified genomic DNA in both rapid population
surveys and prenatal diagnosis of beta-thalassemia.
------------------------------------------------------------------------------------------------------------------------------------------------
Angelini G, de Preval C, Gorski J,
Mach B.
High-resolution analysis
of the human HLA-DR polymorphism by hybridization with sequence-specific
oligonucleotide probes.
Proc Natl Acad Sci U S A. 1986 Jun: 83(12): 4489-93. Erratum in: Proc Natl Acad
Sci U S A 1986 Sep: 83(17): 6664.
The human major histocompatibility complex class II antigens of the HLA-D are
highly polymorphic, surface proteins essential in the cellular interactions
necessary for an immune response. The analysis of this polymorphism is crucial
for (i) histocompatibility matching for transplantation and (ii) understanding
the association between HLA-D and certain important diseases. The polymorphism
of certain HLA-D haplotypes may escape detection by current methodologies.
Analysis at the genomic level of the polymorphism of one of the HLA-D subregions
HLA-DR, using oligonucleotide probes specific for the polymorphic regions, is
capable of distinguishing single nucleotide differences. The DRw6 haplotype was
analyzed in view of the lack of DRw6 specific sera. On the basis of nucleotide
sequence analysis, the DRw6 haplotype consists of at least two subtypes. When
analyzed with oligonucleotide probes, this split identifies new polymorphic
groups that differ from the DRw6 serological subgroups.
------------------------------------------------------------------------------------------------------------------------------------
Antonarakis SE, Boehm CD,
Giardina PJ, Kazazian HH Jr.
Nonrandom association of polymorphic
restriction sites in the beta-globin gene cluster.
Proc Natl Acad Sci U S A. 1982 Jan: 79(1): 137-41.
By using probes for
-,
Yβ1-,
and β-globin genes, we found four additional polymorphic restriction sites that
have frequencies >0.1 in persons of Mediterranean area origin, Asian Indians,
and American Blacks. Three of these (HincII sites) and the two previously
described polymorphic HindIII sites [one in intervening sequence (IVS) II
of each γ-globin gene] are distributed over 32 kilobases (kb) of DNA located 5′
to the δ-globin gene. This region of DNA comprises two-thirds of the β-globin
gene cluster. Since each of these five polymorphic sites can be present (+) or
absent (-), in theory there exist 32 possible combinations of sites (haplotypes).
However, in Italians, Greeks, Indians, and Turks, 3 of the 32 haplotypes,
(+----), (-+-++), and (-++-+), account for 92% of 89 βA chromosomes
examined. The observed frequencies for these haplotypes are 0.64, 0.15, and 0.13
in the populations studied, in contrast to expected frequencies (based on the
observed gene frequencies at each of the five sites) of 0.20, 0.006, and 0.005,
respectively. In American Blacks, a fourth haplotype, (----+), which is rare in
non-Black populations, has a frequency of 0.37 in contrast to its expected
frequency of 0.05. These results suggest a nonrandom association of DNA
sequences over 32 kb 5′ to the δ-globin gene in all populations studied. Two
other polymorphic sites 3′ to the δ gene (the newly discovered Ava II
site in IVS II of the β-globin gene and the BamHI site 3′ to it) are
nonrandomly associated with each other but randomly distributed with respect to
the above haplotypes. This suggests that randomization of sequences has occurred
within 12 kb of DNA between these two nonrandomly associated sequence clusters.
Nonrandom association of polymorphic restriction sites has practical
consequences in that it limits the usefulness of these additional HincII
sites for prenatal diagnosis of hemoglobinopathies by linkage analysis. These
sites provide little additional information for detection of β-thalassemia,
while the polymorphic Ava II site, which lies outside the nonrandomly
associated sequences 5′ to the δ gene, improves the test applicability from 52%
to 70% of couples at risk.
------------------------------------------------------------------------------------------------------------------------------------------------
Antonarakis SE, Phillips JA 3rd,
Kazazian HH Jr.
Genetic diseases:
diagnosis by restriction endonuclease analysis.
J Pediatr. 1982 Jun: 100(6): 845-56.
We have summarized a number of different genetic disorders which can be
diagnosed at the DNA level using restriction endonuclease fragment analysis. A
whole spectrum of defects can be recognized: point mutations, deletions,
additions, and crossing-over products or hybrid genes. These same restriction
endonuclease techniques can enable different genes to be marked by polymorphism
patterns. Thus, abnormal genes can be identified even if their exact DNA lesion
is unknown or cannot be directly detected. The progress that has been made with
the hemoglobinopathies and the experience from this group of single gene
disorders should find application to other diseases as soon as specific probes
become available.
------------------------------------------------------------------------------------------------------------------------------------------------
Antonarakis SE, Orkin SH, Kazazian
HH Jr, Goff SC, Boehm CD, Waber PG, Sexton JP, Ostrer H, Fairbanks VF,
Chakravarti A.
Evidence for multiple origins of the
beta E-globin gene in Southeast Asia.
Proc Natl Acad Sci U S A. 1982 Nov: 79(21): 6608-11.
To investigate whether recurrent mutation has contributed to the high frequency
of the beta E-globin gene in Southeast Asia, we used the haplotypes at three
polymorphic restriction sites within and to the 3' side of the beta-globin gene
to predict the framework of 23 beta E-globin genes. These haplotypes suggested
that beta E-globin genes are present in two different beta-globin gene
frameworks. DNA sequence determination of one gene representing each framework
demonstrated that the same mutation (GAG leads to AAG at codon 26) was present
in both frameworks. Moreover, the frameworks differed at three nucleotide
positions known to be polymorphic in Mediterraneans. These polymorphic sites are
located 70 nucleotides to the 5' side of the beta E mutation and 382 and 1032
nucleotides to the 3' side of it. The existence of the beta E mutation in these
two beta-globin gene frameworks can be explained by (i) recurrent mutation
giving rise to beta E-globin, (ii) a double crossing-over event, or (iii) two
single crossing-over events. Mathematical analysis suggests that the first
alternative, recurrent mutation of G leads to A at the first nucleotide of codon
26, is most likely.
------------------------------------------------------------------------------------------------------------------------------------------------
Antonarakis SE, Kittur SD, Metaxotou
C, Watkins PC, Patel AS.
Analysis of DNA haplotypes suggests
a genetic predisposition to trisomy 21 associated with DNA sequences on
chromosome 21.
Proc Natl Acad Sci U S A. 1985 May: 82(10): 3360-4.
To test the hypothesis that there is a genetic predisposition to nondisjunction
and trisomy 21 associated with DNA sequences on chromosome 21, we used DNA
polymorphism haplotypes for chromosomes 21 to examine the distribution of
different chromosomes 21 in Down syndrome and control families from the same
ethnic group. The chromosomes 21 from 20 Greek families with a Down syndrome
child and 27 control Greek families have been examined for DNA polymorphism
haplotypes by using four common polymorphic sites adjacent to two closely linked
single-copy DNA sequences (namely pW228C and pW236B), which map somewhere near
the proximal long arm of chromosome 21. Three haplotypes, +, +---, and - with
respective frequencies of 43/108, 24/108, and 23/108, account for the majority
of chromosomes 21 in the control families. However, haplotype - was found to be
much more commonly associated with chromosomes 21 that underwent nondisjunction
in the Down syndrome families (frequency of 21/50; X2 for the two distributions
is 9.550; P = 0.023; degrees of freedom, 3). The two populations (control and
trisomic families) did not differ in the distribution of haplotypes for two DNA
polymorphisms on chromosome 17. The data from this initial study suggest that
the chromosome 21, which is marked in Greeks with haplotype - for the four above
described polymorphic sites, is found more commonly in chromosomes that
participate in nondisjunction than in controls. We propose an increased tendency
for nondisjunction due to DNA sequences associated with a subset of chromosomes
21 bearing this haplotype.
------------------------------------------------------------------------------------------------------------------------------------------------
Antonarakis SE, Copeland KL,
Carpenter RJ Jr, Carta CA, Hoyer LW, Caskey CT, Toole JJ, Kazazian HH Jr.
Prenatal diagnosis of haemophilia A
by factor VIII gene analysis.
Lancet. 1985 Jun 22: 1(8443): 1407-9.
Cloned factor VIII deoxyribose nucleic acid (DNA) sequences were used as probes
in the prenatal diagnosis of haemophilia A. Fetal DNA from cultured amniotic
fluid cells was examined for a DNA polymorphism within the factor VIII gene
which marked the haemophilia A gene in the pregnant obligate carrier. The fetus
was predicted to be an affected male, and the diagnosis of haemophilia A was
confirmed both in utero and after termination of the pregnancy.
------------------------------------------------------------------------------------------------------------------------------------------------
Antonarakis SE, Waber PG, Kittur SD,
Patel AS, Kazazian HH Jr, Mellis MA, Counts RB, Stamatoyannopoulos G, Bowie EJ,
Fass DN, et al.
Hemophilia A. Detection of molecular
defects and of carriers by DNA analysis.
N Engl J Med. 1985 Oct 3: 313(14): 842-8.
To understand the molecular basis of hemophilia A and to provide heterozygote
detection and prenatal diagnosis by DNA analysis, we used cloned factor VIII:C
DNA fragments to study 10 affected families. In four of these families,
inhibitors of factor VIII:C had developed in affected persons. In one such
family a deletion of approximately 80 kb within the factor VIII:C gene was
identified. Carriers of the deletion were identified through detection of an
abnormal DNA fragment located at the deletion end points. In another family a
single nucleotide change in the coding region of the factor VIII:C gene produced
a nonsense codon leading to premature termination of factor VIII:C synthesis.
Carrier detection was performed in eight female members of this four-generation
family. In a third family a small change in the size of a restriction-endonuclease
fragment correlated with the presence of the mutant gene, and in the other seven
families the molecular defect has not yet been identified. In addition, we used
two common polymorphic sites in the factor VIII:C gene to differentiate the
normal from the defective gene in four of six obligate female carriers from
families with patients in whom inhibitors did not develop. Carrier detection was
possible in other members of these families. These data suggest that DNA
analysis of the factor VIII:C gene provides an accurate method of carrier
detection and, potentially, of prenatal diagnosis in at least 50 per cent of the
pedigrees affected by hemophilia A.
------------------------------------------------------------------------------------------------------------------------------------------------
Antonarakis SE, Oettgen P,
Chakravarti A, Halloran SL, Hudson RR, Feisee L, Karathanasis SK.
Department of Pediatrics, Johns Hopkins University School of Medicine,
Baltimore, MD 21205.
DNA polymorphism haplotypes of the
human apolipoprotein APOA1-APOC3-APOA4 gene cluster.
Hum Genet. 1988 Nov: 80(3): 265-73.
The genes coding for apolipoproteins A1, C3, and A4 (APOA1, APOC3, APOA4) are
closely linked and tandemly organized within a 15-kilobase (kb) DNA segment on
the long arm of human chromosome 11. The nucleotide variability of a 61-kb DNA
segment containing these genes and their flanking sequences was studied by
restriction analysis of a sample of 18 unrelated Northern Europeans using seven
different genomic DNA probes. Eleven restriction site polymorphisms located
within this DNA segment were used for haplotype analysis of 129 Mediterranean
and 67 American black chromosomes. Estimation of the extent of nonrandom
association between these polymorphisms indicated considerable linkage
disequilibrium within the APOA1-APOC3-APOA4 gene cluster. Several haplotypes
arose by recombination, and the rate of recombination within this gene cluster
was estimated to be at least 4 times greater than that expected based on uniform
recombination. The polymorphism information content of each of these
polymorphisms, taken individually, ranges between 0.053 and 0.375, while that of
their haplotypes ranges between 0.858 and 0.862. Therefore, DNA polymorphism
haplotypes in the APOA1-APOC3-APOA4 gene cluster constitute a highly informative
genetic marker on the long arm of human chromosome 11.
------------------------------------------------------------------------------------------------------------------------------------------------
Antonarakis SE, Kang J, Lam VM, Tam
JW, Li AM.
Department of Paediatrics, Johns Hopkins University School of Medicine,
Baltimore, MD 21205.
Molecular characterization of beta-globin
gene mutations in patients with beta-thalassaemia intermedia in south China.
Br J Haematol. 1988 Nov: 70(3): 357-61.
We have studied the spectrum of mutations producting beta-thalassaemia
intermedia in South China. The methods of mutation detection include
oligonucleotide analysis, polymerase chain reaction amplification of the beta-globin
gene and direct genomic sequencing. The mutations have been identified in 22
beta-globin genes from the patients in 11 unrelated families. Seven different
mutations have been identified and the A to G substitution in the TATA box of
the beta-globin gene accounts for 42% of these mutant beta-globin genes. Most
patients have a beta(+) thalassaemia and one copy of the TATA box mutation. In
two patients with beta(0) thalassaemia intermedia the mild phenotype may be
explained in one by the presence of the - + - + + 5' beta-globin gene cluster
haplotype which contains the Xmn I site -158 nt to the G gamma-globin gene or in
the other by the number of alpha-globin genes present.
------------------------------------------------------------------------------------------------------------------------------------
Arai K, Madison J, Huss K, Ishioka
N, Satoh C, Fujita M, Neel JV, Sakurabayashi I, Putnam FW.
Department of Biology, Indiana University, Bloomington 47405.
Point
substitutions in Japanese alloalbumins.
Proc Natl Acad Sci U S A. 1989 Aug: 86(16): 6092-6.
We have completed the structural study of five rare types of inherited albumin
variants (alloalbumins) discovered in the Biochemical Genetics Study of 15,581
unrelated children in Hiroshima and Nagasaki. We have also identified the
structural change in five other alloalbumin specimens detected during clinical
electrophoresis of sera from Japanese living near Tokyo. Each of the five
albumin variants from Nagasaki and Hiroshima has a single amino acid
substitution. All of these substitutions differ, and none has been reported in
non-Japanese populations. No instances of proalbumin variants or of albumin B
(the most frequent alloalbumins in Caucasians) were detected in the children
in Hiroshima and Nagasaki. However, one instance of a variant proalbumin and
two examples of albumin B occurred in Japanese from the vicinity of Tokyo. In
addition a previously unreported point substitution was found in albumin
Tochigi, which is present in two unrelated persons from Tochigi prefecture.
Four of the point mutations in the Japanese alloalbumins are in close
proximity in a short segment of the polypeptide chain (residues 354-382) in
which three additional point substitutions have been reported in diverse
populations. These results, combined with earlier data, suggest that point
substitutions are grouped in certain segments of the albumin molecule.
------------------------------------------------------------------------------------------------------------------------------------
Arnheim N, Strange C, Erlich H
Use of pooled DNA samples to detect
linkage disequilibrium of polymorphic restriction fragments and human disease:
studies of the HLA class II loci.
Proc Natl Acad Sci U S A. 1985 Oct: 82(20): 6970-4.
A rapid method has been developed and used to search for restriction fragment
length polymorphisms (RFLPs) that are in linkage disequilibrium with
disease-associated loci. By using genomic blot-hybridization analysis with DQ
beta-chain and DR beta-chain cDNA probes, we examined DNA polymorphisms within
the HLA class II loci associated with susceptibility to insulin-dependent
mellitus (IDDM). To facilitate the search for informative RFLPs, we compared
pooled DNA samples from IDDM patients with pooled DNA samples from randomly
selected control individuals, instead of using the conventional approach of
examining DNA samples from individuals in two groups. (The conditions under
which this approach is useful are treated theoretically in the Appendix.)
Several specific polymorphic restriction fragments associated with IDDM were
revealed by using this economical and rapid approach. The restriction enzymes
and probes identified as informative in this screening were then used to analyze
HLA-DR-typed IDDM families, homozygous typing cells, and unrelated individuals
to determine the association of the specific restriction fragments with HLA-DR
serological type and the frequency in control and IDDM populations. Some
individual polymorphic fragments for which the IDDM population was enriched
correlated strongly with HLA-DR3, whereas others correlated strongly with
HLA-DR4. Some fragments (e.g., a 10-kilobase Taq I fragment detected with the DR
beta probe) that were more prevalent in the IDDM population subdivided the
serologically defined HLA-DR type and may be informative markers for IDDM
susceptibility.
------------------------------------------------------------------------------------------------------------------------------------
Arpaia E, Dumbrille-Ross A, Maler T,
Neote K, Tropak M, Troxel C, Stirling JL, Pitts JS, Bapat B, Lamhonwah AM, et
al. Research Institute,
Hospital for Sick Children, Toronto, Ontario, Canada.
Identification of an altered splice
site in Ashkenazi Tay-Sachs disease.
Nature. 1988 May 5: 333(6168): 85-6.
Tay-Sachs disease is an autosomal recessive genetic disorder resulting from
mutation of the HEXA gene encoding the alpha-subunit of the lysosomal enzyme,
beta-N-acetylhexosaminidase A (ref. 1). A relatively high frequency of carriers
(1/27) of a lethal, infantile form of the disease is found in the Ashkenazi
Jewish population, but it is not yet evident whether this has resulted from a
founder effect and random genetic drift or from a selective advantage of
heterozygotes. We have identified a single-base mutation in a cloned fragment of
the HEXA gene from an Ashkenazi Jewish patient. This change, the substitution of
a C for G in the first nucleotide of intron 12 is expected to result in
defective splicing of the messenger RNA. A test for the mutant allele based on
amplification of DNA by the 'polymerase chain rection and cleavage of a DdeI
restriction site generated by the mutation revealed that this case and two other
cases of the Ashkenazi, infantile form of Tay-Sachs disease are heterozygous for
two different mutations. The occurrence of multiple mutant alleles warrants
further examination of the selective advantage hypothesis.
------------------------------------------------------------------------------------------------------------------------------------
Bahnak BR, Lavergne JM, Verweij CL,
Rothschild C, Pannekoek H, Larrieu MJ, Meyer D.
INSERM U.143, Hopital de Bicetre, Paris, France.
Carrier detection in severe (type
III) von Willebrand disease using two intragenic restriction fragment length
polymorphisms.
Thromb Haemost. 1988 Oct 31: 60(2):
178-81.
DNA from a family with a female member affected with severe (type III) vWD was
analysed using three restriction enzymes and a partial vWF cDNA probe. Two
restriction fragment length polymorphisms (RFLPs) detected with the enzymes Bgl
II and Xba I proved to be informative in this family. A 36.0 Kb allele
demonstrated with the enzyme Xba I was rare in the general population but very
important in this family for segregation analysis of the alleles and their
association with the putative defective chromosome. The propositus was
homozygous for the 36.0 Kb Xba I polymorphic band and heterozygous for the Bgl
II polymorphism. She was the only member of the family showing this allelic
pattern. The linkage of the alleles could be determined because her mother was
homozygous for the 9.0 Kb Bgl II polymorphism but heterozygous for the Xba I
polymorphism. The segregation of the alleles could be traced to the proband's
son and a niece. The genotypic analysis revealed that her niece could be
considered as carrying a defective gene for severe vWD.
------------------------------------------------------------------------------------------------------------------------------------------------
Baxter-Lowe LA, Hunter JB, Casper
JT, Gorski J. Blood
Center of Southeastern Wisconsin, Inc., Milwaukee 53233.
HLA gene amplification and
hybridization analysis of polymorphism. HLA matching for bone marrow
transplantation of a patient with HLA-deficient severe combined immunodeficiency
syndrome.
J Clin Invest. 1989 Aug: 84(2): 613-8.
The treatment of choice for certain immunodeficiency syndromes and hematological
disorders is bone marrow transplantation (BMT). The success of BMT is influenced
by the degree of HLA compatibility between recipient and donor. However,
aberrant expression of HLA sometimes makes it difficult, if not impossible, to
determine the patient's HLA type by standard serological and cellular
techniques. We describe here the application of new molecular biological
techniques to perform high resolution HLA typing independent of HLA expression.
A patient with HLA-deficient severe combined deficiency was HLA typed using in
vitro amplification of the HLA genes and sequence-specific oligonucleotide probe
hybridization (SSOPH). Two major advances provided by this technology
are:detection of HLA polymorphism at the level of single amino acid differences;
and elimination of a requirement for HLA expression. Although the patient's
lymphocytes lacked class II HLA proteins, polymorphism associated with
DR7,w53;DQw2;DRw11a (a split of DR5), w52b (a split of DRw52);DQw7 were
identified. The patient's class I expression was partially defective, and typing
was accomplished by a combination of serological (HLA-A and -C) and SSOPH
analysis (HLA-B). Complete patient haplotypes were predicted after typing of
family members [A2;B35(w6); Cw4; DRw11a(w52b);DQw7 and A2;B13(w4); Cw6;DR7(w53);
DQw2]. Potential unrelated donors were typed and a donor was selected for BMT.
------------------------------------------------------------------------------------------------------------------------------------------------
Beaudet AL, Spence JE, Montes M,
O'Brien WE, Estivill X, Farrall M, Williamson R.
Experience with new DNA markers for
the diagnosis of cystic fibrosis.
N Engl J Med. 1988 Jan 7: 318(1): 50-1.
------------------------------------------------------------------------------------------------------------------------------------------------
Bellis M, Jubier-Maurin V, Dod B,
Vanlerberghe F, Laurent AM, Senglat C, Bonhomme F, Roizes G.
Centre National de la Recherche Scientifique, Institut de Biologie, Montpellier,
France.
Distributions of two recently
inserted long interspersed elements of the L1 repetitive family at the Alb and
beta h3 loci in wild mice populations.
Mol Biol Evol. 1987 Jul;4(4):351-63.
The presence of the L1 sequences, L1Md4 next to the pseudogene beta h3 and I12
found in the twelfth intron of the albumin gene, in certain strains of
laboratory mice but not of others has led to the suggestion that these sequences
were recent insertions into the Mus mus domesticus genome. To be sure that they
are really recent insertions and not relics of an ancestral chromosome, we
investigated the presence or absence of these sequences in populations of wild
mice belonging to the semispecies M. m. domesticus and M. m. musculus as well as
in other species of the genus Mus and in related murids. The sequence I12 in the
albumin gene was found in 34% of the chromosomes of the wild mice belonging to
M. m. domesticus and to a lesser extent (6%) in M. m. musculus. Of 114 M. m.
domesticus chromosomes, L1Md4 was found in only nine, seven of which came from
the same locality. Its presence was associated with the haplotype Hbbp, which is
relatively rare in European populations of M. musculus. Since there was no
evidence for the presence of these two L1 sequences in more distantly related
species, we conclude that they are recent insertions in the M. musculus genome.
------------------------------------------------------------------------------------------------------------------------------------------------
Bidwell JL, Bidwell EA, Savage DA,
Middleton D, Klouda PT, Bradley BA.
Molecular Genetics Laboratory, United Kingdom Transplant Service, Bristol,
England.
A DNA-RFLP typing system that
positively identifies serologically well-defined and ill-defined HLA-DR and DQ
alleles, including DRw10.
Transplantation. 1988 Mar;45(3):640-6.
A single enzyme/multiple probe system of HLA-DR and DQ typing using restriction
fragment-length polymorphism (RFLP) analysis is presented. TaqI-digested genomic
DNAs are hybridized sequentially with short DR beta, DQ beta, and DQ alpha cDNA
probes. The DR beta probe discriminates between the DR allelic specificities DR1
to DRw14, with the two exceptions of some DR3/DRw13 and some DR7/DRw9
combinations. We describe the positive identification of a DRw10-specific RFLP
and demonstrate its segregation in families. The DQ beta probe defines an
allelic system that identifies the alleles DQw1, DQw2, and DQw3. This permits
the resolution of DR3/DRw13 and DR7/DRw9 alleles by defining the DR/DQ
association caused by linkage disequilibrium. The DQ alpha probe defines another
allelic series interrelated with, but independent from, the DQ beta series.
Specific DQ beta/DQ alpha RFLP combinations correlate with known Dw splits of
DR2, DRw6, and DR7. Combined use of the three probes permits the identification
of HLA-DR, DQ, and certain Dw specificities and provides an effective and easily
interpretable system for major histocompatibility complex class II
allogenotyping.
------------------------------------------------------------------------------------------------------------------------------------------------
Boehm CD.
Johns Hopkins University School of Medicine, Department of Pediatrics,
Baltimore, MD 21205.
Use of polymerase chain reaction for
diagnosis of inherited disorders.
Clin Chem. 1989 Sep: 35(9): 1843-8.
The polymerase chain reaction (PCR) is a rapid method for generating a 10(6)- to
10(7)-fold increase in the number of copies of a discrete DNA or RNA sequence.
The technique is being used for rapid prenatal diagnosis and carrier testing of
several inherited disorders. After PCR, mutations producing single-gene
disorders can be detected by several different methods, including endonuclease
digestion and gel electrophoresis (applicable when a mutation affects an
endonuclease recognition site), gel electrophoresis (used for detection of
deletions), and hybridization to an oligonucleotide probe specific for a
mutation. Less often, gene sequencing of a PCR product is used to rapidly
identify a mutation. In addition, the PCR technique can be applied to
polymorphism analysis to provide diagnosis by linkage analysis. In other areas,
PCR is being used to detect and characterize microbial pathogens and to
characterize mutations associated with carcinogenesis. The PCR method is useful
in situations in which the amount of DNA sample is limited, such as in forensics
and prenatal testing, or in which the quality of the DNA sample is poor.
------------------------------------------------------------------------------------------------------------------------------------------------
Boehnke M, Arnheim N, Li H, Collins
FS. Department of
Biostatistics, School of Public Health, University of Michigan, Ann Arbor 48109.
Fine-structure genetic mapping of
human chromosomes using the polymerase chain reaction on single sperm:
experimental design considerations.
Am J Hum Genet. 1989
Jul;45(1):21-32.
The polymerase chain reaction (PCR)
makes it possible to rapidly generate a very large number of copies of a
specific region of DNA. Application of PCR to individual human sperm cells
permits the typing of a large number of independent male meiotic events. If the
donor male is heterozygous at three loci, sperm typing using PCR will permit
ordering of loci in a manner analogous to classical methods of experimental
genetics. Sequential analysis of trios of loci by sperm typing will provide a
very accurate means of ordering any number of tightly linked loci. Here, we
describe experimental design and sample-size issues raised by the application of
sperm typing by PCR for mapping human chromosomes, and we demonstrate that sperm
typing will be an efficient method for generating fine-structure human genetic
maps.
------------------------------------------------------------------------------------------------------------------------------------------------
Botstein D, White RL, Skolnick M,
Davis RW.
Construction of a genetic linkage
map in man using restriction fragment length polymorphisms.
Am J Hum Genet. 1980 May: 32(3): 314-31.
We describe a new basis for the construction of a genetic linkage map of the
human genome. The basic principle of the mapping scheme is to develop, by
recombinant DNA techniques, random single-copy DNA probes capable of detecting
DNA sequence polymorphisms, when hybridized to restriction digests of an
individual's DNA. Each of these probes will define a locus. Loci can be expanded
or contracted to include more or less polymorphism by further application of
recombinant DNA technology. Suitably polymorphic loci can be tested for linkage
relationships in human pedigrees by established methods; and loci can be
arranged into linkage groups to form a true genetic map of "DNA marker loci."
Pedigrees in which inherited traits are known to be segregating can then be
analyzed, making possible the mapping of the gene(s) responsible for the trait
with respect to the DNA marker loci, without requiring direct access to a
specified gene's DNA. For inherited diseases mapped in this way, linked DNA
marker loci can be used predictively for genetic counseling.
------------------------------------------------------------------------------------------------------------------------------------
Bouhassira EE, Lachman H,
Krishnamoorthy R, Labie D, Nagel RL.
Division of Hematology, Albert Einstein College of Medicine, Bronx, NY 10461.
A gene conversion located 5' to the
A gamma gene in linkage disequilibrium with the Bantu haplotype in sickle cell
anemia.
J Clin Invest. 1989 Jun: 83(6): 2070-3.
Cloning and sequencing of the gamma-globin gene of a sickle cell anemia patient
homozygous for the Bantu haplotype has revealed a gene conversion that involves
the replacement of an A gamma sequence by a G gamma sequence in the promoter
area of the A gamma gene. This event is similar to another gene conversion
believed to be responsible for the very high homology between gamma-globin
genes, suggesting that the promoter area of these genes is prone to this type of
genetic rearrangement. Further analysis demonstrated that the chromosome bearing
this gene conversion has a very high frequency among Bantu chromosomes and a
very low or nil frequency in other haplotypes linked to the beta s gene. No
correlation was found between the G gamma/A gamma ratio and the presence of the
gene conversion among Bantu haplotype patients, thus excluding a portion of the
gamma gene sequence in the determination of this ratio.
------------------------------------------------------------------------------------------------------------------------------------------------
Brink PA, Steyn LT, Coetzee GA, Van
der Westhuyzen DR.
Familial hypercholesterolemia in
South African Afrikaners. PvuII and StuI DNA polymorphisms in the LDL-receptor
gene consistent with a predominating founder gene effect.
Hum Genet. 1987 Sep: 77(1): 32-5.
Familial hypercholesterolemia (FH), at a prevalence of more than 1 in 100, is at
least five times more common in one South African population group than in
populations in North America and Europe. Fourteen homozygotic familial
hypercholesterolemic subjects from this South African group were genotyped for
two intragenic DNA restriction fragment length polymorphisms (RFLPs) in the LDL-receptor
gene. A StuI polymorphism is located in exon 8, and a PvuII polymorphism, in
intron 15. Of ten unrelated FH homozygotes genotyped for both RFLPs, nine were
homozygous for an S + P- haplotype, and one was heterozygous for an S + P-/S-P +
haplotype. The remaining four were genotyped for PvuII only and were homozygous
for P-. Compared with a previously determined population frequency for the
latter, this represents an association (P less than 0.05) between the frequency
for the P- allele and FH in this population, and this finding is consistent with
the "founder gene effect" previously postulated to be present on genealogical
and biochemical evidence.
------------------------------------------------------------------------------------------------------------------------------------------------
Brinster RL, Allen JM, Behringer RR,
Gelinas RE, Palmiter RD.
Laboratory of Reproductive Physiology, School of Veterinary Medicine, University
of Pennsylvania, Philadelphia 19104.
Introns increase transcriptional
efficiency in transgenic mice.
Proc Natl Acad Sci U S A. 1988 Feb: 85(3): 836-40.
Experiments were designed to test the effect of introns on gene expression in
transgenic mice. Four different pairs of gene constructs, which were identical
except that one member of each pair lacked all introns, were compared for
expression of mRNA after introduction into the murine germ line by
microinjection of fertilized eggs. The expression of two chimeric genes, made by
fusing either the mouse metallothionein I or the rat elastase 1
promoter/enhancer to the rat growth hormone gene, was assayed in fetal liver or
pancreas, respectively, while two natural genes, an oligonucleotide-marked mouse
metallothionein I gene and the human beta-globin gene, were assayed in fetal
liver. In each case there was, on average, 10- to 100-fold more mRNA produced
from the intron-containing construct. Moreover, mRNA levels were proportional to
the relative rates of transcription that were measured in isolated nuclei.
However, when the expression of the two mouse metallothionein I gene-based
constructs was tested after transfection into cultured cells, little difference
was observed. These observations suggest that introns play a role in
facilitating transcription of microinjected genes and that this effect may be
manifest only on genes exposed to developmental influences.
------------------------------------------------------------------------------------------------------------------------------------------------
Brocker-Vriends AH, Briet E, Quadt
R, Dreesen JC, Bakker E, Claassen-Tegelaar R, Kanhai HH, van de Kamp JJ, Pearson
PL.
Genotype assignment of haemophilia A
by use of intragenic and extragenic restriction fragment length polymorphisms.
Thromb Haemost. 1987 Apr 7: 57(2): 131-6.
We performed DNA analysis in 20 families with haemophilia A in order to evaluate
its usefulness for carrier detection and prenatal diagnosis. The polymorphic
BclI site within intron 18 of the factor VIII gene and the extragenic TaqI and
BglII polymorphic sites which are detected by the random DNA probes designated
St14 and DX13, respectively, were investigated for. Two events of recombination
were found between the St14 and the haemophilia A locus in 51 informative
meioses. In one of these recombinant meioses crossing over had also occurred
between the DX13 and the haemophilia A locus. No further crossovers between the
DX13 and the haemophilia A locus were found in 20 informative meioses.
Segregation analysis of the polymorphic markers and the deleterious mutation
within the families allowed a diagnosis at the gene level for 52 out of 57
potential carriers. The new method considerably decreased the uncertainty about
carriership for seventeen of the nineteen women with a probability of
carriership between 5% and 95% based on pedigree analysis and factor VIII
assays. In seven cases chromosome and DNA analysis of a chorionic villus biopsy
was carried out. Three of the fetuses were female, four were male. Three of the
male fetuses had inherited the normal maternal X-chromosome and were, therefore,
not affected. For another male fetus no diagnosis at the gene level was possible
since the mother was homozygous for all the known restriction fragment length
polymorphisms within or closely linked with the haemophilia A locus.
------------------------------------------------------------------------------------------------------------------------------------------------
Buchman VL, Chumakov PM, Ninkina NN,
Samarina OP, Georgiev GP.
Institute of Molecular Biology, U.S.S.R. Academy of Sciences, Moscow.
A variation in the structure of the
protein-coding region of the human p53 gene.
Gene. 1988 Oct 30: 70(2): 245-52.
An extensive analysis of genomic DNA preparations from a number of normal and
malignant tissues revealed BglII site polymorphism of the human p53 gene.
Approximately 10% of p53 gene alleles were found to contain an additional BglII
site localized in a region of intron I. This allelic form of p53 gene was also
responsible for p53 protein having altered electrophoretic mobility. Molecular
cloning and sequencing of both the alleles of p53 gene revealed a base-pair
change in codon 72 causing arginine----proline substitution in the allele with
the additional BglII site. Both variants of the p53 gene may occur in homozygous
state and are therefore functional.
------------------------------------------------------------------------------------------------------------------------------------------------
Bufton L, Bruns GA, Magenis RE,
Tomar D, Shaw D, Brook D, Litt M.
Four restriction fragment length
polymorphisms revealed by probes from a single cosmid map to chromosome 19.
Am J Hum Genet. 1986 Apr: 38(4): 447-60.
We have discovered and characterized a compound polymorphic locus on chromosome
19, defined by an arbitrary genomic DNA segment cloned into a cosmid vector.
Four different restriction fragment length polymorphisms with minor allele
frequencies equal to or greater than 10% are revealed by Southern hybridization
of subclones of cosmid 1-13 with TaqI, MspI, BamHI, and HindIII digests of human
DNAs. Seventy-two percent of unrelated individuals are heterozygous at one or
more loci, and seven of the 24 possible haplotypes occur with frequencies of
3%-38%. Using a somatic cell hybrid panel, we have mapped this locus to
19p13.2----19q13.3, whereas in situ hybridization suggests the probe is on 19p.
Taken together, these results suggest localization to 19p13.2----19cen. The
locus revealed by probes from cosmid 1-13 has been designated D19S11.
------------------------------------------------------------------------------------------------------------------------------------------------
Bugawan TL, Horn GT, Long CM,
Mickelson E, Hansen JA, Ferrara GB, Angelini G, Erlich HA.
Department of Human Genetics, Cetus Corporation, Emeryville, CA 94608.
Analysis of HLA-DP allelic sequence
polymorphism using the in vitro enzymatic DNA amplification of DP-alpha and
DP-beta loci.
J Immunol. 1988 Dec 1: 141(11): 4024-30.
Allelic sequence variation of the HLA DP-alpha and DP-beta genes has been
analyzed in a panel of 34 DP-typed cell lines. The polymorphic second exon of
these genes was specifically amplified in vitro by the polymerase chain reaction
method, using the thermostable DNA polymerase of Thermus, aquaticus. The
analysis of M13 clones containing the amplified DP-beta sequences revealed a
total of 14 allelic variants. In general, specific allelic DP-beta sequences
were associated with each of the defined DPw1-w6 types, with beta allele
subtypes revealed for the DPw2 and DPw4 specificities. An additional six DP-beta
alleles which did not correlate with any of the T cell-defined specificities (DP
"blanks") were also identified. Only the two previously characterized alleles of
DP-alpha were detected. These observations suggest that the T cell-defined DP
specificities are determined by polymorphic residues on the beta-chain. The
sequence polymorphisms in DP-beta are clustered in a few specific regions, and
can be detected using sequence-specific oligonucleotide probes and polymerase
chain reaction amplified DNA in a rapid dot-blot format. This approach provides
a simple and informative method of DP typing. The DP-beta sequences derived from
four DP-typed celiac disease patients were compared with the distribution of
DP-beta alleles in control individuals.
------------------------------------------------------------------------------------------------------------------------------------------------
Cai SP, Chang CA, Zhang JZ, Saiki RK,
Erlich HA, Kan YW.
Department of Medicine, University of California, San Francisco 94143-0724.
Rapid prenatal diagnosis of beta
thalassemia using DNA amplification and nonradioactive probes.
Blood. 1989 Feb: 73(2): 372-4.
We used in vitro DNA amplification by the polymerase chain reaction and
nonradioactive probes for prenatal diagnosis of beta thalassemia in Chinese from
the Guangdong province. Exact molecular diagnoses were made in all 20 fetuses
studied over a 6-month period. We conclude that this method of prenatal
diagnosis for beta thalassemia is a viable approach in many parts of the world
where this disease is common.
------------------------------------------------------------------------------------------------------------------------------------------------
Camerino G, Grzeschik KH, Jaye M, De
La Salle H, Tolstoshev P, Lecocq JP, Heilig R, Mandel JL.
Regional localization on the human X
chromosome and polymorphism of the coagulation factor IX gene (hemophilia B
locus).
Proc Natl Acad Sci U S A. 1984 Jan: 81(2): 498-502.
Hemophilia B is an X-linked disease caused by a functional deficiency in
coagulation factor IX. A cDNA clone corresponding to factor IX has been used to
detect homologous sequences in the human genome. All DNA fragments hybridizing
to the probe, under medium- or high-stringency conditions, are X-linked, and the
patterns obtained suggest that a single large (greater than or equal to 20
kilobases) gene is detected. The gene has been mapped to the q26-q27 region of
the long arm of the X chromosome by hybridization to DNA from a panel of
human-mouse hybrid cell lines. A search for restriction fragment length
polymorphisms using seven restriction enzymes has led to the detection of a Taq
I polymorphism, with allelic frequencies of about 0.71 and 0.29. This genetic
marker should be useful for the detection of carriers of the hemophilia B trait
and for prenatal diagnosis in informative families and, more generally, for the
establishment of a linkage map of the human X chromosome.
------------------------------------------------------------------------------------------------------------------------------------------------
Camerino G, Oberle I, Drayna D,
Mandel JL.
A new MspI restriction fragment
length polymorphism in the hemophilia B locus.
Hum Genet. 1985: 71(1): 79-81.
Using a partial cDNA probe for human
coagulation factor IX, we have detected a new restriction fragment length
polymorphism in human DNA digested with MspI. The frequency of the minor allele
is 0.20 +/- 0.05 and average heterozygosity is about 0.32. The MspI RFLP is in
strong linkage disequilibrium with the TaqI RFLP previously described, but
should nevertheless be useful in segregation analysis in case of homozygosity
for the TaqI minor allele.
------------------------------------------------------------------------------------------------------------------------------------------------
Cavalli-Sforza LL.
Department of Genetics, Stanford University, CA 94305-5120.
Opinion: how can one study
individual variation for 3 billion nucleotides of the human genome?
Am J Hum Genet. 1990 Apr: 46(4): 649-51.
------------------------------------------------------------------------------------------------------------------------------------------------
Chamberlain JS, Gibbs RA, Ranier JE,
Nguyen PN, Caskey CT.
Institute for Molecular Genetics, Baylor College of Medicine, Houston, TX 77030.
Deletion screening of the Duchenne
muscular dystrophy locus via multiplex DNA amplification.
Nucleic Acids Res. 1988 Dec 9: 16(23): 11141-56.
The application of recombinant DNA technology to prenatal diagnosis of many
recessively inherited X-linked diseases is complicated by a high frequency of
heterogeneous, new mutations (1). Partial gene deletions account for more than
50% of Duchenne muscular dystrophy (DMD) lesions, and approximately one-third of
all cases result from a new mutation (2-5). We report the isolation and DNA
sequence of several deletion prone exons from the human DMD gene. We also
describe a rapid method capable of detecting the majority of deletions in the
DMD gene. This procedure utilizes simultaneous genomic DNA amplification of
multiple widely separated sequences and should permit deletion scanning at any
hemizygous locus. We demonstrate the application of this multiplex reaction for
prenatal and postnatal diagnosis of DMD.
------------------------------------------------------------------------------------------------------------------------------------
Chao S, Sharp PJ, Worland AJ, Warham
EJ, Koebner RMD, GaleMD.
RFLP-based genetic maps of wheat
homoeologous group 7 chromosomes.
Theor Appl Genet 1989: 78(4):
495-504.
------------------------------------------------------------------------------------------------------------------------------------------------
Chebloune Y, Pagnier J, Trabuchet G,
Faure C, Verdier G, Labie D, Nigon V.
Departement de Biologie Generale et Appliquee Unite Associee 92, Universite
Claude Bernard-Lyon, Villeurbane.
Structural analysis of the
5' flanking region of the beta-globin gene in African sickle cell anemia
patients: further evidence for three origins of the sickle cell mutation in
Africa.
Proc Natl Acad Sci U S A. 1988 Jun:
85(12): 4431-5.
Haplotype analysis of the beta-globin gene cluster shows two regions of DNA
characterized by nonrandom association of restriction site polymorphisms. These
regions are separated by a variable segment containing the repeated sequences (ATTTT)n
and (AT)xTy, which might be involved in recombinational events. Studies of
haplotypes linked to the sickle cell gene in Africa provide strong argument for
three origins of the mutation: Benin, Senegal, and the Central African Republic.
Nevertheless, the haplotype determination does not give any information about
the variable segment and does not totally exclude the possibility of
recombination leading to different haplotypes linked to the mutation. The
structure of the variable segment in the three African populations was studied
by S1 nuclease mapping of genomic DNA, which allows a comparison of several
samples. A 1080-base-pair DNA segment was sequenced for one sample from each
population. S1 nuclease mapping confirmed the homogeneity of each population
with regard to both (ATTTT)n and (AT)xTy repeats. We found three additional
structures for (AT)xTy correlating with the geographic origin of the patients.
Ten other nucleotide positions, 5' and 3' to the (AT)xTy copies, were found to
be variable when compared to homologous sequences from human and monkey DNAs.
These results allow us to propose an evolutionary scheme for the polymorphisms
in the 5' flanking region of the beta-globin gene. The results strongly support
the hypothesis of three origins for the sickle mutation in Africa.
------------------------------------------------------------------------------------------------------------------------------------------------
Chehab FF, Doherty M, Cai SP, Kan YW,
Cooper S, Rubin EM.
Detection of sickle cell anaemia and
thalassaemias.
Nature. 1987 Sep 24-30: 329(6137):
293-4. Erratum in: Nature 1987 Oct 22-28: 329(6141): 678.
------------------------------------------------------------------------------------------------------------------------------------------------
Chelly J, Concordet JP, Kaplan JC,
Kahn A. Unite de
Recherches en Genetique et Pathologie Moleculaires, Unite 129, Institut National
de la Sante et de la Recherche Medicale, CHU Cochin, Paris, France.
Illegitimate
transcription: transcription of any gene in any cell type.
Proc Natl Acad Sci U S A. 1989 Apr:
86(8): 2617-21.
Using in vitro amplification of cDNA by the polymerase chain reaction, we have
detected spliced transcripts of various tissue-specific genes (genes for anti-Mullerian
hormone, beta-globin, aldolase A, and factor VIIIc) in human nonspecific cells,
such as fibroblasts, hepatoma cells, and lymphoblasts. In rats, erythroid- and
liver-type pyruvate kinase transcripts were also detected in brain, lung, and
muscle. The abundance of these "illegitimate" transcripts is very low; yet,
their existence and the possibility of amplifying them by the cDNA polymerase
chain reaction provide a powerful tool to analyze pathological transcripts of
any tissue-specific gene by using any accessible cell.
------------------------------------------------------------------------------------------------------------------------------------------------
Chow CM, Metzenberg RL, Rajbhandary
UL. Department of
Biology, Massachusetts Institute of Technology, Cambridge 02139.
Nuclear gene for mitochondrial
leucyl-tRNA synthetase of Neurospora crassa: isolation, sequence, chromosomal
mapping, and evidence that the leu-5 locus specifies structural information.
Mol Cell Biol. 1989 Nov: 9(11): 4631-44.
We have isolated and characterized the nuclear gene for the mitochondrial
leucyl-tRNA synthetase (LeuRS) of Neurospora crassa and have established that a
defect in this structural gene is responsible for the leu-5 phenotype. We have
purified mitochondrial LeuRS protein, determined its N-terminal sequence, and
used this sequence information to identify and isolate a full-length genomic DNA
clone. The 3.7-kilobase-pair region representing the structural gene and
flanking regions has been sequenced. The 5' ends of the mRNA were mapped by S1
nuclease protection, and the 3' ends were determined from the sequence of cDNA
clones. The gene contains a single short intron, 60 base pairs long. The
methionine-initiated open reading frame specifies a 52-amino-acid mitochondrial
targeting sequence followed by a 942-amino-acid protein. Restriction fragment
length polymorphism analyses mapped the mitochondrial LeuRS structural gene to
linkage group V, exactly where the leu-5 mutation had been mapped before. We
show that the leu-5 strain has a defect in the structural gene for mitochondrial
LeuRS by restoring growth under restrictive conditions for this strain after
transformation with a wild-type copy of the mitochondrial LeuRS gene. We have
cloned the mutant allele present in the leu-5 strain and identified the defect
as being due to a Thr-to-Pro change in mitochondrial LeuRS. Finally, we have
used immunoblotting to show that despite the apparent lack of mitochondrial
LeuRS activity in leu-5 extracts, the leu-5 strain contains levels of
mitochondrial LeuRS protein to similar to those of the wild-type strain.
------------------------------------------------------------------------------------------------------------------------------------------------
Clark AG.
Department of Biology, Pennsylvania State University, University Park 16802.
Inference of haplotypes
from PCR-amplified samples of diploid populations.
Mol Biol Evol. 1990 Mar;7(2):111-22.
Direct sequencing of genomic DNA from diploid individuals leads to ambiguities
on sequencing gels whenever there is more than one mismatching site in the
sequences of the two orthologous copies of a gene. While these ambiguities
cannot be resolved from a single sample without resorting to other experimental
methods (such as cloning in the traditional way), population samples may be
useful for inferring haplotypes. For each individual in the sample that is
homozygous for the amplified sequence, there are no ambiguities in the
identification of the allele's sequence. The sequences of other alleles can be
inferred by taking the remaining sequence after "subtracting off" the sequencing
ladder of each known site. Details of the algorithm for extracting allelic
sequences from such data are presented here, along with some population-genetic
considerations that influence the likelihood for success of the method. The
algorithm also applies to the problem of inferring haplotype frequencies of
closely linked restriction-site polymorphisms.
------------------------------------------------------------------------------------------------------------------------------------------------
Claustres M, Bellet H, Desgeorges M,
Kjellberg P, Toueri MF, Rollin B, Bonnet H.
DNA amplification in the
study of polymorphisms linked to the cystic fibrosis gene
J Genet Hum. 1989 Sep: 37(3): 243-9.
The highly specific polymerase chain reaction recently described can be used to
amplify selectively several polymorphic regions of DNA genetically close to the
cystic fibrosis gene. This method, providing automated, revolutionizes the
classical methods of prenatal diagnosis and carrier detection.
------------------------------------------------------------------------------------------------------------------------------------------------
Cohen JB, Levinson AD.
Department of Cell Genetics, Genentech Inc., South San Francisco, California
94080.
A point mutation in the
last intron responsible for increased expression and transforming activity of
the c-Ha-ras oncogene.
Nature. 1988 Jul 14: 334(6178):
119-24.
The T24/EJ allele of the Ha-ras proto-oncogene owes its powerful oncogenic
activity not merely to the well documented mutation that perturbs the structure
of the encoded polypeptide, but in addition to a second single nucleotide
alteration in an intron that causes a tenfold increase in expression. This
effect on expression is maintained upon transfer of the surrounding DNA to a
heterologous gene, and as such defines a novel regulatory element.
------------------------------------------------------------------------------------------------------------------------------------------------
Coleman RT, Gonzalez PA, Funke H,
Assmann G, Levy-Wilson B, Frossard PM.
Polymorphisms in the
apolipoprotein AI-CIII gene complex.
Mol Biol Med. 1986 Jun: 3(3):
213-28.
We report the presence of five restriction fragment length polymorphisms in the
apolipoprotein AI-CIII (apo AI-CIII) gene complex as well as their respective
allelic frequencies in a German population (pi) that we studied: an SstI (BanII)
polymorphism in the 3' non-coding region of apo CIII q1(pi) = 0.13); an MspI
polymorphism in the third intron of apo AI (q2(pi) = 0.12); a PvuII polymorphism
in the first intron of apo CIII (q3(pi) = 0.30); and two XmnI polymorphisms in
the 5' side of apo AI (q4(pi) = 0.20 and q5(pi) = 0.05).
------------------------------------------------------------------------------------------------------------------------------------------------
Coleman RT, Malloy MJ, Kane JP,
Frossard PM. California
Biotechnology, Inc., Mountain View 94043.
NcoI dimorphic site located 8kb 3'
to the human apolipoprotein AIV (APOA4) gene.
Nucleic Acids Res. 1988 Feb 11:
16(3): 1222.
------------------------------------------------------------------------------------------------------------------------------------------------
Cooper DN, Schmidtke J.
DNA restriction fragment length
polymorphisms and heterozygosity in the human genome.
Hum Genet. 1984: 66(1): 1-16.
A list is presented of published reports of DNA polymorphisms found in the human
genome by restriction enzyme analysis. While the list indicates the large number
of restriction fragment length polymorphisms (RFLPs) detected to date, the
information collated is insufficient to permit an estimate of heterozygosity for
the genome as a whole. Data from our laboratory are therefore also presented on
RFLPs detected using a random sample of cloned DNA segments. Such an analysis
has permitted a first unbiassed estimate of heterozygosity for the human genome.
Since this figure is an order of magnitude higher than previous estimates
derived from protein data, the majority of polymorphic variation present in the
human genome must, by implication, occur in noncoding sequences. In addition it
was confirmed that enzymes containing the dinucleotide CpG in their recognition
sequences detect more polymorphic variation than those that do not contain a CpG.
Also presented are the clinical applications of DNA polymorphisms in the
diagnosis of human genetic disease.
------------------------------------------------------------------------------------------------------------------------------------------------
Cooper DN, Smith BA, Cooke HJ,
Niemann S, Schmidtke J.
An estimate of unique DNA
sequence heterozygosity in the human genome.
Hum Genet. 1985: 69(3): 201-5.
Fifteen different restriction fragment length polymorphisms (RFLPs) were
detected in the human genome using 19 cloned DNA segments, derived from
flow-sorted metaphase chromosomes or total genomic DNA, as hybridization probes.
Since these clones were selected at random with respect to their coding
potential, their analysis permitted an unbiased estimate of single-copy DNA
sequence heterozygosity in the human genome. Since our estimate (h = 0.0037) is
an order of magnitude higher than previous estimates derived from protein data,
most of the polymorphic variation present in the genome must occur in non-coding
sequences. In addition, it was confirmed that enzymes containing the
dinucleotide CpG in their recognition sequence detect more polymorphic variation
than those that do not contain CpG.
------------------------------------------------------------------------------------------------------------------------------------------------
Cox DW, Billingsley GD, Mansfield T.
Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada.
DNA restriction-site
polymorphisms associated with the alpha 1-antitrypsin gene.
Am J Hum Genet. 1987 Nov: 41(5):
891-906.
Restriction-site variation in and around the alpha 1-antitrypsin gene has been
studied using two genomic probes. With use of restriction enzymes SstI, MspI,
and AvaII, three polymorphic sites have been described with a 4.6-kb probe in
the 5' portion of the gene. With use of a 6.5-kb probe, polymorphisms in the
coding and 3' regions of the gene have been detected with AvaII, MaeIII, and
TaqI. All of these polymorphisms are of sufficiently high frequency to be useful
in genetic mapping studies. The polymorphisms with AvaII and MaeIII (6.5-kb
probe) are particularly useful for prenatal diagnosis. PI types and M subtypes
tend to be associated with specific DNA haplotypes; there are two different
types of DNA haplotypes associated with PI M1. The extent of linkage
disequilibrium differs throughout the region of the alpha 1-antitrypsin gene.
------------------------------------------------------------------------------------------------------------------------------------
Cremer T, Lichter P, Borden J, Ward
DC, Manuelidis L.
Section of Neuropathology, Yale University School of Medicine, New Haven, CT
06510.
Detection of chromosome aberrations
in metaphase and interphase tumor cells by in situ hybridization using
chromosome-specific library probes.
Hum Genet. 1988 Nov: 80(3): 235-46.
Chromosome aberrations in two glioma
cell lines were analyzed using biotinylated DNA library probes that specifically
decorate chromosomes 1, 4, 7, 18 and 22 from pter to qter. Numerical changes,
deletions and rearrangements of these chromosomes were readily visualized in
metaphase spreads, as well as in early prophase and interphase nuclei. Complete
chromosomes, deleted chromosomes and segments of translocated chromosomes were
rapidly delineated in very complex karyotypes. Simultaneous hybridizations with
additional subregional probes were used to further define aberrant chromosomes.
Digital image analysis was used to quantitate the total complement of specific
chromosomal DNAs in individual metaphase and interphase cells of each cell line.
In spite of the fact that both glioma lines have been passaged in vitro for many
years, an under-representation of chromosome 22 and an over-representation of
chromosome 7 (specifically 7p) were observed. These observations agree with
previous studies on gliomas. In addition, sequences of chromosome 4 were also
found to be under-represented, especially in TC 593. These analyses indicate the
power of these methods for pinpointing chromosome segments that are altered in
specific types of tumors.
------------------------------------------------------------------------------------------------------------------------------------
Davies KE, Pearson PL, Harper PS,
Murray JM, O'Brien T, Sarfarazi M, Williamson R.
Linkage analysis of two
cloned DNA sequences flanking the Duchenne muscular dystrophy locus on the short
arm of the human X chromosome.
Nucleic Acids Res. 1983 Apr 25:
11(8): 2303-12.
The inheritance of two restriction fragment length polymorphisms (RFLPs) on the
short arm of the human X chromosome has been studied relative to Duchenne
muscular dystrophy. This provides a partial genetic map of the short arm of the
human X chromosome between Xp110 and Xp223. The data were derived from the
segregation between a RFLP located at Xp21-Xp223, the DMD locus, and a RFLP
located at Xp110-Xp113. The genetic distance from Xp110 to Xp223 was found to be
approximately 40 centimorgans (cM). This provides experimental confirmation that
1cM corresponds to approximately 1,000 kilobase pairs of DNA for this region of
the human X chromosome. Our data confirm that the DMD mutation lies between
Xp223 and Xp110. The availability of flanking probes surrounding the DMD locus
will assist in the ordering of further DNA sequences relative to the mutation.
------------------------------------------------------------------------------------------------------------------------------------------------
Delpech M, Deburgrave N, Baudis M,
Maissonneuve P, Bardin JM, Sultan Y, Kaplan JC.
De novo mutation in
hemophilia A established by DNA haplotype analysis and precluding prenatal
diagnosis.
Hum Genet. 1986 Nov: 74(3): 316-7.
In a family with a single case of hemophilia A genetic counselling was requested
by the pregnant aunt of the propositus. The haplotypes generated by two extra-genic
RFLPs, at DXS52 (St14/Taq1) and DXS15 (DX13/BglII), and one intragenic RFLP in
F8C (647/BclI) indicated that: she was not a carrier; the case of hemophilia
resulted from a de novo mutation in a grandfather's gamete.
------------------------------------------------------------------------------------------------------------------------------------------------
de Preval C, Angelini G, Boogh B,
Ferrara GB, Mach B.
Department of Microbiology, School of Medicine, University of Geneva,
Switzerland.
DNA typing of HLA-DR beta chain
genes can discriminate between undetected alleles and real homozygotes.
Immunogenetics. 1987: 26(4-5):
249-57.
The polymorphism of HLA-DR antigens has been studied by Southern blot
hybridization under conditions specific for the detection of the DR beta chain
genes. Haplotype-specific patterns were defined with DNA from DR1, 2, 3, 4, 7,
w8, w11, w12, and W13 homozygous typing cells, with restriction enzymes Eco RI,
Bgl I, and Pvu II. Certain serological specificities, such as DR2, DR3, and DR7,
can be encoded by distinct allelic forms of DR beta chain genes. The procedure
of "DNA typing" was applied to family analysis of individuals expressing only a
single DR specificity upon serological typing. Three cases are described here:
(1) in family GR, phenotypic DR 7 homozygotes correspond to genomic
heterozygotes, and a novel DR7 allele is described: (2) in family RU, the genes
corresponding to a serologically undetected (blank) DR allele were identified by
restriction fragment length polymorphism (RFLP); this novel DR haplotype has an
RFLP pattern similar to those of the DRw52 family, even though this specificity
was not expressed on the DR-blank lymphocytes; (3) in family RG, there is no
blank allele, but a homozygote RFLP situation at the DR subregion.
------------------------------------------------------------------------------------------------------------------------------------
(Free Full Text)
Deng GR. Beijing Institute for Cancer Research, China.
A sensitive non-radioactive PCR-RFLP
analysis for detecting point mutations at 12th codon of oncogene c-Ha-ras in
DNAs of gastric cancer.
Nucleic Acids Res. 1988 Jul 11:
16(13): 6231.
------------------------------------------------------------------------------------------------------------------------------------------------
Deng TL, Li Y, Johnson LF.
Department of Biochemistry, Ohio State University, Columbus 43210.
Thymidylate synthase gene
expression is stimulated by some (but not all) introns.
Nucleic Acids Res. 1989 Jan 25:
17(2): 645-58.
We previously described the construction of an intronless mouse thymidylate
synthase (TS) minigene that has the normal 5' and 3' flanking regions of the
gene linked to full length TS cDNA. Transfection of the minigene into ts-
hamster V79 cells led to low level expression of normal mouse TS mRNA and
protein. In the present study we analyzed the effect of introns on the
expression of the TS minigene in transient transfection assays. Inclusion of
introns 5 and 6 at their normal locations in the coding region led to an
8-9-fold stimulation of the level of TS and TS mRNA. Almost all of introns 5 and
6 could be deleted without diminishing the stimulatory effect. Inclusion of
intron 3 also stimulated the expression of the minigene, although to a lesser
extent than introns 5 and 6. However, inclusion of intron 4 had no stimulatory
effect. Analysis of minigenes that contained various combinations of introns
revealed that the stimulatory effects of the introns were not additive.
------------------------------------------------------------------------------------------------------------------------------------------------
Denton PH, Fowlkes DM, Lord ST,
Reisner HM. Department
of Microbiology and Immunology, University of North Carolina, Chapel Hill 27599.
Hemophilia B Durham: a
mutation in the first EGF-like domain of factor IX that is characterized by
polymerase chain reaction.
Blood. 1988 Oct: 72(4): 1407-11.
Two men with factor IX (FIX)antigen-positive (CRM+) hemophilia B were selected
for study because of their abnormal expression of an immunologically defined
epitope previously localized to the EGF-like domains of the molecule. Exons IV
and V (coding for the first and second EGF-like domains) of FIX were amplified
10(7) times from the patients' genomic DNA by using polymerase chain reaction (PCR)
technology and sequenced. Both patients had identical mutations which resulted
in the highly conserved Gly 60 residue being changed to Ser. PCR-amplified exon
IV from six normal males had the previously defined canonic sequence. The
correlation between the mutation and defective epitope expression in the two
patients suggests that a change in the tertiary structure of the EGF-like domain
is likely to cause the mild hemophilia B.
------------------------------------------------------------------------------------------------------------------------------------------------
Dennis ES, Sachs MM, Gerlach WL,
Beach L, Peacock WJ.
CSIRO, Division of Plant Industry, Canberra ACT, Australia.
The Ds1 transposable
element acts as an intron in the mutant allele Adh1-Fm335 and is spliced from
the message.
Nucleic Acids Res. 1988 May 11:
16(9): 3815-28.
The Ds-induced maize Adh1 allele Adh1-Fm335 retains its anaerobic regulation and
normal transcription start site despite the presence of the 405 bp Ds element in
the 5' untranslated leader region of the gene. The steady state level of
Adh1-specific transcript is reduced to about 1% that of the progenitor or
revertant alleles. Run-on transcription studies show that the reduced level of
Adh1 specific mRNA is not attributable to a decreased transcription rate. S1
mapping indicates that the Ds element is spliced from the Adh1-Fm335 transcript
using a donor site 14 bp into the Ds element and an acceptor site at the 3'
junction of the Ds element with the flanking genome DNA.
------------------------------------------------------------------------------------------------------------------------------------------------
(Free Full Text)
Detera-Wadleigh SD,
Coffman D, Shimada T.
Clinical Neurogenetics Branch, National Institute of Mental Health, Bethesda, MD
20892.
A frequent DHFR polymorphism
detected by an intron fragment.
Nucleic Acids Res. 1989 Aug 11:
17(15): 6432.
------------------------------------------------------------------------------------------------------------------------------------------------
Dicker AP, Volkenandt M, Adamo A,
Barreda C, Bertino JR.
Cornell University Graduate School of Medical Sciences, Memorial Sloan-Kettering
Cancer Center.
Sequence analysis of a
human gene responsible for drug resistance: a rapid method for manual and
automated direct sequencing of products generated by the polymerase chain
reaction.
Biotechniques. 1989 Sep: 7(8):
830-8.
We developed a system for rapid, manual and automated sequence analysis by
utilizing and modifying methods used in conjunction with the polymerase chain
reaction (PCR). We are using these techniques to detect single base mutations in
the dihydrofolate reductase (DHFR) gene giving rise to methotrexate (MTX)
resistance of tumor cells obtained from patients with malignancies. Amplifying
in vitro both genomic DNA and transcripts of the human DHFR we are able to
reproducibly generate single-stranded templates. Utilizing [alpha-35S]dATP and
both the universal and reverse sequencing primers we obtain sequence information
from either strand. The methods described have been successfully used for
automated sequencing with the Applied Biosystems Model 370A Sequencer using both
modified T7 DNA polymerase and Taq I. DNA polymerase for dideoxy-termination
sequencing. The use of this methodology to detect a single base change in a
human colon carcinoma cell line, HCT-8, is illustrated.
------------------------------------------------------------------------------------------------------------------------------------------------
DiLella AG, Marvit J, Lidsky AS,
Guttler F, Woo SL.
Tight linkage between a splicing
mutation and a specific DNA haplotype in phenylketonuria.
Nature. 1986 Aug 28-Sep 3: 322(6082): 799-803.
The first phenylketonuria mutation identified in the human phenylalanine
hydroxylase gene is a single base substitution (GT----AT) in the canonical
5'-splice donor site of intron 12. Direct hybridization analysis using specific
oligonucleotide probes demonstrates that the mutation is tightly associated with
a specific restriction fragment-length polymorphism haplotype among mutant
alleles. The splicing mutation is the most prevalent phenylketonuria allele
among Caucasians, and the results suggest the possibility of detecting carriers
of the genetic trait who have no family history of phenylketonuria.
------------------------------------------------------------------------------------------------------------------------------------------------
DiLella AG, Huang WM, Woo SL.
Howard Hughes Medical Institute, Department of Cell Biology, Baylor College of
Medicine, Houston, Texas.
Screening for phenylketonuria
mutations by DNA amplification with the polymerase chain reaction.
Lancet. 1988 Mar 5: 1(8584): 497-9.
Single base substitutions have been identified in two mutant phenylalanine
hydroxylase (PAH) alleles that cause phenylketonuria (PKU). The two mutant
alleles are common among caucasians of northern European ancestry; detection in
genomic DNA samples of patients and carriers by hybridisation with
oligonucleotides specific for the respective mutant alleles requires
fractionation of restriction-enzyme-digested genomic DNA samples by gel
electrophoresis. This method is too cumbersome for mass screening of PKU
carriers. Identification of carriers of the mutant alleles was achieved by
direct analysis of their genomic DNA samples after specific amplification of a
sub-genomic DNA fragment containing both mutation sites by polymerase chain
reaction. The results suggest that it is technically feasible to develop a
programme for carrier detection of the genetic trait in the population for
individuals without a family history of PKU.
------------------------------------------------------------------------------------------------------------------------------------------------
Di Marzo R, Dowling CE, Wong C,
Maggio A, Kazazian HH Jr.
Department of Hematology, V. Cervello Hospital, Palermo, Italy.
The spectrum of beta-thalassaemia
mutations in Sicily.
Br J Haematol. 1988 Jul: 69(3):
393-7.
To characterize beta-thalassaemia genes among the Sicilian population we have
previously determined the DNA haplotypes in the beta-globin gene cluster of 99
beta-thal chromosomes. We found seven haplotypes, although 95 of 99 beta-thal
chromosomes contained framework 1 and framework 3 beta genes. We have now
determined the mutation in all 99 of these beta-thal genes by the use of
oligonucleotide hybridization. PCR-amplification and direct genomic sequencing,
and direct restriction analysis. Our results indicate that (1) the beta (0)-39
mutation is most frequent (35%); (2) beta(0)-39, IVS-1 nt 110 and IVS-1 nt 6
mutations account for 90% of beta-thal genes: (3) the IVS-1 nt 6 mutation is
more frequent in thalassaemia intermedia (77%) than in Cooley's disease (34%):
(4) the association between haplotypes and specific mutations is imperfect, but
mutation spread has occurred within haplotypes containing the same beta-gene
framework: (5) the beta(0)-39 and the IVS-1 nt 6 mutations, with a mutation
spread to two major haplotypes, may be older than the IVS-1 nt 110 mutation: (6)
these data make possible first-trimester prenatal diagnosis in many families
(85%) in Sicily using only three pairs of oligonucleotides. In addition, a new
mutation, a frameshift at codon 76 due to loss of a C residue, was found in a
single beta-thal chromosome.
------------------------------------------------------------------------------------------------------------------------------------------------
Din N, Schwartz M, Kruse T,
Vestergaard SR, Ahrens P, Caput D, Hartog K, Quiroga M.
Factor VIII gene specific probe for
prenatal diagnosis of haemophilia A.
Lancet. 1985 Jun 22: 1(8443):
1446-7.
------------------------------------------------------------------------------------------------------------------------------------------------
Dorsett D, Viglianti GA, Rutledge BJ,
Meselson M. Department
of Biochemistry and Molecular Biology, Harvard University, Cambridge,
Massachusetts 02138.
Alteration of hsp82 gene expression
by the gypsy transposon and suppressor genes in Drosophila melanogaster.
Genes Dev. 1989 Apr: 3(4): 454-68.
Several mutations in Drosophila result from insertion of the gypsy
retrotransposon. Gypsy insertion mutagenesis and its modulation by
allele-specific modifier genes were investigated by inserting gypsy or fragments
of it into the intron of the Drosophila hsp82 heat shock gene. With gypsy in the
parallel orientation, nearly all transcripts in transfected cells and
transformed pupae were truncated in the 5' long terminal repeat (LTR).
Truncation also occurred in or near the 3' LTR. The 5' LTR polyadenylation
signal was strongly potentiated by a downstream 326-bp internal gypsy segment in
either orientation. Anti-parallel gypsy reduced the amount of normal transcript
to a much smaller extent, and a low level of truncation occurred within gypsy.
No evidence was found for effects of the gypsy insertions on the hsp82 promoter.
Mutations in the allelespecific modifier genes su(f) and su(w alpha) had effects
on the amounts of readthrough transcripts consistent with their genetic
behavior, whereas the effects of mutations in su(Hw) were only partly in accord
with genetic expectations.
------------------------------------------------------------------------------------------------------------------------------------------------
Drayna D, Davies K, Hartley D,
Mandel JL, Camerino G, Williamson R, White R.
Genetic mapping of the human X
chromosome by using restriction fragment length polymorphisms.
Proc Natl Acad Sci U S A. 1984 May:
81(9): 2836-9.
Using a human X chromosome-specific DNA library, we have found arbitrary
single-copy DNA sequences that reveal useful restriction fragment length
polymorphisms. The inheritance of these and other available polymorphic DNA
markers has been studied in a series of unrelated three-generation families with
large sibships. These families reveal parental phase and allow determination of
recombination frequencies by counting recombinant and nonrecombinant
chromosomes. The resulting genetic map indicates that the minimal distance from
Xp22 to Xqter is 215 recombination units. The spacing of the marker loci is such
that the majority of the loci on the X chromosome, including disease loci, will
lie within 20 centimorgans of at least one of these loci.
------------------------------------------------------------------------------------------------------------------------------------------------
Driscoll MC, Dispenzieri A, Tobias
E, Miller CH, Aledort LM.
Department of Pediatrics, Mount Sinai School of Medicine, NY.
A second BamHI DNA polymorphism and
haplotype association in the factor IX gene.
Blood. 1988 Jul: 72(1): 61-5.
A second BamHI DNA polymorphism has been identified in the factor IX gene in an
American black population at an allelic frequency of 0.13. This site has been
localized within 500 basepairs (bp) 5' to the XmnI intron 3 polymorphic site and
increases the heterozygosity of black females at the factor IX gene locus. In
addition, haplotype analysis of factor IX genes at five polymorphic loci
indicates that although there is conservation of sequences between the races,
factor IX genes show more heterogeneity in an American black population and thus
more heterozygosity is observed in black females compared with whites. This
increased heterogeneity is due to DNA polymorphisms unique to black populations
and to linkage equilibrium between the most 5' and 3' polymorphic sites in
factor IX genes in blacks.
------------------------------------------------------------------------------------------------------------------------------------
Duceman BW, Ness D, Rende R, Chorney
MJ, Srivastava R, Greenspan DS, Pan J, Weissman SM, Grumet FC.
HLA-JY328: mapping studies and
expression of a polymorphic HLA class I gene.
Immunogenetics. 1986: 23(2): 90-9.
The JY328 clone was identified in a human genomic library using cDNA
corresponding to mRNA for HLA-B7 as a probe. The L/328 cell line was established
by cotransformation of mouse Ltk- cells with the herpes thymidine kinase gene
and clone JY328. On Northern blots, RNA from L/328 strongly hybridized to an HLA
class I probe, and an antigen was recognized by an anti-HLA class I framework
antibody on the cell surface. A DNA probe corresponding to a segment of intron 7
was developed by comparing the nucleotide sequence of clone JY328 with that of
other HLA class I-type genes. Using the radiolabeled probe to screen Southern
blots of DNA from families with siblings exhibiting intra-HLA recombinations, a
restriction fragment length polymorphism was revealed--a 1.4 kb BstE II band not
present in all individuals. A corresponding fragment was apparent in the base
sequence of clone JY328. The occurrence of this band on Southern blots
established that JY328 maps distinct from and centromeric to the HLA-C locus and
near to the HLA-B locus. Antibody absorption studies and cytotoxicity tests
indicated that the JY328 gene product was not an HLA-B antigen but that it did
specifically absorb CW7-specific antibody. In sum, these results suggest a
novel, polymorphic HLA class I gene which expresses a product serologically
similar to HLA-Cw7 but which does not map within the corresponding locus.
------------------------------------------------------------------------------------------------------------------------------------------------
Duyk GM, Kim SW, Myers RM, Cox DR.
Department of Pediatrics, University of California, San Francisco 94143-0554.
Exon trapping: a genetic
screen to identify candidate transcribed sequences in cloned mammalian genomic
DNA.
Proc Natl Acad Sci U S A. 1990 Nov:
87(22): 8995-9.
Identification and recovery of transcribed sequences from cloned mammalian
genomic DNA remains an important problem in isolating genes on the basis of
their chromosomal location. We have developed a strategy that facilitates the
recovery of exons from random pieces of cloned genomic DNA. The basis of this "exon
trapping" strategy is that, during a retroviral life cycle, genomic sequences of
nonviral origin are correctly spliced and may be recovered as a cDNA copy of the
introduced segment. By using this genetic assay for cis-acting sequences
required for RNA splicing, we have screened approximately 20 kilobase pairs of
cloned genomic DNA and have recovered all four predicted exons.
------------------------------------------------------------------------------------------------------------------------------------------------
Embury SH, Scharf SJ, Saiki RK,
Gholson MA, Golbus M, Arnheim N, Erlich HA.
Rapid prenatal diagnosis of sickle
cell anemia by a new method of DNA analysis.
N Engl J Med. 1987 Mar 12: 316(11): 656-61.
We have used a new method of DNA analysis for the rapid prenatal diagnosis of
sickle cell anemia in two fetuses at risk for this disease. This method of
detecting the sickle gene is a modification of standard restriction-enzyme
techniques and requires only a small amount of DNA. The first step involves a
200,000-fold enzymatic amplification of the specific beta-globin DNA sequences
that may carry the sickle mutation. This provides a sufficient quantity of DNA
for the analysis. Next, a short radiolabeled synthetic DNA sequence homologous
to normal beta A-globin gene sequences is hybridized to the amplified target
sequences. The hybrid "duplexes" are then digested sequentially with two
restriction endonucleases. The presence of beta A- or beta S-globin gene
sequences in the amplified target DNA from the patient determines whether the
beta A-hybridization probe anneals perfectly or with a single nucleotide
mismatch. This difference affects the restriction-enzyme digestion of the DNA
and the size of the resulting radiolabeled digestion products, which can be
distinguished by electrophoresis followed by autoradiography. This method is
sufficiently sensitive and rapid that the prenatal diagnosis of sickle cell
anemia can be made on the same day that the fetal DNA is made available. It can
also be applied to the diagnosis of hemoglobin C disease.
------------------------------------------------------------------------------------------------------------------------------------------------
Emrie PA, Jones C, Hofmann T, Fisher
JH. University of
Colorado Health Sciences Center, Department of Medicine, Denver 80206.
The coding sequence for the human
18,000-dalton hydrophobic pulmonary surfactant protein is located on chromosome
2 and identifies a restriction fragment length polymorphism.
Somat Cell Mol Genet. 1988 Jan:
14(1): 105-10.
The 18-kd hydrophobic pulmonary surfactant protein (PSP-B) is a developmentally
regulated protein which is important for normal lung function. A complementary
DNA probe for 221 NH2 terminal amino acids of PSP-B was used to determine the
chromosomal location of this gene and identify a restriction fragment length
polymorphism (RFLP). Southern blot hybridization to genomic DNA isolated from a
panel of human-CHO somatic cell hybrids unambiguously maps this gene to
chromosome 2. Human DNA cut with BamHI yields a RFLP with variable bands at 2.8
and 2.6 kb. Since there is a relative lack of polymorphic markers for chromosome
2, this sequence may be useful in linkage analysis.
------------------------------------------------------------------------------------------------------------------------------------------------
Erlich HA, Higuchi R, Lichtenwalter
K, Reynolds R, Sensabaugh G.
Reliability of the HLA-DQ alpha PCR-based
oligonucleotide typing system.
J Forensic Sci. 1990 Sep: 35(5):
1017-9.
------------------------------------------------------------------------------------------------------------------------------------------------
Estivill X, Scambler PJ, Wainwright
BJ, Hawley K, Frederick P, Schwartz M, Baiget M, Kere J, Williamson R, Farrall
M. Department of
Biochemistry and Molecular Genetics, St. Mary's Hospital Medical School,
University of London, England.
Patterns of polymorphism and linkage
disequilibrium for cystic fibrosis.
Genomics. 1987 Nov: 1(3): 257-63.
Four polymorphic markers that map within 80 kb of an HTF island which is
genetically very close to the cystic fibrosis locus have been identified. We
have analyzed the linkage disequilibrium between each of these markers and the
cystic fibrosis mutation in 89 families from four European countries, Denmark,
Finland, Spain, and Great Britain. Strong linkage disequilibrium between three
polymorphic sites and cystic fibrosis was observed. The markers on the J3.11
(D7S8) side of the HTF island show stronger disequilibrium than those on the met
side. Linkage disequilibrium between markers and disease alters the probability
that a person of a given haplotype is a carrier in some populations and helps to
identify regions of a sequence that are most likely to contain the cystic
fibrosis mutation.
------------------------------------------------------------------------------------------------------------------------------------------------
Farrall M, Law HY, Rodeck CH, Warren
R, Stanier P, Super M, Lissens W, Scambler P, Watson E, Wainwright B, et al.
First-trimester prenatal
diagnosis of cystic fibrosis with linked DNA probes.
Lancet. 1986 Jun 21: 1(8495):
1402-5.
Linkage analysis with cloned gene probes has shown that the mutation causing
cystic fibrosis is located in the middle of the long arm of chromosome 7.
First-trimester diagnosis of cystic fibrosis is reported in four informative
families and second-trimester diagnosis in one family with fetal DNA prepared
from chorionic villi, hybridised with the tightly linked DNA probes, pJ3.11 and
met. Risk calculations show that the expected false-negative and false-positive
rates are approximately 2% and 6%, respectively, for typical nuclear families
with one affected living child. Existing probes are sufficiently informative to
allow full diagnosis in about two-thirds of couples presenting with at least one
affected child. In half of the remainder, the inheritance of one parental mutant
chromosome can be deduced.
------------------------------------------------------------------------------------------------------------------------------------------------
Feener CA, Koenig M, Kunkel LM.
Division of Genetics,
Children's Hospital Harvard Medical School, Boston, Massachusetts 02115.
Alternative splicing of
human dystrophin mRNA generates isoforms at the carboxy terminus.
Nature. 1989 Apr 6: 338(6215): 509-11.
Dystrophin is the protein product of the Duchenne/Becker muscular dystrophy
locus. It has a relative molecular mass of 427,000 and is encoded by a large RNA
transcript processed from more than 65 exons spread over two million base pairs
of the human X chromosome. We have used the polymerase chain reaction to see
whether any of these exons are used alternatively in the different tissues that
express dystrophin. As reported for rat dystrophin, we find that the first exons
of the human dystrophin transcript is different in brain and muscle, indicating
that dystrophin expression could be differentially regulated in these tissues by
usage of distinct promoters. The 3' end of the dystrophin transcript can be
alternatively spliced to create numerous isoforms differing at their carboxyl
domains; this is the only domain of dystrophin that does not share any
similarity with the related cytoskeletal alpha-actinins. These alternative
transcripts yield dystrophin molecules which may interact with different
proteins of the tissues expressing dystrophin.
------------------------------------------------------------------------------------------------------------------------------------------------
Feldman GL, Williamson R, Beaudet
AL, O'Brien WE.
Prenatal diagnosis of cystic
fibrosis by DNA amplification for detection of KM-19 polymorphism.
Lancet. 1988 Jul 9: 2(8602): 102.
------------------------------------------------------------------------------------------------------------------------------------------------
Ferns GA, Galton DJ.
Haplotypes of the human
apoprotein AI-CIII-AIV gene cluster in coronary atherosclerosis.
Hum Genet. 1986 Jul: 73(3): 245-9.
Restriction fragment length polymorphisms of the apoprotein AI-CIII-AIV gene
cluster (on the long arm of chromosome 11) were investigated in a group of
Caucasian survivors of myocardial infarction, using genomic hybridisation
analysis. Four common haplotypes were identified at this locus, M1P1S1, M2P1S1,
M1P2S1, and M2P1S2; where M1 and M2 are the common and uncommon alleles defined
using the restriction enzyme MspI, P1 and P2 are the common and uncommon alleles
defined by the enzyme PstI, and S1 and S2 are the common and uncommon alleles
defined by the enzyme SstI. Seven genotype combinations were observed of
approximate frequencies; a/a 0.70 (33/47), a/d 0.15 (7/47), a/b 0.04 (2/47), d/d
0.04 (2/47), a/c 0.02 (1/47), b/c 0.02 (1/47), and c/d 0.02 (1/47). In contrast
the corresponding values for normotriglyceridaemic Caucasian controls, without a
personal or family history of atherosclerotic heart disease were; 0.83 (40/48),
0.02 (1/48), 0.06 (3/48), 0, 0.04 (2/48), 0.04 (2/48), and 0. The relative
incidence of the d haplotype, characterised by the presence of a cleavage site
for the enzyme SstI in the fourth exon of the ApoCIII gene, was significantly
higher in the patient group (P less than 0.01). However, because of the tight
linkage between the polymorphic loci studied, it was not possible to identify
haplotypes associated with any greater risk of premature atherosclerosis than
when the SstI polymorphism was considered in isolation.
------------------------------------------------------------------------------------------------------------------------------------------------
Fey MF, Wainscoat JS, Mukwala EC,
Falusi AG, Vulliamy TJ, Luzzatto L.
Department of Haematology, John Radcliffe Hospital, Oxford, UK.
A PvuII restriction
fragment length polymorphism of the glucose-6-phosphate dehydrogenase gene is an
African-specific marker.
Hum Genet. 1990 Apr: 84(5): 471-2.
The site of a PvuII restriction fragment length polymorphism (RFLP) of the human
glucose-6-phosphate dehydrogenase (G6PD) gene has been located in intron V, 60
bp upstream of G6PD exon VI. A population survey shows this RFLP to be specific
for African populations, with frequencies of the rarer allele (PvuII type 2 site
present) of 0.32-0.40 in Kenyans, Nigerians, Zambians, and West Indians. This
allele has not been found in the European, Asian and Middle Eastern populations
studied. Such population-specific markers may be useful in the study of
population affinities and may provide insight into prehistoric migrations of
peoples.
------------------------------------------------------------------------------------------------------------------------------------
Fojo SS, Beisiegel U, Beil U,
Higuchi K, Bojanovski M, Gregg RE, Greten H, Brewer HB Jr.
Molecular Disease Branch, National Heart, Lung and Blood Institute, Bethesda,
Maryland 20892.
Donor splice site mutation
in the apolipoprotein (Apo) C-II gene (Apo C-IIHamburg) of a patient with Apo
C-II deficiency.
J Clin Invest. 1988 Nov: 82(5):
1489-94.
The DNA, RNA, and protein of apo C-II have been analyzed in a patient with apo
C-II deficiency (apo C-IIHamburg). Markedly reduced levels of plasma and
intrahepatic C-II apolipoprotein were demonstrated by immunoblotting and
immunohistochemical analysis. Northern, slot blot, and in situ hybridization
studies revealed low levels of a normal-sized apo C-II mRNA. No major
rearrangement of the apo C-II gene was detected by Southern blotting. Sequence
analysis of apo C-II genomic clones revealed a G-to-C substitution within the
donor splice site of intron II. This base substitution resulted in the formation
of a new Dde I and loss of a Hph I restriction enzyme cleavage site.
Amplification of the mutant sequence by the polymerase chain reaction and
digestion with Dde I and Hph I restriction enzymes established that the patient
was homozygous for the G-to-C mutation. This is the initial report of the DNA
sequence of an abnormal apo C-II gene from a patient with deficiency of apo
C-II. We propose that this donor splice site mutation is the primary genetic
defect that leads to defective splicing and ultimately to an apo C-II deficiency
in this kindred.
------------------------------------------------------------------------------------------------------------------------------------------------
Forrest D, Onions D, Lees G, Neil JC.
Altered structure and
expression of c-myc in feline T-cell tumours.
Virology. 1987 May: 158(1): 194-205.
The c-myc gene is rearranged in a subset of feline T-cell lymphosarcomas.
Detailed mapping of c-myc rearrangements showed that some result from feline
leukaemia virus (FeLV) proviral integration within or upstream of c-myc, but one
case involves a complex 3' alteration and amplification which is apparently not
directly virus-induced. S1 nuclease mapping of RNA from normal cells using c-myc
probes revealed two presumptive 5' ends, each corresponding to a promoter-like
sequence (P1 and P2), and a major 3' discontinuity which mapped to the 3'-most
of two possible polyadenylation signals. Analysis of RNA from a series of
tumours revealed different modes of c-myc expression. All tumours produced P1
and P2 transcripts with apparently normal structure except for one case where an
insertion in intron 1 displaced exon 1 sequences. The abundance ratio of P1/P2
transcripts varied considerably and was high in tumours which carry a
rearrangement adjacent to c-myc, but some other T-cell tumours with no apparent
myc alteration displayed an equally high ratio. However, a consistent feature
was the lack of detectable RNA from normal c-myc alleles in tumours which
express a rearranged c-myc allele or a transduced FeLV v-myc gene. We suggest
that this may prove to be a useful indicator of the presence of an oncogenically
active myc gene, whether this is a rearranged c-myc or transduced v-myc
sequence.
------------------------------------------------------------------------------------------------------------------------------------------------
Fournier D, Karch F, Bride JM, Hall
LM, Berge JB, Spierer P.
INRA, Centre de Recherche d'Antibes, France.
Drosophila melanogaster
acetylcholinesterase gene. Structure, evolution and mutations.
J Mol Biol. 1989 Nov 5: 210(1):
15-22.
Acetylcholinesterase is a key component of cholinergic neurotransmission. In
Drosophila melanogaster, acetylcholinesterase is encoded by the Ace locus. We
have determined the complete organization of the locus. The transcription unit
is 34 kb (1 kb = 10(3) bases) long and encompasses ten exons. We have mapped the
5' end of the transcript, sequenced all the intron/exon boundaries, as well as
the 3' end of the transcript. The deduced mature transcript is 4291 nucleotides
long without poly(A). Sequencing of the promoter region reveals a potential TATA
box and (GA)n motives. The Drosophila coding sequence is more split than its
vertebrate counterparts, but the splicing sites of the two last exons are
precisely conserved among Drosophila and vertebrate cholinesterases, and
intriguingly also with the bovine thyroglobulin gene. Finally, a number of the
mutations isolated in earlier genetic work are precisely placed on our molecular
map in introns, exons and promoter regions. Among them, for example, a short
deletion known to affect acetylcholinesterase level and tissue distribution
removes promoter regions and the first non-coding exon.
------------------------------------------------------------------------------------------------------------------------------------------------
Freedenberg DL, Chen SH, Kurachi K,
Scott CR.
MspI polymorphic site
within the factor IX gene. Localization of the site and an improved method for
detection.
Hum Genet. 1987 Jul: 76(3): 262-4.
We have localized the position of the MspI polymorphic site that exists within
the factor IX gene. The location of the MspI polymorphic site is within intron
D, 1.9 kb upstream from the beginning of exon V and 4 kb downstream from a known
polymorphic TaqI site. The use of a specific genomic probe simplifies the
interpretation of the MspI polymorphism by reducing the number of non-overlaping
DNA fragments to three bands; 2.4, 3.4, and 5.8 kb.
------------------------------------------------------------------------------------------------------------------------------------------------
Frossard PM, Coleman RT, Lim DW.
BanI dimorphic site in the third
intron of the human apolipoprotein AI gene (Apo A1).
Nucleic Acids Res. 1987 Jan 12:
15(1): 381.
------------------------------------------------------------------------------------------------------------------------------------------------
Fugger L, Morling N, Ryder LP, Odum
N, Georgsen J, Svejgaard A.
Department of Clinical Immunology, State University Hospital (Rigshospitalet),
Copenhagen, Denmark.
Typing for HLA-DPB1*03 and
HLA-DPB1*06 using allele-specific DNA in vitro amplification and allele-specific
oligonucleotide probes. Detection of "new" DPB1*06 variants.
Immunogenetics. 1989: 30(3): 208-13.
DP gene typing using in vitro DNA amplification combined with sequence-specific
oligonucleotide probes has recently been reported. The resulting DNA
amplification was specific for the HLA-DPB locus. Typing for the individual DPB
alleles was exclusively dependent on the hybridizations of the probes but
hampered by close sequence homology between different DP alleles yielding
complex patterns of reactivity with a panel of probes. We report the combined
use of allele-specific DNA in vitro amplification and allele-specific
oligonucleotides in typing for DPB1*03 and DPB1*06. Complete concordance with
PLT typing was observed for the DPB1*03 alleles, while in the DPB1*06 group, at
least three variant DPB1*06 alleles were identified which have not been
described previously.
------------------------------------------------------------------------------------------------------------------------------------------------
Fujisaku A, Harley JB, Frank MB,
Gruner BA, Frazier B, Holers VM.
Arthritis and Immunology Program, Oklahoma Medical Research Foundation, Oklahoma
City.
Genomic organization and
polymorphisms of the human C3d/Epstein-Barr virus receptor.
J Biol Chem. 1989 Feb 5: 264(4): 2118-25.
The human C3d/Epstein-Barr virus receptor (CR2/CD21) is a 145-kDa protein
primarily expressed on mature B lymphocytes. CR2 is a member of the regulators
of complement activation (RCA) gene family found on band q32 of chromosome 1.
The RCA proteins are characterized by the presence of 60-70 amino acid short
consensus repeats (SCR). A full length CR2 cDNA was cloned and used to identify
overlapping cosmid genomic clones. Analysis of CR2 exon-intron junctions
revealed the presence of three types of exons in the short consensus repeat
region of CR2. First, four exons each of which encodes two SCR are present. Five
exons encode a single SCR. Six exons encode SCRs which are split in identical
positions. The order of these types of exons is in a repeated array of four SCRs,
indicating that the contemporary CR2 gene likely evolved from a more primitive
gene containing four SCRs. The CR2 full length cDNA clone was used to find
restriction fragment length polymorphisms (RFLPs). Restriction enzyme TaqI
generated 2.55- and 2.10-kilobase (kb) polymorphic bands. This RFLP was mapped
near the exon containing the first two SCRs. HaeIII digestion generated
polymorphic bands of 1.45, 1.55, and 1.75 kb. The HaeIII 1.45-kb RFLP band maps
near the exon containing the 15th SCR. The TaqI and HaeIII RFLPs will provide
tools for the genetic analysis of CR2. The organization of the CR2 gene provides
insights into the evolution of human CR2 and the RCA gene family.
------------------------------------------------------------------------------------------------------------------------------------------------
Funke H, Klug J, Frossard P,
Kowalski J, Reckwerth A, Assmann G.
Detection of a new Msp I
restriction fragment length polymorphism in the apolipoprotein A-I gene.
J Clin Chem Clin Biochem. 1987 Mar:
25(3): 131-4.
We report the existence of a Msp I restriction fragment length polymorphism in
the first intron of the apolipoprotein A-I gene that is different from the one
described by Seilhamer et al. (DNA 3, 309 (1984)). Size comparison of the newly
discovered Msp I fragment with a restriction map of the apolipoprotein A-I gene
revealed that most likely the cutting site at the 5'-end of the normally seen
673 bp fragment is lost giving rise to the observed 719 bp Msp I fragment. Based
on analyses of 136 DNAs of healthy and non-related caucasians the allelic
frequency was determined to be 0.06. The observed Msp I genotype frequencies are
in Hardy-Weinberg equilibrium.
------------------------------------------------------------------------------------------------------------------------------------------------
Gaitskhoki VS, Voronina OV, Potapova
OYu, Kirjukhina LV, Gembitskaya TE, Kapranov NI, Petrova NV, Khafizova ZA,
Schwartz EI. Institute
for Experimental Medicine, Russian Academy of Medical Sciences, St. Petersburg.
Linkage disequilibrium
between cystic fibrosis mutations and polymorphic 4-bp repeat within CFTR gene.
Biochem Med Metab Biol. 1993 Oct:
50(2): 186-9.
The PCR technique was used in a study of the linkage of cystic fibrosis
mutations and a polymorphic (GATT)n repeat in intron 6 of the CFTR gene.
Absolute linkage disequilibrium was found between the common delta F-508
mutation and the (GATT)6 allele. This allele was also in linkage disequilibrium
with other unidentified mutations in the CFTR gene resulting in the pancreatic
insufficient form of disease. The frequency of (GATT)n alleles in the pancreatic
sufficient form of CF did not differ significantly from the data obtained in the
total population. The significance of the (GATT)n polymorphic repeat for the
diagnosis of CF is discussed.
------------------------------------------------------------------------------------------------------------------------------------------------
Gatti RA, Shaked R, Mohandas TK,
Salser W. Department of
Pathology, University of California at Los Angeles.
Human ferritin genes:
chromosomal assignments and polymorphisms.
Am J Hum Genet. 1987 Oct: 41(4): 654-67.
The ferritins are a family of proteins that function intracellularly to
sequester iron that otherwise would be toxic to the cell. The molecules are
comprised of 24 heavy and light subunits, the heavy:light ratio varying widely
in a tissue-specific manner. We cloned DNA sequences for both the heavy
(HL217-1) and light (HL227) subunits from a cDNA library derived from messages
that are strongly regulated during in vitro-induced differentiation of a
promyelocytic leukemia cell line, HL-60, into either neutrophils or macrophages.
The heavy-subunit family (FTH) includes 15-20 genes and/or pseudogenes; the
light-subunit family (FTL) includes at least three genes. We have confirmed and
extended the chromosomal localization of the heavy-subunit "genes" to
chromosomes 1-6, 8, 9, 11, 13, 14, 17, and X. We have also identified and
characterized two genetic polymorphisms: FTH/BamHI and FTH/TaqI. FTH/BamHI
localizes to chromosome 3, is biallelic, and has a heterozygosity frequency of
.39, a minor allele frequency of .33, and a polymorphic information content (PIC)
of .34. FTH/TaqI is measured by the presence or absence of a single 6-kb
fragment that is absent (i.e., "homozygosity" being presumed) in approximately
63% of Caucasians (PIC = .27). We discuss the possibility that gene-family
probes that hybridize to many discrete members of dispersed gene families could
be used in conjunction with pulsed- or inverted-field gels to screen a large
number of specific genomic regions for microdeletions.
------------------------------------------------------------------------------------------------------------------------------------------------
Geisel J, Weisshaar B, Oette K,
Doerfler W. Abteilung
fur Klinische Chemie, Universitat zu Koln.
A new Apa LI restriction
fragment length polymorphism in the low density lipoprotein receptor gene.
J Clin Chem Clin Biochem. 1988 Jul:
26(7): 429-33.
The existence of a new Apa LI restriction fragment length polymorphism in the
third intron of the low density lipoprotein (LDL) receptor gene was described.
As a gene probe we used a newly constructed derivative of pLDLR 3 which did not
contain the highly repetitive Alu-sequences in exon 18. This new gene probe
detected all exon sequences containing restriction fragments, and enabled us to
demonstrate all described polymorphisms, which might be useful for genetic
linkage studies. Based on analysis of 72 unrelated normo- and
hypercholesterolaemic persons, the frequency of the allele A2, which showed the
additional cutting site, was determined to be 0.05. With the simplified gene
probe, pLDLR delta, we also studied other polymorphisms. A clear linkage
disequilibrium between the Pvu II and Msp I polymorphisms was detected. This,
and the previously described linkage disequilibrium of the two Msp I
polymorphisms, demonstrate that the LDL receptor gene is apparently less
heterogeneous than expected from the number of described polymorphisms.
------------------------------------------------------------------------------------------------------------------------------------------------
Giannelli F, Anson DS, Choo KH, Rees
DJ, Winship PR, Ferrari N, Rizza CR, Brownlee GG.
Characterisation and use
of an intragenic polymorphic marker for detection of carriers of haemophilia B
(factor IX deficiency).
Lancet. 1984 Feb 4: 1(8371): 239-41.
DNA from 33 healthy White subjects was analysed with a 2 X 5 kilobase subgenomic
DNA probe derived from the gene for coagulation factor IX, containing the exon
"d" region of that gene. Intragenic Taq I restriction-fragment length
polymorphism was revealed, with allelic frequencies estimated at 0 X 65 and 0 X
35 (SE = 0 X 06), also detectable by a cDNA probe. The genomic DNA probe is
technically superior to the cDNA probe and has been used in three families with
haemophilia B (factor IX deficiency). The polymorphic marker segregates with the
deleterious mutation, allowing the identification or exclusion of carriers. The
allelic frequencies of the Taq I polymorphism are virtually ideal. Therefore,
such a polymorphism should be helpful both in genetic counselling of
approximately 40% of affected families and in prenatal diagnosis.
------------------------------------------------------------------------------------------------------------------------------------------------
Gibbs RA, Nguyen PN, McBride LJ,
Koepf SM, Caskey CT.
Baylor College of Medicine, Houston, TX.
Identification of
mutations leading to the Lesch-Nyhan syndrome by automated direct DNA sequencing
of in vitro amplified cDNA.
Proc Natl Acad Sci U S A. 1989 Mar: 86(6): 1919-23.
The Lesch-Nyhan (LN) syndrome is a
severe X chromosome-linked disease that results from a deficiency of the purine
salvage enzyme hypoxanthine phosphoribosyltransferase (HPRT). The mutations
leading to the disease are heterogeneous and frequently arise as de novo events.
We have identified nucleotide alterations in 15 independently arising HPRT-deficiency
cases by direct DNA sequencing of in vitro amplified HPRT cDNA. We also
demonstrate that the direct DNA sequence analysis can be automated, further
simplifying the detection of new mutations at this locus. The mutations include
DNA base substitutions, small DNA deletions, a single DNA base insertion, and
errors in RNA splicing. The application of these procedures allows DNA diagnosis
and carrier identification by the direct detection of the mutant alleles within
individual families affected by LN.
------------------------------------------------------------------------------------------------------------------------------------------------
Gibson JB, Wilks AV.
Research School of Biological Sciences, Australian National University,
Canberra.
Molecular structure of a
naturally occurring alcohol dehydrogenase null activity allele in Drosophila
melanogaster.
Biochem Genet. 1989 Dec: 27(11-12): 679-88. Erratum in: Biochem Genet 1990 Aug:
28(7-8): 443.
An alcohol dehydrogenase null activity allele, AdhnAH52, extracted from a
natural population of Drosophila melanogaster has been cloned and sequenced.
Compared with the wild-type consensus sequence, the nucleotide sequence of
AdhnAH52 contains eight extra bases in intron 2, adjacent to the 5' splice site.
It seems likely that the extra bases result from two structural changes, with a
10-base pair insertion at the same site as a 2-base pair deletion. The insertion
includes an 8-base pair duplication of an adjoining region. This structural
change alters transcription to give rise to an mRNA which is longer than normal
and at 10% of the wild-type level.
------------------------------------------------------------------------------------------------------------------------------------------------
Gitschier J, Drayna D, Tuddenham EG,
White RL, Lawn RM.
Genetic mapping and
diagnosis of haemophilia A achieved through a BclI polymorphism in the factor
VIII gene.
Nature. 1985 Apr 25-May 1:
314(6013): 738-40.
Haemophilia A is the most common inherited bleeding disorder in man, affecting
approximately 1 male in 10,000. The disease is caused by a deficiency in the
gene for factor VIII, a component of the intrinsic coagulation pathway. Due to
the broad range of clotting activity in normal and heterozygous females, it is
often difficult to confirm the status of women at risk for carrying the disease.
A genetic marker in the form of a restriction fragment length polymorphism (RFLP)
within or tightly linked to the factor VIII gene would serve as a tag for the
haemophilia gene, thus allowing both accurate carrier detection and improved,
earlier prenatal diagnosis by chorionic villi sampling. The recent isolation of
the factor VIII gene has allowed a search for RFLPs within the gene, and we
report here the identification of a common polymorphism within the factor VIII
gene, revealed by the restriction enzyme BclI, which can be used diagnostically
in about 42% of all families. Although the disease haemophilia A has been mapped
to the distal portion of Xq, the BclI RFLP makes possible higher-resolution
genetic linkage mapping with respect to other polymorphic markers on this
portion of the X chromosome. We have established close linkage of the factor
VIII gene to several useful RFLP markers, including the highly informative
marker St14. These markers should also be useful for prenatal diagnosis of
haemophilia A and for detection of its carriers.
------------------------------------------------------------------------------------------------------------------------------------
Gitschier J, Kogan S, Levinson B,
Tuddenham EG. Howard
Hughes Medical Institute, University of California, San Francisco 94143.
Mutations of factor VIII
cleavage sites in hemophilia A.
Blood. 1988 Sep: 72(3): 1022-8.
Hemophilia A is caused by a defect in coagulation factor VIII, a protein that
undergoes extensive proteolysis during its activation and inactivation. To
determine whether some cases of hemophilia are caused by mutations in important
cleavage sites, we screened patient DNA samples for mutations in these sites by
a two-step process. Regions of interest were amplified from genomic DNA by
repeated rounds of primer-directed DNA synthesis. The amplified DNAs were then
screened for mutations by discriminant hybridization using oligonucleotide
probes. Two cleavage site mutations were found in a survey of 215 patients. A
nonsense mutation in the activated protein C cleavage site at amino acid 336 was
discovered in a patient with severe hemophilia. In another severely affected
patient, a mis-sense mutation results in a substitution of cysteine for arginine
in the thrombin activation site at amino acid 1689. This defect is associated
with no detectable factor VIII activity, but with normal levels of factor VIII
antigen. The severe hemophilia in this patient was sporadic; analysis of the
mother suggested that the mutation originated in her gametes or during her
embryogenesis. The results demonstrate that this approach can be used to
identify factor VIII gene mutations in regions of the molecule known to be
important for function.
------------------------------------------------------------------------------------------------------------------------------------
Gotoda T, Senda M, Murase T, Yamada
N, Takaku F, Furuichi Y.
Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo,
Japan.
Gene polymorphism identified by
PvuII in familial lipoprotein lipase deficiency.
Biochem Biophys Res Commun. 1989 Nov 15: 164(3): 1391-6.
We previously demonstrated that the PvuII polymorphism is a useful marker to
analyze the genetic defects in familial lipoprotein lipase (LPL) deficiency. In
this study, we have mapped this polymorphic site and cloned the gene fragments
containing this site from a patient and a normal subject. Comparative sequence
analysis revealed that a C-T transition occurred in the gene of the patient at
the PvuII site in the intron 6. Interestingly, the sequence near the PvuII site
showed a significant homology to the consensus sequence of the 3' splice site.
In addition, the insertional event into the human LPL gene, which was recently
reported for a population of Caucasian patients, was not observed for eight
unrelated Japanese patients, suggesting that genetic defects underlying familial
LPL deficiency should be heterogeneous among races.
------------------------------------------------------------------------------------------------------------------------------------------------
Graham JB, Kunkel GR, Tennyson GS,
Lord ST, Fowlkes DM.
Department of Pathology, School of Medicine, University of North Carolina,
Chapel Hill 27599.
The Malmo polymorphism of
factor IX: establishing the genotypes by rapid analysis of DNA.
Blood. 1989 Jun: 73(8): 2104-7.
A DNA polymorphism in the coding region of coagulation factor IX--potentially
valuable for carrier detection, prenatal diagnosis, and population studies--was
described in 1985. It had been discovered with monoclonal antibodies that
distinguish between threonine and alanine as the 148th residue of the peptide.
Its use as a diagnostic tool has been limited because threonine-containing
factor IX (Malmo A) is dominant to alanine-containing factor IX (Malmo B) in
immunoassays of plasma; therefore, detection of Malmo heterozygotes is not
possible in all instances. A DNA method for recognizing all heterozygotes has
been developed, but it also has limitations. We report the development of
another DNA procedure based on amplification of the relevant DNA with the
polymerase chain reaction (PCR). This method is quick, avoids the use of
isotopes and x-ray film, and specifically identifies all the Malmo genotypes:
hemizygotes, homozygotes, and heterozygotes. The procedure can be performed
satisfactorily on small samples of blood (less than 1 mL) as suggested by Kogan
et al (N Engl J Med 317:985, 1987). The method described is applicable to any
genetic polymorphism that overlaps a restriction enzyme recognition site.
------------------------------------------------------------------------------------------------------------------------------------------------
Grandchamp B, Picat C, Mignotte V,
Wilson JH, Te Velde K, Sandkuyl L, Romeo PH, Goossens M, Nordmann Y.
Laboratoire de Genetique Moleculaire, Faculte de Medecine X, Paris, France.
Tissue-specific splicing
mutation in acute intermittent porphyria.
Proc Natl Acad Sci U S A. 1989 Jan:
86(2): 661-4.
An inherited deficiency of porphobilinogen deaminase [porphobilinogen ammonia-lyase
(polymerizing), EC 4.3.1.8] in humans is responsible for the autosomal dominant
disease acute intermittent porphyria. Different classes of mutations have been
described at the protein level suggesting that this is a heterogeneous disease.
It was previously demonstrated that porphobilinogen deaminase is encoded by two
distinct mRNA species expressed in a tissue-specific manner. Analysis of the
genomic sequences indicated that these two mRNAs are transcribed from two
promoters and only differ in their first exon. The first mutation identified in
the human porphobilinogen deaminase gene is a single-base substitution (G----A)
in the canonical 5' splice donor site of intron 1. This mutation leads to a
particular subtype of acute intermittent porphyria characterized by the
restriction of the enzymatic defect to nonerythropoietic tissues. Hybridization
analysis using oligonucleotide probes after in vitro amplification of genomic
DNA offers another possibility of detecting asymptomatic carriers of the
mutation in affected families.
------------------------------------------------------------------------------------------------------------------------------------------------
Greenberg A, Hijazzi M, Sharir H,
Cohen L, Bergman Y, Ber R, Laskov R.
Hubert H. Humphrey Center for Experimental Medicine and Cancer Research,
Hadassah Medical School, Jerusalem, Israel.
Extinction of expression of the
translocated myc gene in somatic cell hybrids between mouse myeloma and L-cells.
Int J Cancer. 1989 Jan 15: 43(1):
87-92.
Most murine plasma-cell tumors show a t(12;15) reciprocal chromosomal
translocation which truncates the first exon of one of the myc gene alleles and
fuses it to one of the switch regions of the immunoglobulin (Ig) heavy-chain
locus. This results in constitutive activation of the translocated myc gene and
the production of smaller-sized mRNA molecules, which are initiated at new sites
in the first myc intron. The normal myc allele is not expressed in these myeloma
cells. We have studied the expression of the translocated myc gene in somatic
cell hybrids between mouse myeloma and L-cells. Our previous findings show that
Ig gene expression is extinguished in such hybrids. In the present work we found
that the hybrids contain the normal and translocated myc genes. In contrast to
the myeloma parental cells which express the translocated myc gene, the hybrids
are similar to the L-cells in expressing only the normal myc allele. Our results
suggest that the L-cell, fibroblast-like phenotype, is dominant in these
hybrids, and show that the translocated myc gene is expressed in a
tissue-specific manner in the context of the myeloma cell, and is not expressed
when subjected to a fibroblast-like cellular environment.
------------------------------------------------------------------------------------------------------------------------------------------------
Griffiths LR, Zwi MB, McLeod JG,
Nicholson GA. Department
of Medicine, University of Sydney, Australia.
Chromosome I linkage
studies in Charcot-Marie-Tooth neuropathy type I.
Am J Hum Genet. 1988 May: 42(5):
756-71.
Charcot-Marie-Tooth neuropathy type 1 (CMT1) is an autosomal dominant disorder
of peripheral nerve. The gene for CMT1 was originally localized to chromosome 1
by linkage to the Duffy blood group, but it has since been shown that not all
CMT1 pedigrees show this linkage. We report here the results of linkage studies
using five chromosome 1 markers--Duffy (Fy), antithrombin III (AT3), renin (REN),
beta-nerve growth factor (NGFB), and salivary amylase (AMY1)--in 16 CMT1
pedigrees. The total lod scores exclude close linkage of CMT1 to any of these
markers. However, individual families show probable linkage of CMT1 to Duffy,
AT3, and/or AMY1. No linkage was indicated with REN or NGFB. These results
indicate the possible location of a CMT1 gene between the AMY1 and AT3 loci at
p21 and q23, respectively, on chromosome 1 and support the theory that there is
at least one other CMT1 gene.
------------------------------------------------------------------------------------------------------------------------------------------------
Gusella JF, Jones C, Kao FT, Housman
D, Puck TT.
Genetic fine-structure
mapping in human chromosome 11 by use of repetitive DNA sequences.
Proc Natl Acad Sci U S A. 1982 Dec:
79(24): 7804-8.
A method is described for mapping of the DNA fragments of a human chromosome
produced by restriction enzyme treatment of the total DNA from a hybrid cell
containing a single human chromosome. The method involves production and
selection of somatic cell mutants containing deletions of the human chromosome
and application of a hybridization probe consisting of an individual member copy
of a repetitive human DNA family. A linear map has been constructed of 19 marker
DNA fragments and 5 immunological and biochemical markers on human chromosome
11, selected as a model chromosome for these studies. This approach appears to
be widely applicable, is independent of cytogenetic analysis, promises to be
capable of revealing the existence of rearrangements as well as deletions,
appears to be amenable to further increase in resolving power, and offers
potential application in various human genetic problems.
------------------------------------------------------------------------------------------------------------------------------------------------
Gusella JF, Wexler NS, Conneally PM,
Naylor SL, Anderson MA, Tanzi RE, Watkins PC, Ottina K, Wallace MR, Sakaguchi
AY, et al.
A polymorphic DNA marker
genetically linked to Huntington's disease.
Nature. 1983 Nov 17-23: 306(5940):
234-8.
Family studies show that the Huntington's disease gene is linked to a
polymorphic DNA marker that maps to human chromosome 4. The chromosomal
localization of the Huntington's disease gene is the first step in using
recombinant DNA technology to identify the primary genetic defect in this
disorder.
------------------------------------------------------------------------------------------------------------------------------------------------
Gyllensten UB, Erlich HA.
Department of Human Genetics, Cetus Corporation, Emeryville, CA 94608.
Generation of
single-stranded DNA by the polymerase chain reaction and its application to
direct sequencing of the HLA-DQA locus.
Proc Natl Acad Sci U S A. 1988 Oct:
85(20): 7652-6.
Single-copy sequences can be enzymatically amplified from genomic DNA by the
polymerase chain reaction. By using unequal molar amounts of the two
amplification primers, it is possible in a single step to amplify a single-copy
gene and produce an excess of single-stranded DNA of a chosen strand for direct
sequencing or for use as a hybridization probe. Further, individual alleles in a
heterozygote can be sequenced directly by using allele-specific oligonucleotides
either in the amplification reaction or as sequencing primers. By using these
methods, we have studied the allelic diversity at the HLA-DQA locus and its
association with the serologically defined HLA-DR and -DQ types. This analysis
has revealed a total of eight alleles and three additional haplotypes. This
procedure has wide applications in screening for mutations in human genes and
facilitates the linking of enzymatic amplification of genes to automated
sequencing.
------------------------------------------------------------------------------------------------------------------------------------------------
Gyllensten UB, Erlich HA.
Department of Human Genetics, Cetus Corporation, Emeryville, CA 94608.
Ancient roots for
polymorphism at the HLA-DQ alpha locus in primates.
Proc Natl Acad Sci U S A. 1989 Dec:
86(24): 9986-90.
The genes encoding the human histocompatibility antigens (HLA) exhibit a
remarkable degree of polymorphism as revealed by immunologic and molecular
analyses. This extensive sequence polymorphism either may have been generated
during the lifetime of the human species or could have arisen before speciation
and been maintained in the contemporary human population by selection or,
possibly, by genetic drift. These two hypotheses were examined using the
polymerase chain reaction method to amplify polymorphic sequences from the DQ
alpha locus, as well as the DX alpha locus, an homologous but nonexpressed
locus, in a series of primates that diverged at known times. In general, the
amino acid sequence of a specific human DQ alpha allelic type is more closely
related to its chimpanzee or gorilla counterpart than to other human DQ alpha
alleles. Phylogenetic analysis of the silent nucleotide position changes shows
that the similarity of allelic types between species is due to common ancestry
rather than convergent evolution. Thus, most of the polymorphism at the DQ alpha
locus in the human species was already present at least 5 million years ago in
the ancestral species that gave rise to the chimpanzee, gorilla, and human
lineages. However, one of the DQ alpha alleles may have arisen after speciation
by recombination between two ancestral alleles.
------------------------------------------------------------------------------------------------------------------------------------------------
Haber DA, Buckler AJ, Glaser T, Call
KM, Pelletier J, Sohn RL, Douglass EC, Housman DE.
Center for Cancer Research, Massachusetts Institute of Technology, Cambridge
02139.
An internal deletion
within an 11p13 zinc finger gene contributes to the development of Wilms' tumor.
Cell. 1990 Jun 29: 61(7): 1257-69.
We have recently described the isolation of a candidate for the Wilms' tumor
susceptibility gene mapping to band p13 of human chromosome 11. This gene,
primarily expressed in fetal kidney, appears to encode a DNA binding protein. We
now describe a sporadic, unilateral Wilms' tumor in which one allele of this
gene contains a 25 bp deletion spanning an exon-intron junction and leading to
aberrant mRNA splicing and loss of one of the four zinc finger consensus domains
in the protein. The mutation is absent in the affected individual's germline,
consistent with the somatic inactivation of a tumor suppressor gene. In addition
to this intragenic deletion affecting one allele, loss of heterozygosity at loci
along the entire chromosome 11 points to an earlier chromosomal nondisjunction
and reduplication. We conclude that inactivation of this gene, which we call
WT1, is part of a series of events leading to the development of Wilms' tumor.
------------------------------------------------------------------------------------------------------------------------------------------------
Hamada H, Petrino MG, Kakunaga T.
Molecular structure and
evolutionary origin of human cardiac muscle actin gene.
Proc Natl Acad Sci U S A. 1982 Oct: 79(19): 5901-5.
Two recombinant phages that contain cardiac muscle actin gene were isolated from
a human DNA library and their structures were determined. Restriction analysis
indicates that both clones carry the same EcoRI 13-kilobase fragment where the
coding sequence is mapped. The cloned DNA hybridized with polyadenylylated RNA
from human fibroblasts, which directs the synthesis of cytoplasmic beta- and
gamma-actin in vitro. However, sequence determination of the cloned DNA showed
that the entire coding sequence perfectly matched the amino acid sequence of
cardiac muscle actin. The initiation codon is followed by a cysteine codon that
is not found at the amino-terminal site of any actin isoform, suggesting the
necessity of post-translational processing for in vivo actin synthesis. There
are five introns interrupting exons at codons 41/42, 150, 204, 267, and 327/328.
Surprisingly, these intron locations are exactly the same as those of the rat
skeletal muscle actin gene but different from those of nonmuscle beta-actin
gene. Nucleotide sequences of all exon/intron boundaries agree with the G-T/A-G
rule (G-T at the 5' and A-G at the 3' termini of each intron). The
3'-untranslated sequence has no homology to that of nonmuscle beta- or gamma-actin
gene, but Southern blot hybridization has shown that this region has
considerable homology to that of one of the other actin genes. These results
indicate that the recombinant phages, which we have isolated, contain cardiac
muscle actin gene and that cardiac muscle actin gene and skeletal muscle actin
genes are derived from their ancestor gene at a relatively recent time in
evolutionary development.
------------------------------------------------------------------------------------------------------------------------------------------------
Harper JF, Mages W.
Department of Biology, Washington University, St. Louis, MO 63130.
Organization and structure
of Volvox beta-tubulin genes.
Mol Gen Genet. 1988 Aug: 213(2-3): 315-24.
Genomic clones encoding two Volvox beta-tubulin genes have been isolated and
shown to represent the only two beta-tubulin genes in the genome. Restriction
fragment length polymorphism analysis was used to demonstrate that the two genes
are genetically linked. One of these genes was sequenced and the mRNA start
site(s) determined by primer extension. A comparison of its sequence to those of
the two beta-tubulin genes of Chlamydomonas revealed: (1) a high degree of
conservation of the coding region, with the predicted amino acid sequence
differing only in the C-terminal residue; (2) extensive sequence conservation in
the 5' untranslated leader region and a 16 bp (putative regulatory) sequence in
the promoter region; (3) the same number and location of introns, with a short
region of homology in intron 1, but little significant homology in introns 2 and
3.
------------------------------------------------------------------------------------------------------------------------------------Hastbacka
J, de la Chapelle A, Kaitila I, Sistonen P, Weaver A, Lander E. Department
of Medical Genetics, University of Helsinki, Finland.
Linkage disequilibrium
mapping in isolated founder populations: diastrophic dysplasia in Finland.
Erratum in:
Nat Genet 1992 Dec;2(4):343.
Linkage disequilibrium mapping in isolated populations provides a powerful
tool for fine structure localization of disease genes. Here, Luria and
Delbruck's classical methods for analysing bacterial cultures are adapted to
the study of human isolated founder populations in order to estimate (i) the
recombination fraction between a disease locus and a marker; (ii) the expected
degree of allelic homogeneity in a population; and (iii) the mutation rate of
marker loci. Using these methods, we report striking linkage disequilibrium
for diastrophic dysplasia (DTD) in Finland indicating that the DTD gene should
lie within 0.06 centimorgans (or about 60 kilobases) of the CSF1R gene.
Predictions about allelic homogeneity in Finland and mutation rates in simple
sequence repeats are confirmed by independent observations.
------------------------------------------------------------------------------------------------------------------------------------
Haugen A,
Mann D, Murray C, Weston A, Willey JC.
Laboratory of Human Carcinogenesis, National Cancer Institute, Bethesda,
Maryland.
Interleukin-1 alpha gene
intron containing variable repeat region coding for the SP1 transcription
factor recognition sequence is polymorphic.
Mol Carcinog.
1989: 2(2): 68-71.
Interleukin-1 alpha (IL-1 alpha) is a cytokine produced by a number of cell
types including macrophages, fibroblasts, keratinocytes, and mesangial cells.
We were interested in identifying a DNA restriction fragment length
polymorphism (RFLP) for the IL-1 alpha gene for use in studies of genetic
alteration in various human cancers. Human genomic DNA from 32 unrelated
individuals was digested with various restriction enzymes, alone and in
combination, and subjected to Southern blot analysis. Hybridization to
32P-labeled IL-1 alpha cDNA revealed an insertion-deletion-type polymorphic
pattern. After digestion with RsaI, insertion-deletion-type polymorphic bands
with sizes of 3.4 kb, 3.1 kb, and 2.8 kb and one invariant band of 0.8 kb were
observed. These three alleles, designated A1, A2, and A3, had relative
frequencies of 0.18, 0.06, and 0.78 with heterozygosity observed in 38% of the
unrelated individuals studied. Evaluation of nine related individuals for this
RsaI polymorphism was consistent with a Mendelian inheritance. Comparison of
restriction patterns following Southern analysis of DNA digested with several
different enzymes showed that the polymorphic region resides within the sixth
intron. Furthermore, this RFLP results from a variable length region
containing multiple copies of a recognition sequence for SP1, an imperfect
copy of viral enhancer elements, and an inverse and complementary sequence of
the glucocorticoid receptor binding site. The identified polymorphism may be
of value in analyses of chromosome 2 and may help to elucidate mechanisms by
which IL-1 alpha transcription is regulated.
------------------------------------------------------------------------------------------------------------------------------------
Hay CW,
Robertson KA, Yong SL, Thompson AR, Growe GH, MacGillivray RT.
Use of a BamHI
polymorphism in the factor IX gene for the determination of hemophilia B
carrier status.
Blood. 1986
May: 67(5): 1508-11.
A BamHI
polymorphism has been identified in the human factor IX gene. This
polymorphism, which occurs in approximately 6% of X chromosomes, has been used
to determine the carrier status of a female in a family with a history of
hemophilia B. This family was uninformative for the previously reported TaqI
and Xmnl polymorphisms in the factor IX gene.
Hejtmancik JF, Holcomb JD, Howard J,
Vanderford M. Institute
for Molecular Genetics, Baylor College of Medicine, Houston, Texas.
In vitro amplification of
the alpha 1-antitrypsin gene: application to prenatal diagnosis.
Prenat Diagn. 1989 Mar: 9(3):
177-86. Erratum in: Prenat Diagn 1989 Jul: 9(7): 534.
Discrimination of the M, Z, and S alleles of alpha 1-antritrypsin (AAT) has been
carried out using in vitro gene amplification with the polymerase chain reaction
(PCR). Amplification of 90 nucleotides surrounding the Z mutation site and 120
nucleotides surrounding the S mutation site dramatically improves the
sensitivity and reliability of allele-specific oligonucleotide (ASO)
hybridization for direct detection of these alleles. Analysis is performed using
Southern blots or dot blots hybridized with 19 base oligonucleotides and
differentially washed for allele specificity. Amplification of the Z and S
mutation sites can be combined in one PCR to allow detection of both mutations
when analysed by gel electrophoresis and Southern transfer. This technique can
be performed reliably using less than 0.1 micrograms of genomic DNA or less than
100 amniocytes or white blood cells. This technique has been used to perform
prenatal diagnosis on a chorionic villus sample (CVS) in a fetus at risk for the
ZZ Pi type form of AAT deficiency.
------------------------------------------------------------------------------------------------------------------------------------------------
Helentjaris T, Gesteland R.
Evaluation of random cDNA
clones as probes for human restriction fragment polymorphisms.
J Mol Appl Genet. 1983: 2(3):
237-47.
The purpose of this study was to evaluate the usefulness of randomly isolated
human cDNA clones as probes for human restriction fragment polymorphisms. Clones
were chosen from two human cDNA libraries and tested by hybridization against
Southern blots of genomic DNA prepared from nine individuals. Three types of
hybridization patterns were seen with the individual clones tested, those
representative of single copy genes, others representative of gene families, and
one characteristic of a mitochondrial gene. Only two of these cDNA clones
revealed any polymorphisms among the individuals tested: pDK-08 and RW12, both
representative of gene families. Both revealed independent polymorphisms with
several of the restriction enzymes tested, and inheritance of these
polymorphisms as Mendelian alleles was verified by human pedigree analysis. The
results are discussed with regard to the usefulness of such cDNA clones in
revealing polymorphisms in human genetic analysis.
------------------------------------------------------------------------------------------------------------------------------------------------
Helmuth R, Fildes N, Blake E, Luce
MC, Chimera J, Madej R, Gorodezky C, Stoneking M, Schmill N, Klitz W, et al.
Department of Human Genetics, Cetus Corporation, Emeryville, CA 94608.
HLA-DQ alpha allele and
genotype frequencies in various human populations, determined by using enzymatic
amplification and oligonucleotide probes.
Am J Hum
Genet. 1990 Sep: 47(3): 515-23. Comment in:
Am
J Hum Genet. 1991 Mar;48(3):636-7.
Allele and genotype frequencies at the HLA-DQ alpha locus have been determined
by the use of polymerase chain reaction (PCR) amplification and nonradioactive
oligonucleotide probes. The probes define six alleles and 21 genotypes in a
dot-blot format. A total of over 1,400 individuals from 11 populations has been
typed by two different laboratories using this method. In contrast to some
variable-number-of-tandem-repeat markers that have been used for identity
determination, DQ alpha genotype frequencies do not deviate significantly from
Hardy-Weinberg equilibrium in all populations studied. The distribution of
alleles varies significantly between most of these populations. In Caucasians,
the allele frequencies range from 4.3% to 28.5%. In this population, the power
of discrimination is .94, and, for paternity determination, the power of
exclusion is .642. These population data will allow the use of the HLA-DQ alpha
marker in paternity determination, the analysis of individual identity in
forensic samples, and anthropological studies.
------------------------------------------------------------------------------------------------------------------------------------------------
Herbert CJ, Dujardin G, Labouesse M,
Slonimski PP. Centre de
Genetique Moleculaire du CNRS, Laboratoire propre associe a l'Universite Pierre
et Marie Curie, Gif-sur-Yvette, France.
Divergence of the
mitochondrial leucyl tRNA synthetase genes in two closely related yeasts
Saccharomyces cerevisiae and Saccharomyces douglasii: a paradigm of incipient
evolution.
Mol Gen Genet. 1988 Aug: 213(2-3):
297-309.
We studied the NAM2 genes of Saccharomyces douglasii and Saccharomyces
cerevisiae, and showed that they are interchangeable for all the known functions
of these genes, both mitochondrial protein synthesis and mitochondrial mRNA
splicing. This confirms the prediction that the S. douglasii NAM2D gene encodes
the mitochondrial leucyl tRNA synthetase (EC 6.1.1.4.). The observation that
these enzymes are interchangeable for their mRNA splicing functions, even though
there are significant differences in the intron/exon structure of their
mitochondrial genome, suggests that they may have a general role in yeast
mitochondrial RNA splicing. A short open reading frame (ORF) precedes the
synthetase-encoding ORF, and we showed that at least in S. cerevisiae this is
not essential for the expression of the gene; however, it may be involved in a
more subtle type of regulation. Sequence comparisons of S. douglasii and S.
cerevisiae revealed a particularly interesting situation from the evolutionary
point of view. It appears that the two yeasts have diverged relatively recently:
there is remarkable nucleotide sequence conservation, with no deletions or
insertions, but numerous (albeit non-saturating) silent substitutions resulting
from transitions. This applies not only to the NAM2 coding regions, but also to
two other ORFs flanking the NAM2 ORF. The regions between the ORFs (believed to
be intergenic regions) are much less conserved, with several deletions and
insertions. Thus S. douglasii and S. cerevisiae provide an ideal system for the
study of molecular evolution, being two yeasts "caught in the act" of
speciation.
------------------------------------------------------------------------------------------------------------------------------------------------
Higuchi R, von Beroldingen CH,
Sensabaugh GF, Erlich HA.
Department of Human Genetics, Cetus Corporation, Emeryville, California 94608.
DNA typing from single
hairs.
Nature. 1988 Apr 7: 332(6164):
543-6.
The characterization of genetic variation at the DNA level has generated
significant advances in gene and disease mapping, and in the forensic
identification of individuals. The most common method of DNA analysis, that of
restriction fragment length polymorphism (RFLP), requires microgram amounts of
relatively undegraded DNA for multi-locus typing, and hundreds of nanograms for
single-locus comparisons. Such DNA frequently cannot be obtained from forensic
samples such as single hairs and blood stains, or from anthropological, genetic
or zoological samples collected in the field. To detect polymorphic DNA
sequences from single human hairs, we have used the polymerase chain reaction (PCR),
in which specific short regions of a gene can be greatly amplified in vitro from
as little as a single molecule of DNA. We have detected genetically variable
mitochondrial and nuclear DNA sequences from the root region of shed, as well as
freshly-plucked, single hairs; mitochondrial DNA (mtDNA) sequences have been
detected in a sample from a single hair shaft. We have used three different
means of DNA typing on these samples: the determination of amplified DNA
fragment length differences, hybridization with allele-specific oligonucleotide
probes, and direct DNA sequencing.
------------------------------------------------------------------------------------------------------------------------------------------------
Hill AV, Bowden DK, O'Shaughnessy
DF, Weatherall DJ, Clegg JB.
Nuffield Department of Clinical Medicine, University of Oxford, England.
Beta thalassemia in
Melanesia: association with malaria and characterization of a common variant
(IVS-1 nt 5 G----C).
Blood. 1988 Jul: 72(1): 9-14.
Data on the distribution of beta thalassemia among over 6,000 Melanesians
reveals a major difference in the carrier rates between populations in the
malarious coastal regions of New Guinea and those living in the historically
malaria-free Highlands. The island of Maewo in Vanuatu has a particularly high
incidence of beta + thalassemia associated with a single restriction enzyme
haplotype. Direct cloning into a plasmid vector and sequence analysis
demonstrate that the mutation is a G to C transversion at position 5 of intron 1
of the beta-globin gene. Oligonucleotide probe surveys indicate that this
variant accounted for all cases of beta thalassemia studied from Maewo. It is
also common in coastal Papua New Guinea where haplotype and oligonucleotide
probe data suggest that the molecular basis of beta thalassmia is more
heterogeneous.
------------------------------------------------------------------------------------------------------------------------------------------------
Hixson JE, Cox LA, Borenstein S.
Department of Genetics, Southwest Foundation for Biomedical Research, San
Antonio, Texas 78284.
The baboon apolipoprotein
E gene: structure, expression, and linkage with the gene for apolipoprotein C-1.
Genomics. 1988 May: 2(4): 315-23.
To develop the baboon model for molecular genetic studies of atherosclerosis, we
have cloned and sequenced the baboon apolipoprotein E (apo E) gene. The baboon
apo E gene encodes the E4 isoform with respect to specific amino acid positions,
suggesting that the common epsilon 3 allele is not the primal human allele.
Rather than accumulating predominantly synonymous nucleotide changes, 50% of
substitutions in human and baboon apo E gene coding regions cause amino acid
substitutions. However, comparisons of these apo E proteins show conservation of
amphipathic helices required for apo E--lipid interactions. The human and baboon
apo E genes have diverged less extensively than those from rat and mouse,
providing further evidence for a slowing of molecular evolution in primate
species. The baboon and rhesus monkey apo E genes (intron 2) contain two Alu
repeats that are absent in the human gene, indicating insertion after the
divergence of human and cercopithecine lineages, but before the baboon/rhesus
divergence. S1 nuclease studies show that transcription of the baboon apo E gene
starts at two different positions, one of which corresponds to the human gene
start site. To examine linkage of apolipoprotein genes in the baboon genome, we
have used a human cDNA probe to detect apo C-I gene sequences approximately 4 kb
from the 3' end of the baboon apo E gene.
------------------------------------------------------------------------------------------------------------------------------------------------
Ho CK, Abelson J.
Division of Chemistry, California Institute of Technology, Pasadena, CA 91125.
Testing for intron
function in the essential Saccharomyces cerevisiae tRNA(SerUCG) gene.
J Mol Biol. 1988 Aug 5: 202(3):
667-72.
The gene sup61+, which codes for the essential Saccharomyces cerevisiae
tRNA(SerUCG), is the only single-copy tRNA gene in this organism know to contain
an intron. To assess the role of this intron in tRNA gene expression, an intron-deleted
sup61+ gene was constructed in vitro and introduced into the yeast genome.
Isogenic intron- and intron+ strains were found to be indistinguishable by
criteria that include growth rates, ability to undergo meiosis, levels of mature
tRNA(SerUCG) transcribed in vivo, and the suppressor efficiency of amber- and
ochre-specific alleles of this gene.
------------------------------------------------------------------------------------------------------------------------------------------------
Ho CK, Rauhut R, Vijayraghavan U,
Abelson J. Division of
Biology, California Institute of Technology, Pasadena 91125.
Accumulation of pre-tRNA
splicing '2/3' intermediates in a Saccharomyces cerevisiae mutant.
EMBO J. 1990 Apr: 9(4): 1245-52.
In an effort to identify genes involved in the excision of tRNA introns in
Saccharomyces cerevisiae, temperature-sensitive mutants were screened for
intracellular accumulation of intron-containing tRNA precursors by RNA
hybridization analysis. In one mutant, tRNA splicing intermediates consisting of
the 5' exon covalently joined to the intron ('2/3' pre-tRNA molecules) were
detected in addition to unspliced precursors. The mutant cleaves pre-tRNA(Phe)
in vitro at the 3' exon/intron splice site, generating the 3' half molecule and
2/3 intermediate. The 5' half molecule and intron are not produced, indicating
that cleavage at the 5' splice site is suppressed. This partial splicing
activity co-purifies with tRNA endonuclease throughout several chromatographic
steps. Surprisingly, the splicing defect does not appreciably affect cell growth
at normal or elevated temperatures, but does confer a pseudo cold-sensitive
phenotype of retarded growth at 15 degrees C. The mutant falls into the
complementation group SEN2 previously defined by the isolation of mutants
defective for tRNA splicing in vitro [Winey, M. and Culbertson, M.R. (1988)
Genetics, 118, 609-617], although its phenotypes are distinct from those of the
previous sen2 isolates. The distinguishing genetic and biochemical properties of
this new allele, designated sen2-3, suggests the direct participation of the
SEN2 gene product in tRNA endonuclease function.
------------------------------------------------------------------------------------------------------------------------------------
Hodges PE, Rosenberg LE.
Yale University School of Medicine, Department of Human Genetics, New Haven, CT
06510.
The spfash mouse: a
missense mutation in the ornithine transcarbamylase gene also causes aberrant
mRNA splicing.
Proc Natl Acad Sci U S A. 1989 Jun: 86(11): 4142-6.
Ornithine transcarbamylase (ornithine carbamoyltransferase;
carbamoyl-phosphate:L-ornithine carbamoyltransferase, EC 2.1.3.3) is a
mitochondrial matrix enzyme of the mammalian urea cycle. The X chromosome-linked
spfash mutation in the mouse causes partial ornithine transcarbamylase
deficiency and has served as a model for the human disease. We show here that
the spfash mutation is a guanine to adenine transition of the last nucleotide of
the fourth exon of the ornithine transcarbamylase gene. This nucleotide change
produces two remarkably different effects. First, this transition causes
ornithine transcarbamylase mRNA deficiency because the involved exon nucleotide
plays a part in the recognition of the adjacent splice donor site. As a result
of the mutation, ornithine transcarbamylase pre-mRNA is spliced inefficiently
both at this site and at a cryptic splice donor site 48 bases into the adjacent
intron. Second, two mutant proteins are translated from these mRNAs. From the
correctly spliced mRNA, the transition results in a change of amino acid 129
from arginine to histidine. This missense substitution has no discernable effect
on mitochondrial import, subunit assembly, or enzyme activity. On the other
hand, the elongated mRNA resulting from mis-splicing is translated into a
dysfunctional ornithine transcarbamylase subunit elongated by the insertion of
16 amino acid residues.
------------------------------------------------------------------------------------------------------------------------------------------------
Houwen RH, Baharloo S, Blankenship
K, Raeymaekers P, Juyn J, Sandkuijl LA, Freimer NB.
Wilhelmina Children's Hospital, Utrecht, The Netherlands.
Genome screening by
searching for shared segments: mapping a gene for benign recurrent intrahepatic
cholestasis.
Nat Genet. 1994 Dec: 8(4): 380-6.
It is now feasible to map disease genes by screening the genome for linkage
disequilibrium between the disease and marker alleles. This report presents the
first application of this approach for a previously unmapped locus. A gene for
benign recurrent intrahepatic cholestasis (BRIC) was mapped to chromosome 18 by
searching for chromosome segments shared by only three distantly related
patients. The screening results were confirmed by identifying an extended
haplotype conserved between the patients. Probability calculations indicate that
such segment sharing is unlikely to arise by chance. Searching the genome for
segments shared by patients is a powerful empirical method for mapping disease
genes. Computer simulations suggest that, in appropriate populations, the
approach may be used to localize genes for common diseases.
------------------------------------------------------------------------------------------------------------------------------------------------
Hsia YE, Ford CA, Shapiro LJ, Hunt
JA, Ching NS. Department
of Genetics, John A. Burns School of Medicine, University of Hawaii, Honolulu.
Molecular screening for
haemoglobin constant spring.
Lancet. 1989 May 6: 1(8645): 988-91.
Haemoglobin H/Constant Spring is an important cause of severe haemoglobin H
disease, but the Constant Spring protein is difficult to detect by
electrophoresis. A technique for allele specific polymerase chain amplification
of the 3'-end of the alpha 2 globin gene improved detection of the alpha cs
alpha haemoglobin variant in DNA samples by slot-blot hybridisation. The alpha
cs alpha mutation was confirmed in subjects that had been previously diagnosed
by haemoglobin electrophoresis, and it was also detected in patients who were
negative by protein electrophoresis. 10 of 103 unrelated Laotians with HbE were
alpha cs alpha heterozygotes. Of these, 3 were negative to the normal probe
because they had -alpha 3.7/alpha cs alpha with a single alpha globin deletion.
5 samples did not amplify or hybridise to either probe because they had
deletions of both alpha 2 globin regions. The gene frequency for alpha cs alpha
is about 0.05 for Laotians. This technique, which is highly specific and
sensitive for rapid detection of the alpha cs alpha mutation, is suitable for
clinical diagnoses and population studies. The true incidence of alpha cs alpha
may prove to be greater than previously suspected from protein electrophoresis.
------------------------------------------------------------------------------------------------------------------------------------------------
Huang LS, Ripps ME, Korman SH,
Deckelbaum RJ, Breslow JL.
Laboratory of Biochemical Genetics and Metabolism, Rockefeller University, New
York, New York 10021.
Hypobetalipoproteinemia
due to an apolipoprotein B gene exon 21 deletion derived by Alu-Alu
recombination.
J Biol Chem. 1989 Jul 5: 264(19):
11394-400.
We report the molecular defect in an
individual with homozygous hypobetalipoproteinemia. A unique TaqI restriction
fragment length polymorphism was found in the midportion of the apolipoprotein B
(apoB) gene using the genomic probe, pB51. The probe, which identifies TaqI
fragments of 8.4 and 2.8 kilobases (kb) in normal individuals, hybridized to a
single 11-kb fragment in the proband. The parents of the proband showed all
three TaqI fragments, implying that they are heterozygotes for the mutant apoB
allele. In this family, the mutant allele cosegregated with low total
cholesterol levels and formal linkage analysis gave a decimal logarithm of the
ratio score of 3.3 at a recombination frequency of 0. The polymorphic TaqI site
was localized to an EcoRI fragment of 4 kb in normal individuals. The
corresponding fragment in the proband was 3.4 kb, suggesting a 0.6-kb deletion
in the mutant allele. Both the normal 4-kb EcoRI fragment and the mutant 3.4-kb
EcoRI fragment were cloned and sequenced. In the normal allele, the 4-kb EcoRI
fragment extends from intron 20 to 23. Exon 21 is flanked by Alu sequences that
are in the same orientation. The mutant allele had a 694-bp deletion in this
region which included a small part of the Alu sequence in intron 20, the entire
exon 21, and most of the Alu sequence in intron 21. The polymorphic TaqI site,
which lies within the Alu sequence in intron 21, was absent in the proband as a
result of the deletion. The deletion of exon 21 results in a frame shift
mutation and the introduction of a stop codon. Translation of the encoded mRNA
would yield a prematurely terminated protein. This mutant apoB protein would be
1085 amino acids long with the 73 carboxyl-terminal residues out of frame. We
postulate that the deletion of exon 21 is the consequence of a crossover event
between the Alu sequences in introns 20 and 21 resulting in nonreciprocal
exchange between two chromosomes.
------------------------------------------------------------------------------------------------------------------------------------------------
Huang LS, Ripps ME, Breslow JL.
Laboratory of Biochemical Genetics and Metabolism, Rockefeller University, New
York, NY 10021.
Molecular basis of five
apolipoprotein B gene polymorphisms in noncoding regions.
J Lipid Res. 1990 Jan: 31(1): 71-7.
(Free Full Text Article)
Restriction fragment length polymorphisms (RFLPs) are useful in linkage and
clinical association studies of human diseases. In this report, we characterize
the molecular basis and frequencies of two new RFLPs, AvaII and BalI, two
previously reported RFLPs, HincII and PvuII, and one new sequence polymorphism
in the human apolipoprotein B gene. For the AvaII RFLP, the two alleles yield
either a 1 kb fragment or 0.7 and 0.3 kb fragments, and have frequencies of 20%
and 80%, respectively. The polymorphic site is about 4 kb upstream of exon 1.
For the BalI RFLP, the two alleles yield either a 4.9 or 6.2 kb fragment, and
have about equal frequencies. The polymorphic site is within an Alu sequence in
intron 20, 146 bp 5' to exon 21. The BalI recognition sequence TGGCCA is
replaced by TAGCCA. For the HincII RFLP, the two alleles yield either a 1.7 or
1.3 kb fragment and have frequencies of 80% and 20%, respectively. The
polymorphic site is in intron 4, 171 bp 3' to exon 4. The HincII recognition
sequence GTTAAC, present in the minor allele, is replaced by GTTACC. HincII
fragments of 7.4 and 7.0 kb, previously reported for this polymorphism, are the
result of partial digestion at the invariant HincII site in intron 3, 334 bp 3'
to exon 3. For the PvuII RFLP, the two alleles yield either a 7.5 or 5.5 kb
fragment and have frequencies of 96% and 4%, respectively. The polymorphic site
is within an Alu sequence in intron 4, 523 bp 5' to exon 5.
------------------------------------------------------------------------------------------------------------------------------------------------
Janco RL, Phillips JA 3rd, Orlando
PJ, Woodard MJ, Wion KL, Lawn RM.
Detection of hemophilia A
carriers using intragenic factor VIII:C DNA polymorphisms.
Blood. 1987 May: 69(5): 1539-41.
A DNA polymorphism for an Xbal site in intron 22 of the human factor VIII:C gene
extends the utility of DNA methods for carrier detection in families segregating
for hemophilia A. While the DNA polymorphism detected by a BclI site in intron
18 of the factor VIII:C gene was informative for 41% of females studied, the
BglI/intron 25 polymorphism provided no additional information because of
apparent linkage disequilibrium. In contrast, the Xbal intron 22 polymorphism
was useful in 53% of women who were uninformative (homozygous) for either the
BclI or BglI polymorphisms. Using the BclI/intron 18 and Xbal/intron 22
intragenic polymorphisms, we could provide highly accurate information for 68%
of women we studied who were at risk for carriership. The carrier status of the
remaining 32% could be determined utilizing the closely linked Taql/St14 DNA
polymorphism.
------------------------------------------------------------------------------------------------------------------------------------------------
Jeffreys AJ.
DNA sequence variants in
the G gamma-, A gamma-, delta- and beta-globin genes of man.
Cell. 1979 Sep: 18(1): 1-10.
DNA prepared from 60 unrelated individuals was cleaved with one of eight
different restriction endonucleases and the resulting DNA fragments were
separated by agarose gel electrophoresis. DNA fragments containing G gamma-, A
gamma-, delta- or beta-globin genes were detected by Southern blot
hybridization, using as probe either a 32P-labeled cloned DNA copy of rabbit
beta-globin messenger RNA or labeled human beta- and G gamma- globin cDNA
plasmids. Three types of variant restriction enzyme patterns of globin DNA
fragments were detected in otherwise normal individuals. One variant pattern,
found in only one person, was caused by an additional restriction endonuclease
Pst I cleavage site in the center of the delta- globin gene intervening
sequence; the subject was heterozygous for the presence of this cleavage site
and was shown to have inherited it from her mother. Another variant pattern
resulted from the appearance of an endonuclease Hind III cleavage site in the
intervening sequence of the A gamma-globin gene; this variant is polymorphic,
with a gene frequency for the presence of the intragenic Hind III site of 0.23.
This Hind III cleavage site polymorphism is also found in the G gamma-globin
gene intervening sequence and thus the polymorphism itself appears to be
duplicated over the pair of gamma-globin loci. These variants can be used to
derive an approximate estimate of the total number of different DNA sequence
variants in man.
------------------------------------------------------------------------------------------------------------------------------------------------
Jeffreys AJ, Wilson V, Thein SL.
Hypervariable 'minisatellite'
regions in human DNA.
Nature. 1985 Mar 7-13: 314(6006):
67-73.
The human genome contains many dispersed tandem-repetitive 'minisatellite'
regions detected via a shared 10-15-base pair 'core' sequence similar to the
generalized recombination signal (chi) of Escherichia coli. Many minisatellites
are highly polymorphic due to allelic variation in repeat copy number in the
minisatellite. A probe based on a tandem-repeat of the core sequence can detect
many highly variable loci simultaneously and can provide an individual-specific
DNA 'fingerprint' of general use in human genetic analysis.
------------------------------------------------------------------------------------------------------------------------------------------------
Jeffreys AJ, Wilson V, Neumann R,
Keyte J. Department of
Genetics, University of Leicester, UK.
Amplification of human
minisatellites by the polymerase chain reaction: towards DNA fingerprinting of
single cells.
Nucleic Acids Res. 1988 Dec 9:
16(23): 10953-71.
Hypervariable minisatellites can be amplified from human DNA by the polymerase
chain reaction, using primers from DNA flanking the minisatellite to amplify the
entire block of tandem repeat units. Minisatellite alleles up to 5-10 kb long
can be faithfully amplified. At least six minisatellite loci can be co-amplified
from the same DNA sample and simultaneously detected to provide a reproducible
and highly variable DNA fingerprint which can be obtained from nanogram
quantities of human DNA. The polymerase chain reaction can also be used to
analyse single target minisatellite molecules and single human cells, despite
the appearance of spurious PCR products from some hypervariable loci. DNA
fingerprinting at the level of one or a few cells therefore appears possible.
------------------------------------------------------------------------------------------------------------------------------------------------
Jenkins RN, Osborne-Lawrence SL,
Sinclair AK, Eddy RL Jr, Byers MG, Shows TB, Duby AD.
Harold C. Simmons Arthritis Research Center, Dallas, Texas.
Structure and chromosomal
location of the human gene encoding cartilage matrix protein.
J Biol Chem. 1990 Nov 15: 265(32): 19624-31.
Cartilage matrix protein (CMP) is a major component of the extracellular matrix
of nonarticular cartilage. The structure and chromosomal location of the human
gene encoding CMP was determined by molecular cloning analysis. We used a
partial chicken CMP cDNA probe to isolate three overlapping human genomic
clones. From one of these clones, a probe containing 2 human CMP exons was
isolated and used to map the gene to chromosome 1p35 and to screen a human
retina cDNA library. Two overlapping cDNA clones were isolated. The predicted
protein sequence of 496 amino acids includes a 22-residue signal peptide and a
474-residue mature protein of Mr 51,344. The human CMP gene and polypeptide are
strikingly similar to the chicken CMP gene and polypeptide. Human CMP is 79%
identical to chicken CMP and contains two homologous domains separated by an
epidermal growth factor-like domain. One potential N-glycosylation site is
conserved between the two species. The human CMP gene spans 12 kilobase pairs
with 8 exons and 7 introns which are similar in size to those of the chicken CMP
gene. Both RNA splice junctions of intron G in the human and chicken CMP genes
are nonconforming to the consensus splice sequences. This suggests that the CMP
gene utilizes a new RNA splicing mechanism.
------------------------------------------------------------------------------------------------------------------------------------------------
Jinks DC, Minter M, Tarver DA,
Vanderford M, Hejtmancik JF, McCabe ER.
Department of Microbiology, State University of New York, Buffalo 14214.
Molecular genetic
diagnosis of sickle cell disease using dried blood specimens on blotters used
for newborn screening.
Hum Genet. 1989 Mar: 81(4): 363-6.
The protein-based technologies used to screen newborns for sickle cell disease
require confirmation with a liquid blood specimen. We have developed a strategy
for rapid and specific genotypic diagnosis using DNA extracted from a dried
blood spot on the filter paper blotter used to screen newborns. DNA could be
microextracted from a specimen as small as a 1/8 inch diameter punched disc
representing the dried equivalent of approximately 3 microliters of whole blood.
We utilized the DNA from a 1/4 inch diameter specimen (12 microliters
equivalent) for polymerase chain reaction amplification of the beta-globin
region spanning the sickle cell mutation with detection by allele-specific
oligonucleotide probes. Molecular confirmation of genotype from the original
blotter would reduce the personnel costs associated with obtaining follow-up
liquid blood specimens and would provide information to the family in a more
timely and less equivocal manner.
------------------------------------------------------------------------------------------------------------------------------------------------
Kagnoff MF, Harwood JI, Bugawan TL,
Erlich HA. Department of
Medicine, University of California at San Diego, La Jolla 92093.
Structural analysis of the
HLA-DR, -DQ, and -DP alleles on the celiac disease-associated HLA-DR3 (DRw17)
haplotype.
Proc Natl Acad Sci U S A. 1989 Aug:
86(16): 6274-8.
Celiac disease is strongly associated with the HLA class II D-region serologic
markers DR3 (DRw17) and DQw2. Moreover, by restriction fragment length
polymorphism analysis, greater than 90% of DR3 (DRw17), DQw2 celiac disease
patients have a polymorphic 4.0-kilobase Rsa I DP B gene DNA fragment. The
present study sought to determine if there is a unique HLA class II D-region A
or B gene structural variant on the DR3 (DRw17) haplotype found in celiac
disease. The polymorphic second exons of the coding DRB, DQA and DQB, and DPA
and DPB genes in celiac disease patients with the DR3 (DRw17) haplotype were
sequenced after amplification by the polymerase chain reaction. To define the DP
B genes associated with celiac disease, the second exons of the coding DP B
genes from 27 celiac disease patients were amplified similarly and probed by
using a panel of sequence specific oligonucleotides. The HLA-DR, -DQ, and -DP A
and B gene second exon sequences of celiac disease patients were noted to be
identical to sequences that can be found also, although at a significantly lower
frequency, in unaffected individuals. This is compatible with a disease model
wherein the HLA class II genes on the DR3 (DRw17) haplotype are necessary, but
not sufficient, for the phenotypic expression of celiac disease. Analysis of the
DP B genes revealed a significant increase in the frequency of the alleles DPB1
and DPB3 in celiac disease. Furthermore, the increased frequency of the
4.0-kilobase Rsa I DP B gene restriction fragment length polymorphism in celiac
disease can be accounted for by the overrepresentation in disease of the alleles
DPB1 and DPB3. The HLA-associated susceptibility to celiac disease appears to be
multigenic, with specific, but structurally normal, allelic variants in the DP
and DQ/DR subregions contributing to disease susceptibility.
------------------------------------------------------------------------------------------------------------------------------------------------
Kan YW, Dozy AM.
Antenatal diagnosis of
sickle-cell anaemia by D.N.A. analysis of amniotic-fluid cells.
Lancet. 1978 Oct 28: 2(8096): 910-2.
The polymorphism of a restriction endonuclease site has been used for antenatal
diagnosis of sickle-cell disease. In a normal person, the beta-globin gene was
contained in a Hpa I-digested D.N.A. fragment 7.6 kilobases (kb) in length. In a
family where the sickle gene was contained in a variant 13.0 kb fragment,
restriction endonuclease mapping was used for antenatal diagnosis. The D.N.A.
from amniotic-fluid cells produced both the 7.6 and the 13.0 bk beta-globin gene
fragments, indicating the diagnosis of sickle-cell trait. This confirmed the
diagnosis reached after investigation of a 100% sample of fetal blood. The
method is sensitive and can be performed with cells obtained from 15 ml of
uncultured amniotic fluid. This approach may prove useful in antenatal diagnosis
of other genetic disorders.
------------------------------------------------------------------------------------------------------------------------------------------------
Kan YW, Dozy AM.
Polymorphism of DNA
sequence adjacent to human beta-globin structural gene: relationship to sickle
mutation.
Proc Natl Acad Sci U S A. 1978 Nov:
75(11): 5631-5.
Restriction endonuclease mapping of the human globin genes revealed a genetic
variation in a Hpa I recognition site about 5000 nucleotides from the 3' end of
the beta-globin structural gene. Instead of a normal 7.6-kilobase (kb) fragment
which contains the beta-globin structural gene, 7.0-kb and 13.0-kb variants were
detected. Both variants were found in people of African origin and were not
detected in Asians or Caucasians. The 13.0-kb variant is frequently associated
with the sickle hemoglobin mutation and may be useful for the prediction of the
sickle cell gene in prenatal diagnosis. Polymorphism in a restriction enzyme
site could be considered as a new class of genetic marker and may offer a new
approach to linkage analysis and anthropological studies.
------------------------------------------------------------------------------------------------------------------------------------------------
Kan YW, Lee KY, Furbetta M, Angius
A, Cao A.
Polymorphism of DNA
sequence in the beta-globin gene region. Application to prenatal diagnosis of
beta 0 thalassemia in Sardinia.
N Engl J Med. 1980 Jan 24: 302(4): 185-8.
We used a restriction endonuclease to analyze the beta-thalassemia gene in
Sardinia. When we digested human DNA with the restriction enzyme Bam HI, the
beta-globin gene split into a 5' portion contained in a fragment of DNA 1.8 kb
in length and a 3' portion in a fragment 9.3 kb in length. In some subjects, a
variation in the nucleotide sequence affecting the site recognized by this
enzyme on the 3' side of the beta-globin gene resulted in a different fragment,
22 kb in length, which contained the 3' portion of the beta-globin gene. In
Sardinians without beta-thalassemia, the frequency of the 9.3-kb fragment was
0.67, and that of the 22-kb fragment was 0.33. In contrast, all the beta
0-thalassemia genes were associated exclusively with the 9.3-kb fragment. Thus,
the beta 0-thalassemia lesion in Sardinians apparently arose on a chromosome
that had the 9.3-kb Bam HI fragment. This observation can be used in prenatal
diagnosis of beta 0-thalassemia in Sardina, since demonstration of the 22.0-kb
fragment would indicate the normal beta-globin genotype and exclude the beta
0-thalassemia lesion on that chromosome. (N Engl J Med 302:185-188, 1980).
------------------------------------------------------------------------------------------------------------------------------------------------
Keim P, Diers BW, Olson TC,
Shoemaker RC. Department
of Agronomy, Iowa State University, Ames 50011.
RFLP mapping in soybean:
association between marker loci and variation in quantitative traits.
Genetics. 1990 Nov: 126(3): 735-42.
We have constructed a genetic map for soybean and identified associations
between genetic markers and quantitative trait loci. One-hundred-fifty
restriction fragment length polymorphisms (RFLPs) were used to identify genetic
linkages in an F2 segregating population from an interspecific cross (Glycine
max x Glycine soja). Twenty-six genetic linkage groups containing ca. 1200
recombination units are reported. Progeny-testing of F2-derived families allowed
quantitative traits to be evaluated in replicated field trials. Genomic regions,
which accounted for a portion of the genetic variation (R2 = 16 to 24%) in
several reproductive and morphological traits, were linked to RFLP markers.
Significant associations between RFLP markers and quantitative trait loci were
detected for eight of nine traits evaluated. The ability to identify genes
within a continuously varying trait has important consequences for plant
breeding and for understanding evolutionary processes.
------------------------------------------------------------------------------------------------------------------------------------------------
Kelly DP, Whelan AJ, Ogden ML,
Alpers R, Zhang ZF, Bellus G, Gregersen N, Dorland L, Strauss AW.
Department of Internal Medicine, Washington University School of Medicine, Saint
Louis, MO 63110.
Molecular characterization
of inherited medium-chain acyl-CoA dehydrogenase deficiency.
Proc Natl Acad Sci U S A. 1990 Dec:
87(23): 9236-40.
Deficiency of medium-chain acyl-CoA dehydrogenase (MCAD) is a common inherited
defect in energy metabolism. Characterization of the mRNA encoding MCAD in a
Dutch MCAD-deficient patient revealed an A----G change at nucleotide position
985 of the MCAD mRNA coding region. This point mutation results in the
substitution of a glutamic acid for a lysine at amino acid position 304 of the
mature protein. The single base change was not found in any wild-type MCAD
mRNAs. A mutant allele-specific oligonucleotide probe was used in a
hybridization analysis of amplified genomic DNA of MCAD-deficient family
members, a carrier, and normal individuals. The hybridization analysis
specifically identified individuals who were heterozygotes or homozygotes. In
addition to the point mutation, a significant proportion of the index patient's
MCAD mRNA contained a variety of deletions and insertions as a result of exon
skipping and intron retention. The missplicing occurred in multiple regions
throughout the MCAD mRNA. Analysis of the patient's MCAD gene in the regions
where the missplicing occurred most frequently did not reveal a mutation in the
splicing acceptor or donor sites. Therefore, the molecular characterization of
this family revealed a crucial point mutation in the MCAD gene and an unusual
abnormality in MCAD pre-mRNA splicing.
------------------------------------------------------------------------------------------------------------------------------------------------
Kerem B, Rommens JM, Buchanan JA,
Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui LC.
Department of Genetics, Hospital for Sick Children, Toronto, Ontario, Canada.
Identification of the
cystic fibrosis gene: genetic analysis.
Science. 1989 Sep 8: 245(4922):
1073-80.
Approximately 70 percent of the mutations in cystic fibrosis patients correspond
to a specific deletion of three base pairs, which results in the loss of a
phenylalanine residue at amino acid position 508 of the putative product of the
cystic fibrosis gene. Extended haplotype data based on DNA markers closely
linked to the putative disease gene locus suggest that the remainder of the
cystic fibrosis mutant gene pool consists of multiple, different mutations. A
small set of these latter mutant alleles (about 8 percent) may confer residual
pancreatic exocrine function in a subgroup of patients who are pancreatic
sufficient. The ability to detect mutations in the cystic fibrosis gene at the
DNA level has important implications for genetic diagnosis.
------------------------------------------------------------------------------------------------------------------------------------------------
Knoll BJ, Rothblum KN, Longley M.
Department of Pathology and Laboratory Medicine, University of Texas Medical
School, Houston 77025.
Nucleotide sequence of the
human placental alkaline phosphatase gene. Evolution of the 5' flanking region
by deletion/substitution.
J Biol Chem. 1988 Aug 25: 263(24): 12020-7. Erratum in: J Biol Chem 1989 Feb
5;264(4):2391.
Three closely related alkaline
phosphatase (ALP) genes reside on the long arm of chromosome 2 in man. One of
these genes (the placental ALP-1) encodes the classic heat-stable placental
alkaline phosphatase. Another gene (the placental ALP-2) is closely related to
the placental ALP-1 and may encode the so-called placental ALP-like enzyme of
the testis and thymus. The third member of this gene family (the intestinal ALP
gene) encodes the intestinal alkaline phosphatase. The expression of the
placental ALP-1 and intestinal ALP genes is highly tissue-specific in spite of
nearly 90% sequence similarity within their exons. To help determine the basis
for this tissue specificity, the nucleotide sequence of the placental ALP-1 gene
and some of its 5' flanking region has been determined and analyzed by
comparison with placental ALP-2 and intestinal ALP gene sequences. The placental
ALP-1 gene transcription unit has 4087 bases between the major cap site and the
most distal of several reported 3' ends. The protein coding region is divided by
10 short introns varying in size from 74 to 241 nucleotides. Three of these
introns bisect regions of the gene that encode residues conserved between the
active site of the Escherichia coli enzyme and the human placental ALP. This
result suggests that the human alkaline phosphatase genes have evolved in an
intron-independent fashion. A comparison of the placental ALP-1 5' flanking
sequence (up to -540) with the analogous sequence of the intestinal ALP gene
revealed several deletion/substitutions which could be important in determining
the tissue-specific expression of these genes.
------------------------------------------------------------------------------------------------------------------------------------------------
Kogan SC, Doherty M, Gitschier J.
Howard Hughes Medical Institute, University of California, San Francisco, CA
94143.
An improved method for
prenatal diagnosis of genetic diseases by analysis of amplified DNA sequences.
Application to hemophilia A.
N Engl J Med. 1987 Oct 15: 317(16): 985-90.
We report the development of a rapid nonradioactive technique for the genetic
prediction of human disease and its diagnostic application to hemophilia A. This
method is based on enzymatic amplification of short segments of human genes
associated with inherited disorders. A novel feature of the procedure is the use
of a heat-stable DNA polymerase, which allows the repeated rounds of DNA
synthesis to proceed at 63 degrees C. The high sequence specificity of the
amplification reaction at this elevated temperature permits restriction-site
polymorphisms, contained in the amplified samples, to be analyzed by visual
inspection of their digestion products on polyacrylamide gels. By means of this
method, we have performed carrier detection and prenatal diagnosis of hemophilia
in two families with use of the factor VIII intragenic polymorphisms identified
by the restriction enzymes BclI and XbaI. Predictions can be made directly from
chorionic villi, without previous DNA extraction, and fetal sex can be
determined by amplification of sequences specific for the Y chromosome. Specific
amplification of genomic sequences with heat-stable DNA polymerase is applicable
to the diagnosis of a wide variety of inherited disorders. These include
diseases diagnosed by restriction-site variation, such as Duchenne's muscular
dystrophy and sickle cell anemia, those due to a collection of known mutations,
such as beta-thalassemia, and those due to gene deletion, such as alpha-thalassemia.
------------------------------------------------------------------------------------------------------------------------------------------------
Kogan S, Gitschier J.
Department of Medicine, University of California, San Francisco 94143-0724.
Mutations and a
polymorphism in the factor VIII gene discovered by denaturing gradient gel
electrophoresis.
Proc Natl Acad Sci U S A. 1990 Mar:
87(6): 2092-6.
Hemophilia A results from mutations in the gene coding for coagulation factor
VIII. We used denaturing gradient gel electrophoresis to screen for mutations in
the region of the factor VIII gene coding for the first acidic domain.
Amplification primers were designed employing the MELTMAP computer program to
optimize the ability to detect mutations. Screening of amplified DNA from 228
unselected hemophilia A patients revealed two mutations and one polymorphism.
Rescreening the same population by making heteroduplexes between amplified
patient and control samples prior to electrophoresis revealed one additional
mutation. The mutations include two missense and one 4-base-pair deletion, and
each mutation was found in patients with severe hemophilia. The polymorphism,
located adjacent to the adenine branch site in intron 7, is useful for genetic
prediction in some cases where the Bcl I and Xba I polymorphisms are
uninformative. These results suggest that DNA amplification and denaturing
gradient gel electrophoresis should be an excellent strategy for identifying
mutations and polymorphisms in defined regions of the factor VIII gene and other
large genes.
------------------------------------------------------------------------------------------------------------------------------------------------
Krawczak M, Konecki DS, Schmidtke J,
Duck M, Engel W, Nutzenadel W, Trefz FK.
Institut fur Humangenetik der Universitat, Gottingen, Federal Republic of
Germany.
Allelic association of the cystic
fibrosis locus and two DNA markers, XV2c and KM19, in 55 German families.
Hum Genet. 1988 Sep: 80(1): 78-80.
Allelic association between cystic fibrosis and two linked markers is
demonstrated in a sample of 55 German families. It is shown by example how these
observations can be used for genetic risk calculation.
------------------------------------------------------------------------------------------------------------------------------------------------
Krawczak M.
Institut fur Humangenetik der Universitat, Gottingen, West Germany.
Algorithms for the
restriction-site mapping of DNA molecules.
Proc Natl Acad Sci U S A. 1988 Oct:
85(19): 7298-301.
Two algorithms are described that rapidly construct restriction maps of DNA
molecules from single- and double-digest data. The implementation of these
algorithms into the Pascal programs AMAPK and AMARD allows such mapping to be
done on microcomputers.
------------------------------------------------------------------------------------------------------------------------------------------------
Kulozik AE, Lyons J, Kohne E,
Bartram CR, Kleihauer E.
Department of Paediatrics II, University of Ulm, F.R.G.
Rapid and non-radioactive
prenatal diagnosis of beta thalassaemia and sickle cell disease: application of
the polymerase chain reaction (PCR).
Br J Haematol. 1988 Dec: 70(4):
455-8.
The standard method for the prenatal diagnosis of the haemoglobinopathies is by
restriction enzyme mapping of chorionic villus DNA using Southern blotting and
radioactively labelled gene probes. An improvement of the procedure which
involves the selective amplification of DNA fragments by the polymerase chain
reaction allows one to visualize restriction fragments directly without the use
of radioactivity and within 2 d after obtaining the sample. We report here the
prenatal diagnosis of two pregnancies at risk for homozygous beta thalassaemia
and homozygous sickle cell disease using this novel approach.
------------------------------------------------------------------------------------------------------------------------------------------------
Labouesse M, Herbert CJ, Dujardin G,
Slonimski PP.
Three suppressor mutations
which cure a mitochondrial RNA maturase deficiency occur at the same codon in
the open reading frame of the nuclear NAM2 gene.
EMBO J. 1987 Mar: 6(3):713-21.
Dominant mutations of the nuclear NAM2 gene are able to compensate for a
deficiency of the maturase encoded by the fourth intron of the mitochondrial
cytochrome b gene. We have determined the complete nucleotide sequence of the
NAM2-1 suppressor allele. The results of S1 nuclease protection experiments show
that two overlapping poly(A)+ RNAs are transcribed from the gene using different
promoters. The longer transcript contains two open reading frames (ORFs), a long
ORF which could encode a protein of 894 amino acids, mol. wt 102,000 daltons,
and a short ORF of 51 codons which is omitted from the shorter transcript. The
wild-type nam2+ and two other suppressor alleles, NAM2-6 and NAM2-7, have been
cloned. A comparison of the sequence of the wild-type and the three suppressor
alleles shows that on three separate occasions the same codon specifying glycine
was mutated (once to serine and twice to cysteine). Finally sequence comparisons
identified two regions in the long ORF, distinct from the position of the
suppressor mutations, that could correspond to binding domains for a nucleotide
and a nucleic acid.
------------------------------------------------------------------------------------------------------------------------------------------------
Lander ES, Botstein D.
Homozygosity mapping: a
way to map human recessive traits with the DNA of inbred children.
Science. 1987 Jun 19: 236(4808):
1567-70.
An efficient strategy for mapping human genes that cause recessive traits has
been devised that uses mapped restriction fragment length polymorphisms (RFLPs)
and the DNA of affected children from consanguineous marriages. The method
involves detection of the disease locus by virtue of the fact that the adjacent
region will preferentially be homozygous by descent in such inbred children. A
single affected child of a first-cousin marriage is shown to contain the same
total information about linkage as a nuclear family with three affected
children. Calculations show that it should be practical to map a recessive
disease gene by studying DNA from fewer than a dozen unrelated, affected inbred
children, given a complete RFLP linkage map. The method should make it possible
to map many recessive diseases for which it is impractical or impossible to
collect adequate numbers of families with multiple affected offspring.
------------------------------------------------------------------------------------------------------------------------------------------------
Landsman D, McBride OW, Bustin M.
Laboratory of Molecular Carcinogenesis, National Cancer Institute, Bethesda, MD
20892.
Human non-histone
chromosomal protein HMG-17: identification, characterization, chromosome
localization and RFLPs of a functional gene from the large multigene family.
Nucleic Acids Res. 1989 Mar 25:
17(6): 2301-14.
The multigene family of chromosomal protein HMG-17 is the largest known human
retropseudogene family. A functional gene was identified and isolated by
screening cDNA-selected genomic clones with a set of 5 oligonucleotides whose
sequence corresponded to regions in which the sequence of the retropseudogenes
differed from that of the cDNA and which did not span previously identified exon/intron
junctions. A 7195 bp genomic fragment containing 6 exons, ranging in size from
30 to 817 bp, two of which encode the entire DNA binding domain of the protein,
was sequenced. The gene has features which are typical to "housekeeping" genes
and is characterized by a very high content of G + C residues in a 1.4 kb
fragment starting 500 bp from the cap site and by an "HTF" island in the 5'
region. Transcriptional regulatory signals, exon/intraon boundaries and features
characteristic of "housekeeping" genes are evolutionary conserved between the
human and chicken genes. The HMG-17 gene was localized to human chromosome
1p12-34. RFLP's useful for further mapping were detected. The experimental
evidence presented leads to the assumption that the gene characterized is the
only functional human HMG-17 gene.
------------------------------------------------------------------------------------------------------------------------------------------------
Lazzeroni LC.
Biostatistics Division, Department of Health Research and Policy, Stanford
University, Stanford, California 94305, USA. Lazzeroni@stanford.edu
A chronology of fine-scale
gene mapping by linkage disequilibrium.
Stat Methods Med Res. 2001
Feb:10(1): 57-76.
The past decade produced several proposals for fine-scale gene mapping using
linkage disequilibrium data. The suggested methods fall into two main groups,
those that rely on pairwise statistics and those that rely on haplotypes. This
paper reviews each strategy's development from a chronological perspective.
------------------------------------------------------------------------------------------------------------------------------------------------
Leitersdorf E, Chakravarti A, Hobbs
HH. Department of
Molecular Genetics, University of Texas Southwestern Medical Center, Dallas
75235.
Polymorphic DNA haplotypes at the
LDL receptor locus.
Am J Hum Genet. 1989 Mar: 44(3):
409-21.
Mutations in the low-density lipoprotein (LDL) receptor gene result in the
autosomal dominant disorder familial hypercholesterolemia (FH). Many different
LDL receptor mutations have been identified and characterized, demonstrating a
high degree of allelic heterogeneity at this locus. The ability to identify
mutant LDL receptor genes for prenatal diagnosis of homozygous FH or to study
the role of the LDL receptor gene in polygenic hypercholesterolemia requires the
use of closely linked RFLPs. In the present study we used 10 different RFLPs,
including three newly described polymorphisms, to construct 123 independent
haplotypes from 20 Caucasian American pedigrees. Our sample contained 31
different haplotypes varying in frequency from 0.8% to 29.3%; the five most
common haplotypes account for 67.5% of the sample. The heterozygosity and PIC of
each site were determined, and these values disclosed that eight of the RFLPs
were substantially polymorphic. Linkage-disequilibrium analysis of the haplotype
data revealed strong nonrandom associations among all 10 RFLPs, especially among
those sites clustered in the 3' region of the gene. Evolutionary analysis
suggests the occurrence of both mutational and recombinational events in the
generation of the observed haplotypes. A strategy for haplotype analysis of the
LDL receptor gene in individuals of Caucasian American descent is presented.
------------------------------------------------------------------------------------------------------------------------------------------------
Lemaire HG, Salbaum JM, Multhaup G,
Kang J, Bayney RM, Unterbeck A, Beyreuther K, Muller-Hill B.
Institute fur Genetik, Universitat Koln, FRG.
The PreA4(695) precursor
protein of Alzheimer's disease A4 amyloid is encoded by 16 exons.
Nucleic Acids Res. 1989 Jan
25:17(2): 517-22.
Alzheimer's disease (AD) is characterized by the cerebral deposition of
fibrillar aggregates of the amyloid A4 protein. Complementary DNA's coding for
the precursor of the amyloid A4 protein have been described. In order to
identify the structure of the precursor gene relevant clones from several human
genomic libraries were isolated. Sequence analysis of the various clones
revealed 16 exons to encode the 695 residue precursor protein (PreA4(695] of
Alzheimer's disease amyloid A4 protein. The DNA sequence coding for the amyloid
A4 protein is interrupted by an intron. This finding supports the idea that
amyloid A4 protein arises by incomplete proteolysis of a larger precursor, and
not by aberrant splicing.
------------------------------------------------------------------------------------------------------------------------------------------------
Lewis RA, Otterud B, Stauffer D,
Lalouel JM, Leppert M.
Cullen Eye Institute, Department of Ophthalmology, Houston, Texas.
Mapping recessive
ophthalmic diseases: linkage of the locus for Usher syndrome type II to a DNA
marker on chromosome 1q.
Genomics. 1990 Jun: 7(2): 250-6.
Usher syndrome is a heterogeneous group of autosomal recessive disorders that
combines variably severe congenital neurosensory hearing impairment with
progressive night-blindness and visual loss similar to that in retinitis
pigmentosa. Usher syndrome type I is distinguished by profound congenital
(preverbal) deafness and retinal disease with onset in the first decade of life.
Usher syndrome type II is characterized by partial hearing impairment and
retinal dystrophy that occurs in late adolescence or early adulthood. The
chromosomal assignment and the regional localization of the genetic mutation(s)
causing the Usher syndromes are unknown. We analyzed a panel of polymorphic
genomic markers for linkage to the disease gene among six families with Usher
syndrome type I and 22 families with Usher syndrome type II. Significant linkage
was established between Usher syndrome type II and the DNA marker locus THH33
(D1S81), which maps to chromosome 1q. The most likely location of the disease
gene is at a map distance of 9 cM from THH33 (lod score 6.5). The same marker
failed to show linkage in families segregating an allele for Usher syndrome type
I. These data confirm the provisional assignment of the locus for Usher syndrome
type II to the distal end of chromosome 1q and demonstrate that the clinical
heterogeneity between Usher types I and II is caused by mutational events at
different genetic loci. Regional localization has the potential to improve
carrier detection and to provide antenatal diagnosis in families at risk for the
disease.
------------------------------------------------------------------------------------------------------------------------------------------------
Li HH, Gyllensten UB, Cui XF, Saiki
RK, Erlich HA, Arnheim N.
Department of Biological Sciences, University of Southern California, Los
Angeles 90089-0371.
Amplification and analysis
of DNA sequences in single human sperm and diploid cells.
Nature. 1988 Sep 29: 335(6189):
414-7.
The use of the polymerase chain reaction for analysing DNA sequences in
individual diploid cells and human sperm shows that two genetic loci can be
co-amplified from a single sperm, which may allow the analysis of previously
inaccessible genetic phenomena.
------------------------------------------------------------------------------------------------------------------------------------------------
Lifton RP, Sardet C, Pouyssegur J,
Lalouel JM.
Endocrine-Hypertension Division, Brigham and Women's Hospital, Boston,
Massachusetts.
Cloning of the human
genomic amiloride-sensitive Na+/H+ antiporter gene, identification of genetic
polymorphisms, and localization on the genetic map of chromosome 1p.
Genomics. 1990 May: 7(1): 131-5.
We have cloned and mapped a 90-kb region spanning the human genomic amiloride-sensitive
Na+/H+ antiporter gene on overlapping cosmid clones. This cloned region extends
27 kb upstream of the 5' end of the longest antiporter cDNA and reveals a
primary transcription unit of at least 60 kb. Using these genomic clones we have
identified polymorphisms in the antiporter gene in human genomic DNA cleaved
with enzymes TaqI and MspI; both are two-allele systems. We have localized both
polymorphisms to the same segment within an intron of the antiporter
transcription unit. Observed heterozygosity for both markers is 47% in 175
unrelated individuals, with the two polymorphic systems showing complete linkage
disequilibrium. We have determined genotypes at the antiporter locus in 667
individuals in 59 reference families. Linkage analysis using 28 other markers on
human chromosome 1 precisely locates the antiporter gene (locus APNH) on the
genetic map of 1 p. The antiporter gene is closely flanked by two highly
informative loci, lying 3 cM proximal to the rhesus blood group locus (Rh) and 4
cM distal to the anonymous DNA marker CMM8 (locus D1S79). These antiporter
polymorphisms and informative flanking markers will prove useful in genetic
linkage studies employing the antiporter gene.
------------------------------------------------------------------------------------------------------------------------------------------------
Limm TM, Ashdown ML, Naughton MJ,
McGinnis MD, Simons MJ.
GeneType Pty Ltd., Fitzroy, Australia.
HLA-DQA1 allele and
suballele typing using noncoding sequence polymorphisms. Application to 4AOHW
cell panel typing.
Hum Immunol. 1993 Sep: 38(1): 57-68.
HLA-DQA1 typing of the 4AOHW cell panel is presented using a novel strategy that
exploits both intron and exon polymorphisms. Intron sequences adjacent to the
variable HLA-DQA1 second exon exhibit stable polymorphisms that are specific for
locus alleles and certain suballelic DR/DQ haplotypes. A PCR-RFLP method has
been developed that is based on amplification of a 780-bp segment extending from
intron 1 through exon 2 to intron 2. Stable sequence polymorphisms provide
restriction enzyme sites and confer mobility variations detected on
polyacrylamide minigel electrophoresis. Direct band comparison of amplified
products and restriction fragments with known standards facilitates pattern
comparison, obviating the requirement for accurate molecular weight
determination. This method, using only two enzymes, identifies a total of 11
allelic and suballelic groups, including all eight DQA1 alleles encoded at the
second exon.
------------------------------------------------------------------------------------------------------------------------------------------------
Litt M, Luty JA.
Department of Biochemistry, Oregon Health Sciences University, Portland 97201.
A hypervariable
microsatellite revealed by in vitro amplification of a dinucleotide repeat
within the cardiac muscle actin gene.
Am J Hum Genet. 1989 Mar: 44(3):
397-401.
The human genome contains approximately 50,000 copies of an interspersed repeat
with the sequence (dT-dG)n, where n = approximately 10-60. In humans, (TG)n
repeats have been found in several sequenced regions. Since minisatellite
regions with larger repeat elements often display extensive length
polymorphisms, we suspected that (TG)n repeats ("microsatellites") might also be
polymorphic. Using the polymerase chain reaction to amplify a (TG)n
microsatellite in the human cardiac actin gene, we detected 12 different allelic
fragments in 37 unrelated individuals, 32 of whom were heterozygous. Codominant
Mendelian inheritance of fragments was observed in three families with a total
of 24 children. Because of the widespread distribution of (TG)n microsatellites,
polymorphisms of this type may be generally abundant and present in regions
where minisatellites are rare, making such microsatellite loci very useful for
linkage studies in humans.
------------------------------------------------------------------------------------------------------------------------------------------------
Little PF, Annison G, Darling S,
Williamson R, Camba L, Modell B.
Model for antenatal
diagnosis of beta-thalassaemia and other monogenic disorders by molecular
analysis of linked DNA polymorphisms.
Nature. 1980 May 15: 285(5761):
144-7.
Polymorphisms of DNA restriction sites within the human fetal globin genes have
been used to identify chromosomes that carry beta-thalassaemia genes in
individuals heterozygous for this disease. This has allowed an antenatal
diagnosis for beta-thalassaemia to be carried out by observation of the pattern
of the inherited polymorphism of a linked DNA sequence not involved in the
genetic pathogenesis of the disease. In the populations we have investigated
there is no constant pattern of polymorphism that segregates with the beta-thalassaemia
gene. The use of linked polymorphisms should, therefore, be applicable to
antenatal diagnosis both of beta-thalassaemia and of any other single-gene
defect for which there is a DNA probe specific for a sequence linked to the
affected locus.
------------------------------------------------------------------------------------------------------------------------------------------------
Love JM, Knight AM, McAleer MA, Todd
JA (Nuffield Department
of Surgery, John Radcliffe Hospital, Headington, Oxford, UK.)
Towards construction of a high
resolution map of the mouse genome using PCR-analysed microsatellites.
Nucleic Acids Res. 1990 Jul 25:18(14): 4123-30.
Fifty sequences from the mouse genome database containing simple sequence
repeats or microsatellites have been analysed for size variation using the
polymerase chain reaction and gel electrophoresis. 88% of the sequences, most of
which contain the dinucleotide repeat, CA/GT, showed size variations between
different inbred strains of mice and the wild mouse, Mus spretus. 62% of
sequences had 3 or more alleles. GA/CT and AT/TA-containing sequences were also
variable. About half of these size variants were detectable by agarose gel
electrophoresis. This simple approach is extremely useful in linkage and genome
mapping studies and will facilitate construction of high resolution maps of both
the mouse and human genomes.
------------------------------------------------------------------------------------------------------------------------------------
Lubahn DB, Brown TR, Simental JA,
Higgs HN, Migeon CJ, Wilson EM, French FS (Laboratoires
for Reproductive Biology, University of North Carolina, Chapel Hill 27599.)
Sequence of the intron/exon
junctions of the coding region of the human androgen receptor gene and
identification of a point mutation in a family with complete androgen
insensitivity.
Proc Natl Acad Sci U S A. 1989 Dec: 86(23): 9534-8. (Erratum in: Proc Natl Acad
Sci U S A 1990 Jun: 87(11): 4411.)
Androgens act through a receptor protein (AR) to mediate sex differentiation and
development of the male phenotype. We have isolated the eight exons in the amino
acid coding region of the AR gene from a human X chromosome library. Nucleotide
sequences of the AR gene intron/exon boundaries were determined for use in
designing synthetic oligonucleotide primers to bracket coding exons for
amplification by the polymerase chain reaction. Genomic DNA was amplified from
46,XY phenotypic female siblings with complete androgen insensitivity syndrome.
AR binding affinity for dihydrotestosterone in the affected siblings was lower
than in normal males, but the binding capacity was normal. Sequence analysis of
amplified exons demonstrated within the AR steroid-binding domain (exon G) a
single guanine to adenine mutation, resulting in replacement of valine with
methionine at amino acid residue 866. As expected, the carrier mother had both
normal and mutant AR genes. Thus, a single point mutation in the steroid-binding
domain of the AR gene correlated with the expression of an AR protein
ineffective in stimulating male sexual development.
------------------------------------------------------------------------------------------------------------------------------------------------
Luty JA, Guo Z, Willard HF,
Ledbetter DH, Ledbetter S, Litt M.
Department of Biochemistry, Oregon Health Sciences University, Portland
97201-3098.
Five polymorphic
microsatellite VNTRs on the human X chromosome.
Am J Hum Genet. 1990 Apr: 46(4): 776-83.
The human genome contains approximately 50,000 copies of an interspersed repeat
with the sequence (dT.dG/dA.dC)n, where n = approximately 10-60. We and others
have found that several of these repeats have variable lengths in different
individuals, with allelic fragments varying in size by multiples of 2 bp. These
"microsatellite" variable number of tandem repeats (VNTRs) may be scored by PCR,
using unique flanking primers to amplify the repeat-containing regions and
resolving the products on DNA sequencing gels. Since few VNTRs have been found
on the X chromosome, we screened a flow-sorted X chromosome-specific genomic
library for microsatellites. Approximately 25% of the phage clones hybridized to
a poly (dT-dG).poly(dA-dC) probe. Of seven X-linked microsatellites present in
positive phages, five are polymorphic and three have both eight or more alleles
and heterozygosities exceeding 75%. Using PCR to amplify genomic DNAs from
hybrid cell panels, we confirmed the X localization of these VNTRs and
regionally mapped four of them. The fifth VNTR was regionally mapped by virtue
of its tight linkage to DXS87 in Centre du Polymorphisme Humain families. We
conclude that whatever factors limit the occurrence of "classical" VNTRs and
RFLPs on the X chromosome do not appear to operate in the case of microsatellite
VNTRs.
------------------------------------------------------------------------------------------------------------------------------------
Lyonnet S, Caillaud C, Rey F,
Berthelon M, Frezal J, Rey J, Munnich A.
Clinique et Unite de Recherches de Genetique Medicale, INSERM U-12, Hopital des
Enfants Malades, Paris.
Molecular genetics of
phenylketonuria in Mediterranean countries: a mutation associated with partial
phenylalanine hydroxylase deficiency.
Am J Hum Genet. 1989 Apr: 44(4):
511-7.
We report the characterization of a mutation in the phenylalanine hydroxylase (PAH)
gene associated with partial residual activity of the enzyme. This point
mutation (280glu----lys) was found by sequencing a mutant cDNA clone derived
from a needle biopsy of the liver in a child with variant form of
phenylketonuria. There is a strict concordance between homozygosity for the
mutation and this particular phenotype. The (280glu----lys) mutation is linked
to an original and rare RFLP haplotype at the PAH locus found in south Europe
and North Africa. So far, this genotype-haplotype association is both inclusive
and exclusive. Thirty-three PAH-deficient patients were screened for the
mutation by using polymerase chain-reaction amplification of their genomic DNA
extracted from Guthrie cards. Since a large number of patients can be screened
for a particular mutation by using Guthrie cards, the possibility arises of
using these samples collected by national newborn screening centers for
prospective and retrospective detection of other mutations in the human genome.
------------------------------------------------------------------------------------------------------------------------------------------------
Ma YH, Ladias JA, Butler R,
Schumaker VN, Antonarakis SE, Lusis AJ, Heinzman C, Kwiterovich PO.
Department of Chemistry and Biochemistry, University of California, Los Angeles
90024.
Apolipoprotein B gene
haplotypes. Association between Ag and DNA polymorphisms.
Arteriosclerosis. 1988 Sep-Oct:
8(5): 521-4.
Berg et al. (Clin Genet 1986;30:515-520) have reported that an Xba I DNA
polymorphic site in exon 26 of the apolipoprotein (apo) B gene is associated
both with the Ag(x/y) immunochemical polymorphism and with elevated serum
lipoprotein levels. Ma et al. (Arteriosclerosis 1987;7:301-305) have reported
that the same Xba I polymorphism is associated with a different immunochemical
polymorphism, Ag(c/g). To extend and clarify these observations, we have
determined the Ag and Xba I polymorphism for 106 individuals. We find that the
Xba I restriction fragment length polymorphism is in linkage disequilibrium with
both Ag(x/y) and Ag(c/g) loci; thus, all 31 Xba I(X1/X1) genotypes observed in
this study are also Ag(y/y). All but one of 22 Xba I(X2/X2) genotypes are also
Ag(g/g). For individuals homozygous at either two or three of these loci, it was
possible to determine the haplotypes for 128 apo B alleles. Of the eight
possible apo B haplotypes, only four were represented in this unambiguous
subpopulation, although other minor haplotypes were present in the total
population from which it was derived. The identification of major apo B
haplotypes in human populations may simplify the search for significant
correlations between certain apo B alleles and lipid levels and atherosclerosis.
------------------------------------------------------------------------------------------------------------------------------------------------
Macek M, Tomasova H, Boue J, Kleijer
WJ, Sedlacek Z, Hronkova J, Vavrova V, Jelinkova E, Kulovany E, Benesova D, et
al. Department of
Medical Genetics, Faculty of Pediatrics Prague, Czechoslovakia.
The experience with the
foetal diagnosis of the cystic fibrosis in the second and first trimester.
Acta Univ Carol [Med] (Praha). 1990:
36(1-4): 120-8.
The amniotic fluid activity of gamma glutamyl transpeptidase (GGT), leucine
aminopeptidase (LAP) and alcaline phosphatase (AP) and disacharidases was
examined in 66 pregnancies with the risk of cystic fibrosis (CF) in the
17th-21st weeks of gestation. So far 28 pregnancies continue. The prenatal
diagnosis was confirmed in all so far delivered children or aborted foetuses if
the GGT activity was higher than 400 U/1 (10th percentile) or lower than 190 U/1
(3rd percentile) in the 17th-18th weeks. The results of other microvillar and
ultrasound examinations were consistent with it. From 3 pregnancies with GGT
activity in the range of 3-5 percentiles and abnormal activities of other
microvillar enzymes, the CF was confirmed only in one aborted foetus with
meconium ileus and with abnormal ultrasound examination. In other 2 pregnancies
with normal ultrasound, healthy children were delivered. In 3 pregnancies with
the GGT in the range of 5-10 percentiles and abnormal other microvillar enzymes,
one false negative GGT and ultrasound examination was disclosed. The other 2
aborted foetuses did not exhibit the signs of CF in necropsy examinations. The
meconium ileus was found in 2/4 of aborted foetuses with GGT lower than 3
percentiles, abnormal activities of other microvillar enzymes and abnormal
ultrasound examination. The ultrasound examination was correct in 2/10 of
pregnancies with GGT lower than 3 percentiles or abnormal activities of other
microvillar enzymes. The GGT examination in 19th-21st weeks provided similarly
reliable diagnostic results. The importance of fetal karyotyping and ultrasound
elimination of other severe congenital anomalies is pointed out for critical
interpretation of microvillar enzyme activities testing.
------------------------------------------------------------------------------------------------------------------------------------------------
Magdolen V, Oechsner U, Muller G,
Bandlow W. Institute for
Genetics and Microbiology, Munich, Federal Republic of Germany.
The intron-containing gene
for yeast profilin (PFY) encodes a vital function.
Mol Cell Biol. 1988 Dec: 8(12): 5108-15.
The gene coding for profilin (PFY), an actin-binding protein, occurs as a single
copy in the haploid genome of Saccharomyces cerevisiae and is required for spore
germination and cell viability. Displacement of one gene copy in a diploid cell
by a nonfunctional allele is recessively lethal: tetrad analysis yields only two
viable spores per ascus. The PFY gene maps on chromosome XV and is linked to the
ADE2 marker. The primary transcript of about 1,000 bases contains an intron of
209 bases and is spliced into a messenger of about 750 bases. The intron was
identified by comparison with a cDNA clone, which also revealed the 3' end of
the transcript. The 5' end of the mRNA was mapped by primer elongation. The gene
is transcribed constitutively and has a coding capacity for a protein of 126
amino acids. The deduced molecular weight of
------------------------------------------------------------------------------------------------------------------------------------------------
Mages W, Salbaum JM, Harper JF,
Schmitt R. Lehrstuhl fur
Genetik, Universitat Regensburg, Federal Republic of Germany.
Organization and structure
of Volvox alpha-tubulin genes.
Mol Gen Genet. 1988 Aug: 213(2-3):
449-58.
Southern analysis of Volvox genomic DNA revealed two genes homologous to
Chlamydomonas reinhardtii alpha-tubulin cDNA. Restriction fragment length
polymorphism analysis indicated that the two genes are not genetically linked.
Clones representing one of the alpha-tubulin genes have been isolated from a
genomic library of Volvox carteri f. nagariensis. A 3153 bp BamHI fragment
containing the entire alpha-tubulin gene (1802 bp) plus 707 bp of the 5'- and
644 bp of the 3'-untranslated regions has been sequenced, revealing the
following features: (1) the derived alpha-tubulin primary structure of 451 amino
acids is highly conserved, differing in two residues from the alpha 1- and in
two additional residues from the alpha 2-tubulin of C. reinhardtii; (2) in
comparison to the C. reinhardtii genes, the Volvox alpha-tubulin gene contains a
third intron; positions of the other two introns are precisely conserved; (3)
codon usages are biased towards G or C, and against A, in the third position; 19
codons are absent from the alpha-tubulin coding sequence, and 5 of these are not
used in any of 7 compiled Volvox genes; (4) transcription begins with an A, 30
bp downstream of the putative TATA box; upstream of the TATA box is a 14 bp
sequence similar to consensus sequences found in all 4 C. reinhardtii tubulin
genes and believed to regulate promoter function.
------------------------------------------------------------------------------------------------------------------------------------------------
Maggio A, Acuto S, Lo Gioco P, Di
Marzo R, Giambona A, Sammarco P, Caronia F.
Beta A and beta thal DNA
haplotypes in Sicily.
Hum Genet. 1986 Mar: 72(3): 229-30.
A close association between specific restriction fragment polymorphism patterns
and specific mutations in Mediterranean people with thalassemia has been
demonstrated by Kazazian et al. (1984). This finding is useful to characterize
the number and types of mutations in each ethnic group for setting up prenatal
diagnosis in the first trimester of pregnancy by the oligonucleotide technique.
For this reason we studied 99 beta thal and 46 beta A chromosomes in the
Sicilian population. We found seven different cleavage patterns, not considering
two new haplotypes so far uncharacterized. Many of the patients (68.3%) were
genetic compounds for different haplotypes while only 31.7% were haplotype
homozygotes. They may still be thalassemia compound heterozygotes. These
findings confirm the molecular basis of the heterogeneity of beta thalassemia in
Sicily.
------------------------------------------------------------------------------------------------------------------------------------------------
Mardis ER, Roe BA.
University of Oklahoma, Norman 73019.
Automated methods for
single-stranded DNA isolation and dideoxynucleotide DNA sequencing reactions on
a robotic workstation.
Biotechniques. 1989 Sep: 7(8):
840-50.
Automated procedures have been developed for both the simultaneous isolation of
96 single-stranded M13 chimeric template DNAs in less than two hours, and for
simultaneously pipetting 24 dideoxynucleotide sequencing reactions on a
commercially available laboratory workstation. The DNA sequencing results
obtained by either radiolabeled or fluorescent methods are consistent with the
premise that automation of these portions of DNA sequencing projects will
improve the reproducibility of the DNA isolation and the procedures for these
normally labor-intensive steps provides an approach for rapid acquisition of
large amounts of high quality, reproducible DNA sequence data.
------------------------------------------------------------------------------------------------------------------------------------------------
Martiniuk F, Mehler M, Tzall S,
Meredith G, Hirschhorn R.
New York University Medical Center, Department of Medicine, NY 10016.
Sequence of the cDNA and
5'-flanking region for human acid alpha-glucosidase, detection of an intron in
the 5' untranslated leader sequence, definition of 18-bp polymorphisms, and
differences with previous cDNA and amino acid sequences.
DNA Cell Biol. 1990 Mar: 9(2):
85-94.
Acid maltase or acid alpha-glucosidase (GAA) is a lysosomal enzyme that
hydrolyzes glycogen to glucose and is deficient in glycogen storage disease type
II. Previously, we isolated a partial cDNA (1.9 kb) for human GAA; we have now
used this cDNA to isolate and determine sequence in longer cDNAs from four
additional independent cDNA libraries. Primer extension studies indicated that
the mRNA extended approximately 200 bp 5' of the cDNA sequence obtained.
Therefore, we isolated a genomic fragment containing 5' cDNA sequences that
overlapped the previous cDNA sequence and extended an additional 24 bp to an
initiation codon within a Kozak consensus sequence. The sequence of the genomic
clone revealed an intron-exon junction 32 bp 5' to the ATG, indicating that the
5' leader sequence was interrupted by an intron. The remaining 186 bp of 5'
untranslated sequence was identified approximately 3 kb upstream. The promoter
region upstream from the start site of transcription was GC rich and contained
areas of homology to Sp1 binding sites but no identifiable CAAT or TATA box. The
combined data gave a nucleotide sequence of 2,856 bp for the coding region from
the ATG to a stop codon, predicting a protein of 952 amino acids. The 3'
untranslated region contained 555 bp with a polyadenylation signal at 3,385 bp
followed by 16 bp prior to a poly(A) tail. This sequence of the GAA coding
region differs from that reported by Hoefsloot et al. (1988) in three areas that
change a total of 42 amino acids. Direct determination of the amino acid
sequence in one of these areas confirmed the nucleotide sequence reported here
but also disagreed with the directly determined amino acid sequence reported by
Hoefsloot et al. (1988). At two other areas, changes in base pairs predicted new
restriction sites that were identified in cDNAs from several independent
libraries. The amino acid changes in all three ares increased the homology to
rabbit-human isomaltase. Therefore, we believe that our nucleotide sequence for
GAA is more precise. We have also identified single base-pair polymorphisms at
18 sites for human GAA, some of which are not silent.
------------------------------------------------------------------------------------------------------------------------------------
Masson P, Rutherford G, Banks JA,
Fedoroff N. Department
of Embryology Carnegie Institution of Washington Baltimore, Maryland 21210.
Essential large
transcripts of the maize Spm transposable element are generated by alternative
splicing.
Cell. 1989 Aug 25: 58(4): 755-65.
We used in vitro mutagenesis and cDNA cloning to identify new Suppressor-mutator
(Spm) transposable element genes. Frameshift mutations in the ORFs of the tnpA
gene's first intron markedly reduce Spm activity in transgenic tobacco,
indicating that intron sequences encode essential gene products. Evidence is
given that Spm encodes large alternatively spliced transcripts, designated tnpB
(4.9 kb), tnpC (5.7 kb), and tnpD (5.8 kb), comprising all of the tnpA exons,
most of the tnpA intron 1 ORF1 sequence, and either none, part, or all of the
intron 1 ORF2 sequence. Two alternative splice donor sites were identified at
the end of exon 1, and the structure of the different exon 1 sequences suggests
that Spm employs a novel mode of translational regulation.
------------------------------------------------------------------------------------------------------------------------------------------------
Marx J.
Dissecting the complex
diseases.
Science. 1990 Mar 30: 247(4950): 1540-2.
------------------------------------------------------------------------------------------------------------------------------------------------
Mathison L, Winey M, Soref C,
Culbertson MR, Knapp G.
Laboratorie of Genetics, University of Wisconsin, Madison 53706.
Mutations in the anticodon
stem affect removal of introns from pre-tRNA in Saccharomyces cerevisiae.
Mol Cell Biol. 1989 Oct: 9(10):
4220-8.
To evaluate the role of exon domains in tRNA splicing, the anti-codon stem of
proline pre-tRNAUGG from Saccharomyces cerevisiae was altered by site-directed
mutagenesis of the suf8 gene. Sixteen alleles were constructed that encode
mutant pre-tRNAs containing all possible base combinations in the last base pair
of the anticodon stem adjacent to the anticodon loop (positions 31 and 39). The
altered pre-tRNAs were screened by using an in vitro endonucleolytic cleavage
assay to determine whether perturbations in secondary structure affect the
intron excision reaction. The pre-tRNAs were cleaved efficiently whenever
secondary structure in the anticodon stem was maintained through standard base
pairing or G.U interactions. However, most of the pre-tRNAs with disrupted
secondary structure were poor substrates for intron excision. We also determined
the extent to which the suf8 alleles produce functional products in vivo. Each
allele was integrated in one to three copies into a yeast chromosome or
introduced on a high-copy-number plasmid by transformation. The formation of a
functional product was assayed by the ability of each allele to suppress the +1
frameshift mutation his4-713 through four-base codon reading, as shown
previously for the SUF8-1 suppressor allele. We found that alleles containing
any standard base pair or G.U pair at position 31/39 in the anticodon stem
failed to suppress his4-713. We could not assess in vivo splicing with these
alleles because the tRNA products, even if they are made, would be expected to
read a normal triplet rather than a quadruplet codon. However, all of the
alleles that contained a disrupted base pair at position 31/ 39 in the anticodon
stem altered the structure of the tRNA in a manner that caused frameshift
suppression. Suppression indicated that splicing must have occurred to some
extent in vivo even though most of the suppression alleles produced pre-tRNAs
that were cleaved with low efficiency or not at all in vitro. These results have
important implications for the interpretation of in vitro cleavage assays in
general and for the potential use of suppressors to select mutations that
affects tRNA splicing.
------------------------------------------------------------------------------------------------------------------------------------------------
Matoskova B, Rorsman F, Svensson V,
Betsholtz C. Department
of Pathology, University Hospital, Uppsala, Sweden.
Alternative splicing of
the platelet-derived growth factor A-chain transcript occurs in normal as well
as tumor cells and is conserved among mammalian species.
Mol Cell Biol. 1989 Jul: 9(7):
3148-50.
Using a polymerase chain reaction approach, we have analyzed the alternative
usage of the platelet-derived growth factor A-chain exon 6 in mRNA from various
cell types. The results show that this sequence is utilized in a small fraction
of the mRNA molecules in normal as well as transformed cells and that this
phenomenon is conserved among mammalian species.
------------------------------------------------------------------------------------------------------------------------------------------------
Mattick JS.
Centre for Molecular and Cellular Biology, University of Queensland, Brisbane,
Australia.
Introns: evolution and
function.
Curr Opin Genet Dev. 1994 Dec: 4(6):
823-31.
The debate continues on the issue of whether nuclear introns were present in
eukaryotic protein-coding genes from the beginning (introns-early) or invaded
them later in evolution (introns-late). Recent studies concerning the location
of introns with respect to gene and protein structure have been interpreted as
providing strong support for both positions, but the weight of argument is
clearly moving in favour of the latter. Consistent with this, there is now good
evidence that introns can function as transposable elements, and that nuclear
introns derived from self-splicing group II introns, which then evolved in
partnership with the spliceosome. This was only made possible by the separation
of transcription and translation. If introns did colonize eukaryotic genes after
their divergence from prokaryotes, the original question as to the evolutionary
forces that have seen these sequences flourish in the higher organisms, and
their significance in eukaryotic biology, is again thrown open. I suggest that
introns, once established in eukaryotic genomes, might have explored new genetic
space and acquired functions which provided a positive pressure for their
expansion. I further suggest that there are now two types of information
produced by eukaryotic genes--mRNA and iRNA--and that this was a critical step
in the development of multicellular organisms.
------------------------------------------------------------------------------------------------------------------------------------
McGee TL, Yandell DW, Dryja TP.
Department of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear
Infirmary, Boston 02114.
Structure and partial
genomic sequence of the human retinoblastoma susceptibility gene.
Gene. 1989 Aug 1: 80(1): 119-28.
This report describes the genomic organization of the human retinoblastoma
susceptibility locus. This gene spans approximately 200 kb of DNA within human
chromosome 13, band q14. The previously determined cDNA sequence comprises 27
exons, ranging in size from 31 bp to 1873 bp, and 26 introns, ranging in size
from 80 bp to 70,500 bp. We have mapped the positions of the exons and the
positions of the recognition sites for six restriction endonucleases. We also
present the sequence of 9.2% of the locus (18,335 bp), including approximately
200 bp of intron sequence immediately flanking each exon. This map of a
wild-type allele will form the foundation for future studies of mutant,
oncogenic alleles at this locus.
------------------------------------------------------------------------------------------------------------------------------------------------
McIntosh I, Curtis A, Millan FA,
Brock DJ. Human Genetics
Unit, University of Edinburgh, Western General Hospital, U.K.
Prenatal exclusion testing
for Huntington disease using the polymerase chain reaction.
Am J Med Genet. 1989 Feb: 32(2):
274-6.
Prenatal exclusion of Huntington disease (HD) may be carried out by analysis of
cosegregating DNA markers on a first-trimester chorionic villus sample. The
conventional Southern blot method is time-consuming and requires microgram
quantities of DNA and milligram quantities of villus tissue. The use of the
polymerase chain reaction (PCR) to amplify genomic DNA by a factor of 10(7) or
more makes it possible to do analyses on very small samples in a few hours and
without recourse to Southern blotting or hybridization with radioactive probes.
We report on a fetus at risk of HD; prenatal testing was carried out by using
the PCR to amplify a polymorphic DNA sequence adjacent to the HD locus. The risk
of the fetus inheriting the HD gene could not be excluded and the pregnancy was
terminated. This represents an example of gene tracking by using amplification
of a restriction fragment length polymorphism at some distance from the relevant
mutation.
------------------------------------------------------------------------------------------------------------------------------------------------
Metherall JE, Collins FS, Pan J,
Weissman SM, Forget BG.
Beta zero thalassemia
caused by a base substitution that creates an alternative splice acceptor site
in an intron.
EMBO J. 1986 Oct: 5(10): 2551-7.
A thalassemic beta-globin gene cloned from a haplotype I chromosome contains a T
to G transversion at position 116 of IVS1 which results in the generation of an
abnormal alternative acceptor splice site. Transient expression studies revealed
a 4-fold decrease in the amount of RNA produced with greater than 99% of it
being abnormally spliced despite preservation of the normal acceptor splice site
at position 130. These results suggest that the mutation at IVS1 position 116
results in beta zero thalassemia. A closely related mutation at position 110 of
IVS1 also generates a novel acceptor site and results in a similar decrease in
total mRNA produced, but approximately 20% of the mRNA produced is normally
spliced and thus the phenotype is that of beta + thalassemia. These observations
suggest that short range position effects may play a dramatic role in the choice
of potential splice acceptor sites. We demonstrate the presence of abnormally
spliced mRNA in reticulocytes of affected individuals and show the mutation at
IVS1 position 116 segregating from the mutation at IVS1 position 110 in a three
generation pedigree. The mutation results in the creation of a MaeI restriction
site, as do a number of other thalassemic mutations, and we demonstrate some
difficulties that may arise in the differential diagnosis of these mutations.
------------------------------------------------------------------------------------------------------------------------------------------------
Miura O, Sugahara Y, Nakamura Y,
Hirosawa S, Aoki N.
First Department of Medicine, Tokyo Medical and Dental University, Japan.
Restriction fragment
length polymorphism caused by a deletion involving Alu sequences within the
human alpha 2-plasmin inhibitor gene.
Biochemistry. 1989 Jun 13: 28(12):
4934-8.
A restriction fragment length polymorphism within the human alpha 2-plasmin
inhibitor gene has been detected by Southern blot hybridization using an alpha
2-plasmin inhibitor cDNA probe. This restriction fragment length polymorphism
can be attributed to the presence of two alleles, A and B, that are distributed
in Hardy-Weinberg equilibrium with frequencies of 73.5% and 2.65%, respectively,
in 66 unrelated Caucasian individuals or with frequencies of 51.0% and 49.0%,
respectively, in 50 unrelated Japanese individuals. The minor allele, B, is due
to a deletion of about 720 base pairs in intron 8 of the alpha 2-plasmin
inhibitor gene. Sequence analysis of the deletion junction in allele B and the
corresponding regions of allele A demonstrated the presence of oppositely
oriented Alu sequences at the 5' and 3' deletion boundaries. These data suggest
that this restriction fragment length polymorphism was caused by intrastrand
recombination between Alu sequences.
------------------------------------------------------------------------------------------------------------------------------------------------
Moller DE, Yokota A, Caro JF, Flier
JS. Charles A. Dana
Research Institute, Boston, Massachusetts.
Tissue-specific expression
of two alternatively spliced insulin receptor mRNAs in man.
Mol Endocrinol. 1989 Aug: 3(8):
1263-9.
Two previously reported insulin receptor cDNA sequences differ by 36 base pairs
(bp) in the distal alpha-subunit, suggesting that alternative mRNA splicing
within the coding region may occur (two insulin receptor isoforms). We developed
a quantitative modification of the polymerase chain reaction technique in order
to detect and characterize differential mRNA splicing at this site within the
distal alpha-subunit. Using RNA derived from a variety of human cell types, we
detected two polymerase chain reaction-amplified cDNA species reflecting the
presence or absence of the above 36 nucleotides. Identity of the two cDNA
species was confirmed by Southern blots, the use of a BANI restriction site
present only in the 36 base pair segment and dideoxy sequencing. The relative
expression of the two mRNA forms varied markedly in a tissue-specific manner.
Buffy coat leukocytes and Epstein-Barr virus-transformed lymphocytes express
only the shorter mRNA. Placenta expresses both species equally; muscle, isolated
adipocytes and cultured fibroblasts express somewhat more of the longer mRNA
(relative ratios of mRNA abundance of 1.51, 3.18, and 2.77, respectively); liver
expresses mostly the longer mRNA (relative ratio of 9.8). In RNA derived from
cultured and fresh cells from patients with several states of insulin
resistance, the relative expression of the two mRNA species was similar to
results obtained with comparable normal tissues. Although the functional
significance of alternative splicing of the insulin receptor mRNA is unknown,
differential expression of these two receptor mRNAs may provide a structural
basis for previously observed tissue-specific differences in insulin binding and
action.
------------------------------------------------------------------------------------------------------------------------------------------------
Monteiro MJ, Cox RA.
Primary structure of an
alpha-tubulin gene of Physarum polycephalum.
J Mol Biol. 1987 Feb 5: 193(3):
427-38.
An alpha-tubulin gene of Physarum was isolated as a phage-lambda NM1149
recombinant (designated phage-lambda N alpha Tu). Phage-lambda N alpha Tu
contained a 4700 base-pair HindIII nuclear DNA fragment of an allele of the altB
locus of Physarum (one of four unlinked alpha-tubulin gene loci). Subfragments
of the 4700 base-pair insert of phage-lambda N alpha Tu were cloned into phage
M13 and the nucleotide sequence was determined by the dideoxy chain termination
method. The start point of transcription was identified by primer extension and
a putative polyadenylation site was located by S1 nuclease analysis. The 4650
base-pair HindIII insert into phage-lambda N alpha Tu spans the complete gene;
sequences upstream from the 5' end contain the RNA transcription promoter
elements (the TATA and CCAAT boxes). The nucleotide sequence encoding alpha-tubulin
contains seven intervening sequences, ranging from 63 to 222 nucleotides in
size. The exons have a sequence that is identical with a Physarum alpha-tubulin
cDNA clone, except for three base changes, one leading to a Val codon in place
of a Met codon, another leading to a Glu codon in place of an Asp codon, and the
third change is silent. The genomic clone provides the nucleotide sequence
coding for the last 26 amino acid residues missing from the cDNA clone. The new
sequence data indicate that the alpha-tubulin gene has a C-terminal methionine
codon and not a tyrosine codon, which has been found in all alpha-tubulin genes
sequenced to date.
------------------------------------------------------------------------------------------------------------------------------------------------
Moschonas N, de Boer E, Flavell RA.
The DNA sequence of the 5'
flanking region of the human beta-globin gene: evolutionary conservation and
polymorphic differences.
Nucleic Acids Res. 1982 Mar 25:
10(6): 2109-20.
We have determined the DNA sequence of a 1464 bp segment immediately flanking
the 5' side of the human beta-globin gene. The sequence shows little similarity
to the corresponding regions of the epsilon- or gamma-globin genes. There is
about 75% homology, however, between the 5' extragenic regions of the beta-globin
genes of man, goat and rabbit respectively. The mouse beta minor globin gene,
but not the mouse beta major globin gene, also shares this extensive homology. A
short segment of simple sequence DNA is found from about 1418 to 1388 bp
upstream from the human beta-globin gene which consists of repeats of the
sequence (TTTTA). Similar DNA sequences are also found at several sites in the
large intron of the beta-globin gene. We have compared the DNA sequence of the
5' extragenic region of the normal beta-globin gene with the same segment of the
beta-globin gene of a patient with beta thalassaemia. Of the two nucleotide
differences observed, one generates a polymorphic HinfI site present 990 bp
upstream from the beta-globin gene in the thalassaemic beta-globin and absent in
the normal gene. A second beta thalassemic beta-globin gene which has the same
molecular defect as the above mentioned case, however, lacks this HinfI site. It
is therefore not yet clear whether this HinfI site will have any value in
prenatal diagnosis of beta thalassaemia.
------------------------------------------------------------------------------------------------------------------------------------------------
Murray JC, Buetow KH, Donovan M,
Hornung S, Motulsky AG, Disteche C, Dyer K, Swisshelm K, Anderson J, Giblett E,
et al.
Linkage disequilibrium of
plasminogen polymorphisms and assignment of the gene to human chromosome
6q26-6q27.
Am J Hum Genet. 1987 Apr: 40(4):
338-50.
Linkage disequilibrium was observed between newly identified DNA polymorphisms
and a previously described protein polymorphism for plasminogen. This finding
implies that the two types of polymorphisms describe variation at the same
locus. The plasminogen gene was mapped to chromosomal bands 6q26-q27 using
somatic-cell hybrids and in situ hybridization. Linkage disequilibrium between
protein and DNA polymorphisms has utility in substituting for protein typing in
instances where only DNA samples are available, such as from deceased
individuals or extinct species. The technique may be useful when
cross-hybridizing sequences make the interpretation of Southern blot patterns
difficult and may obviate the need for extensive DNA sequencing. In some cases,
disequilibrium may provide information useful for determining the appropriate
direction for chromosome walks from a marker locus to a target locus.
------------------------------------------------------------------------------------------------------------------------------------------------
Nafa K, Meriane F, Reghis A,
Benabadji M, Demenais F, Guilloud-Bataille M, Sultan Y, Kaplan JC, Delpech M.
Centre de Transfusion Sanguine, CHU Mustapha, Alger, Algeria.
Investigation of factor
VIII:C gene restriction fragment length polymorphisms and search for deletions
in hemophiliac subjects in Algeria.
Hum Genet. 1990 Apr: 84(5): 401-5.
The frequency of alleles for intragenic (intron 17 and intron 25) and extragenic
(DXS15 and DXS52) F8C RFLPs was investigated in the Algerian population.
Altogether 287 X chromosomes (97 males and 95 females) were studied. The allele
frequencies found with the two intragenic F8C RFLPs were not substantially
different from those reported in a Mediterranean population. At the highly
polymorphic extragenic DXS52 locus the distribution in Algeria differed from
that found in France. A new allele (14 kb), called 1 DZ, was found in 3.1% of
the chromosomes. Fifty-one families with hemophilia A were studied with the same
probes (374 subjects). Of the females, 94% were informative for at least one
intra- or extragenic RFLP. Two recombinations were found between DXS52 and F8C,
of which one occurred between the DXS15, DXS52 block and F8C, indicating that
the two anonymous loci are on the same side of the F8C gene. Only two obvious
gene deletions were observed in 73 unrelated hemophiliacs: one encompassed exons
14-22 (about 4.3 kb of cDNA and 36 kb of genomic DNA); the other removed the
last exon (exon 26, representing 2 kb of cDNA).
------------------------------------------------------------------------------------------------------------------------------------------------
Nakamura Y, Leppert M, O'Connell P,
Wolff R, Holm T, Culver M, Martin C, Fujimoto E, Hoff M, Kumlin E, et al.
Variable number of tandem
repeat (VNTR) markers for human gene mapping.
Science. 1987 Mar 27: 235(4796):
1616-22.
A large collection of good genetic markers is needed to map the genes that cause
human genetic diseases. Although nearly 400 polymorphic DNA markers for human
chromosomes have been described, the majority have only two alleles and are thus
uninformative for analysis of genetic linkage in many families. A few known
marker systems, however, detect loci that respond to restriction enzyme cleavage
by producing a fragment that can have many different lengths. This polymorphism
is due to variation in the number of tandem repeats of a short DNA sequence.
Because most individuals will be heterozygous at such loci, these markers will
provide linkage information in almost all families. Ten oligomeric sequences
derived from the tandem repeat regions of the myoglobin gene, the zeta-globin
pseudogene, the insulin gene, and the X-gene region of hepatitis B virus, were
used to develop a series of single-copy probes. These probes revealed new,
highly polymorphic genetic loci whose allele sizes reflected variation in the
number of tandem repeats.
------------------------------------------------------------------------------------------------------------------------------------------------
Nakamura
Y, Lathrop M, O'Connell P, Leppert M, Barker D, Wright E, Skolnick M,
Kondoleon S, Litt M, Lalouel JM, et al (Howard
Hughes Medical Institute, University of Utah Health Sciences Center, Salt Lake
City 84132.)
A mapped
set of DNA markers for human chromosome 17.
Genomics. 1988 May: 2(4): 302-9.
We have developed and mapped by genetic linkage a primary set of markers for
chromosome 17. The map consists of 21 loci derived from 27 probe/enzyme
systems, including eight highly informative markers at loci containing a
variable number of tandemly repeated DNA sequences (VNTRs). The map is
continuous from the telomeric region of the short arm to the telomeric region
of the long arm, covering estimated genetic distances of 218 cM in males and
279 cM in females. The average heterozygosity among all 21 loci in the
population sample analyzed is 58%; 77% heterozygosity was observed among the
eight VNTR markers that were highly informative. This map will make it
possible to detect by linkage the location of genetic defects associated with
chromosome 17 and will also provide anchor points for a high-resolution map of
this chromosome.
------------------------------------------------------------------------------------------------------------------------------------Nakamura
Y, Carlson M, Krapcho K, Kanamori M, White R (Howard
Hughes Medical Institute, University of Utah Health Sciences Center, Salt Lake
City 84132).
New
approach for isolation of VNTR markers.
Am J Hum Genet. 1988 Dec: 43(6): 854-9.
Elsewhere we have reported an efficient method for isolating VNTR (Variable
Number of Tandem Repeats) markers. Several of the VNTR markers isolated in
those experiments were sequenced, and a DNA sequence of 9 bp (GNNGTGGG)
emerged as an apparent consensus sequence for VNTR markers. To confirm this
result and to develop more VNTR markers, we synthesized nine different
18-base-long oligonucleotides whose sequences each included GNNGTGGG. When 102
cosmid clones selected by these oligonucleotides were tested for polymorphism,
34 (33%) of them showed multiallelic VNTR polymorphisms (average
heterozygosity 68%). This procedure represents a new and efficient approach
for isolating additional VNTR markers and supports the idea that the GNNGTGGG
sequence may play an important role in the generation of the multiallelic
systems within the human genome.
Nakamura Y, Miura O, Sugahara Y,
Maseki N, Kaneko Y, Aoki N.
First Department of Medicine, Tokyo Medical and Dental University, Japan.
DNA rearrangement and
restriction fragment length polymorphism within the first BCR intron in
Philadelphia-positive acute leukemia.
Am J Hematol. 1989 Sep: 32(1): 24-9.
In some patients with Philadelphia (Ph)-chromosome positive acute lymphoblastic
leukemias, breakpoints on chromosome 22 are reported to occur within the first
BCR intron. To analyze the breakpoints in chromosome 22 of Ph-positive acute
leukemia patients without rearrangement of the 5.8 kb bcr, we cloned the 3' part
of the first BCR intron using a synthetic DNA probe. During the course of study,
we mapped the region of the deletion/insertion of 1 kb that causes a restriction
fragment length polymorphism (RFLP) and found a racial difference in the
frequencies of the alleles giving rise to this RFLP. Analyses of the patients'
samples indicated that breakpoints were located within the 8.5 kb EcoRl fragment
of the first BCR intron in two of five Ph-positive acute leukemia patients. The
data, together with the previous reports, indicate that breakpoints within this
approximately 50 kb intron are widely scattered, in contrast to those confined
within the 5.8 kb bcr in chronic myelogenous leukemias.
------------------------------------------------------------------------------------------------------------------------------------------------
Nakano T, Suzuki K.
Department of Neurology, University of North Carolina School of Medicine, Chapel
Hill 27599.
Genetic cause of a
juvenile form of Sandhoff disease. Abnormal splicing of beta-hexosaminidase beta
chain gene transcript due to a point mutation within intron 12.
J Biol Chem. 1989 Mar 25: 264(9):
5155-8.
Abnormal beta-hexosaminidase beta chain cDNA clones were isolated from a library
constructed from cultured fibroblasts of a patient with a juvenile form of
Sandhoff disease (genetic beta-hexosaminidase A and B deficiency). Sequence
analysis of a cDNA clone isolated from these fibroblasts contained an extra
24-base segment between exons 12 and 13. This segment was identified as the 3'
terminus of intron 12. The remainder of the coding sequence was completely
normal. The same 24-base insertion was found in four additional clones by
sequencing. Restriction mapping analysis of seven other clones was consistent
with the presence of the same 24-base intron 12 segment. This insertion is
inframe and adds 8 amino acids between amino acids 491 and 492 of the primary
sequence of the normal enzyme protein. It is located only 5 amino acids away
from a possible glycosylation site. The finding is consistent with the slightly
larger than normal size of the beta subunit precursor protein observed by
immunoprecipitation. No normally spliced mRNA was detected. Gene amplification
by the polymerase chain reaction and subsequent sequencing of genomic DNA
indicated that the patient was a compound heterozygote. In one allele, there was
a single nucleotide transition from normal G to A at 26 bases from the 3'
terminus of intron 12. This mutation generates a consensus sequence for the 3'
splice site for an intron, CAG/G, and thus explains the abnormal mRNAs that
retain 24 bases of the 3' terminus of intron 12. The intron 12 and flanking
exons 12 and 13 sequences were normal in the other allele, which is a priori
also genetically abnormal. The other mutant allele therefore is likely to be of
an mRNA-negative type.
------------------------------------------------------------------------------------------------------------------------------------------------
Nam HG, Giraudat J, Den Boer B,
Moonan F, Loos W, Hauge BM, Goodman HM.
Department of Genetics, Harvard Medical School and Department of Molecular
Biology, Massachusetts General Hospital, Boston, Massachusetts 02114.
Restriction Fragment
Length Polymorphism Linkage Map of Arabidopsis thaliana.
Plant Cell. 1989 Jul: 1(7): 699-705.
We have constructed a restriction fragment length polymorphism (RFLP) linkage
map of the nuclear genome of the small flowering plant Arabidopsis thaliana. The
map is based on the meiotic segregation of both RFLP and morphological genetic
markers from five independent crosses. The morphological markers on each of the
five chromosomes were included in the crosses to allow alignment of the RFLP map
with the established genetic map. The map contains 94 new randomly distributed
molecular markers (nine identified cloned Arabidopsis genes and 85 genomic
cosmid clones) that detect polymorphisms between the Landsberg erecta and
Columbia races. In addition, 17 markers from an independently constructed RFLP
map of the Arabidopsis genome [Chang, C., Bowman, J.L., DeJohn, A.W., Lander,
E.S., and Meyerowitz, E.M. (1988). Proc. Natl. Acad. Sci. USA 85, 6856-6860]
have been included to permit integration of the two RFLP maps.
------------------------------------------------------------------------------------------------------------------------------------------------
Newgard CB, Fletterick RJ, Anderson
LA, Lebo RV.
The polymorphic locus for
glycogen storage disease VI (liver glycogen phosphorylase) maps to chromosome
14.
Am J Hum Genet. 1987 Apr: 40(4):
351-64.
Human liver glycogen phosphorylase deficiency, also known as glycogen storage
disease type VI (GSD VI) or Hers disease, is characterized by hepatomegaly and
reduced or absent glycogenolytic response to the injection of glucagon. The
recently isolated cDNA encoding the liver isozyme of glycogen phosphorylase was
used to map the gene and identify restriction-fragment polymorphisms in normal
Caucasians as a prerequisite for detecting linked GSD VI abnormalities. Results
of restriction-enzyme analysis using a downstream fragment of the liver glycogen
phosphorylase cDNA indicated the existence of a single gene copy per haploid
genome. Hybridization of this downstream liver phosphorylase probe to dual
laser-excited, sorted human chromosomes localized the gene to human chromosome
14. When the downstream probe was tested on genomic DNA cut with seven different
restriction enzymes, a single MspI restriction-fragment-length polymorphism (RFLP)
was observed in a single individual. In contrast, similar Southern blots
performed with an upstream portion of the cDNA encoding liver phosphorylase
revealed common RFLPs for four of eight enzymes tested, with minor polymorphic
allele frequencies ranging from 33% to 44%. One of the four enzymes (TaqI)
revealed two independent polymorphisms. If random distribution of these
haplotypes among normal and disease loci, is assumed, approximately 92% of
fetuses at risk for Hers disease will be informative when tested with the
upstream liver phosphorylase probe.
------------------------------------------------------------------------------------------------------------------------------------
Newton CR, Heptinstall LE, Summers
C, Super M, Schwarz M, Anwar R, Graham A, Smith JC, Markham AF.
ICI Diagnostics, Gadbrook Park, Northwich, Cheshire.
Amplification refractory mutation
system for prenatal diagnosis and carrier assessment in cystic fibrosis.
Lancet. 1989 Dec 23-30: 2(8678-8679): 1481-3.
The amplification refractory mutation system (ARMS) has been applied to prenatal
diagnosis and carrier detection of cystic fibrosis. The nucleotide sequence of
both alleles of the PstI restriction fragment length polymorphism at the KM19
locus, which displays linkage disequilibrium with cystic fibrosis, has been
determined. ARMS enables direct analysis of alleles of this polymorphism in DNA
isolated from chorionic villus biopsy or white blood cells.
------------------------------------------------------------------------------------------------------------------------------------------------
Nottenburg C, St John T, Weissman
IL.
Unusual immunoglobulin DNA
sequences from the nonexpressed chromosome of mouse normal B lymphocytes:
implications for allelic exclusion and the DNA rearrangement process.
J Immunol. 1987 Sep 1: 139(5):
1718-26.
Allelic exclusion of immunoglobulin gene products results in the expression of
only one of two possible alleles in normal B lineage cells. Attempts to define
the role of heavy chain gene rearrangements in this process have revealed the
nonexpressed allele to be rarely in its germline context, but rather
incompletely rearranged (D/J rearrangements) or completely rearranged (V/D/J
rearrangements) and in a context that cannot be expressed as a protein. Nearly
all DNA sequences of heavy chain genes from the nonexpressed allele have
originated from plasmacytomas, virus-induced pre-B leukemias, and hybridomas--all
clonal cell lines perhaps altered by the neoplastic process. In this
communication, we present the first examples of isolation and DNA sequence
analysis of heavy chain gene rearrangements from the nonexpressed allele of
normal B lymphocytes. Splenic B lymphocytes from allotype heterozygous (BALB/c X
C57BL/6J)F1 mice expressing the BALB/c IgD allotype were detected with a
monoclonal antibody, H10-4.22, to the BALB/c delta chain genetic marker and were
isolated with a FACS (fluorescence-activated cell sorter). lambda phage clones
containing the JH gene region from the sorted cells were isolated, and those
containing sequences derived from the C57BL/6J nonexpressed chromosome were
identified by a restriction fragment length polymorphism. DNA sequences of seven
rearranged clones from the nonexpressed allele are presented. Five of these
rearrangements have unexpected compositions. Four of the five clones contain
V/D/J rearrangements with no obvious impediments to expression generated by the
rearrangements. The novel variable region gene in one of these V/D/J
rearrangements is a member of a newly described VH gene family. The fifth clone
has a 3.5 kb deletion removing all of the JH gene segments. The remaining two
clones contain D/J rearrangements that are typical of the initial stage of
variable region assembly. These findings suggest that the mechanisms that
generate nontranslatable heavy chains do not exclusively account for allelic
exclusion. Rather, several different mechanisms may contribute to the
establishment of allelic exclusion in normal B lymphocytes.
------------------------------------------------------------------------------------------------------------------------------------------------
Nozari G, Rahbar S, Wallace RB.
City of Hope National Medical Center, Duarte, California 91010.
Haplotype analysis of the
human beta-globin gene complex using multiple locus specific oligonucleotide
probes.
Anal Biochem. 1988 Jul: 172(1):
180-4.
Three oligonucleotide probes complementary to specific DNA sequences of the six
human globin genes (epsilon, G gamma, A gamma, psi beta, delta, beta) were
synthesized. The oligonucleotides were used either singly or in combination as
hybridization probes to determine the haplotype of the human beta-globin gene
cluster employing the four conventionally used restriction endonucleases HincII,
HindIII, AvaII, and BamHI, in addition to HpaI. Polymorphism in the epsilon- and
psi beta-genes (HincII) can be simultaneously determined with a single probe
mixture. One of the probes complementary to both the psi beta- and gamma-genes
is useful for determining both HindIII and HincII polymorphisms. The advantages
of these probes relative to conventional cDNA probes are discussed.
------------------------------------------------------------------------------------------------------------------------------------------------
Ochman H, Gerber AS, Hartl DL.
Department of Genetics, Washington University School of Medicine, St. Louis,
Missouri 63110.
Genetic applications of an inverse
polymerase chain reaction.
Genetics. 1988 Nov: 120(3): 621-3.
A method is presented for the rapid
in vitro amplification of DNA sequences that flank a region of known sequence.
The method uses the polymerase chain reaction (PCR), but it has the primers
oriented in the reverse direction of the usual orientation. The template for the
reverse primers is a restriction fragment that has been ligated upon itself to
form a circle. This procedure of inverse PCR (IPCR) has many applications in
molecular genetics, for example, the amplification and identification of
sequences flanking transposable elements. In this paper we show the feasibility
of IPCR by amplifying the sequences that flank an IS1 element in the genome of a
natural isolate of Escherichia coli.
------------------------------------------------------------------------------------------------------------------------------------
O'Hara PJ, Grant FJ.
ZymoGenetics, Inc., Seattle, WA 98103.
The human factor VII gene
is polymorphic due to variation in repeat copy number in a minisatellite.
Gene. 1988 Jun 15: 66(1): 147-58.
The gene coding for human factor VII, a vitamin K-dependent coagulation factor,
contains five minisatellite imperfect tandem repeats with monomer element
lengths ranging from 14 to 37 bp, and copy numbers ranging from 6 to 52. Three
of these repeats are entirely within introns, one is entirely in an untranslated
portion of an exon, and one spans an exon-intron border and contains coding
sequence. A consensus sequence derived from a comparison of the monomers is
similar to a core sequence found in other minisatellites. All of the
minisatellites display higher-order periodicities. At least one of these
minisatellites is polymorphic. A variation in repeat copy number has been
observed in a tandem-repeat region in the seventh factor-VII intron.
------------------------------------------------------------------------------------------------------------------------------------------------
Ohno K, Suzuki K.
Department of Neurology, University of North Carolina School of Medicine, Chapel
Hill 27599.
A splicing defect due to
an exon-intron junctional mutation results in abnormal beta-hexosaminidase alpha
chain mRNAs in Ashkenazi Jewish patients with Tay-Sachs disease.
Biochem Biophys Res Commun. 1988 May
31: 153(1): 463-9.
Abnormal beta-hexosaminidase alpha chain mRNAs from an Ashkenazi Jewish patient
with the classical infantile Tay-Sachs disease contained intact or truncated
intron 12 sequences. Sequence analysis showed a single nucleotide transversion
at the 5' donor site of intron 12 from the normal G to C. This provides the
first evidence that this junctional mutation, also found independently in two
other laboratories by analysis of genomic clones, results in functional
abnormality. Analysis with normal and mutant oligonucleotides as probes
indicated that our patient was a compound heterozygote with only one allele
having the transversion. The patient studied in the other two laboratories was
also a compound heterozygote. Another Ashkenazi Jewish patient was normal in
this region in both alleles. Thus, the splicing defect is the underlying genetic
cause in some but not all Ashkenazi Jewish patients with Tay-Sachs disease.
------------------------------------------------------------------------------------------------------------------------------------------------
Old JM, Heath C, Fitches A, Thein
SL, Jeffreys AJ, Petrou M, Modell B, Weatherall DJ.
Meiotic recombination
between two polymorphic restriction sites within the beta globin gene cluster.
J Med Genet. 1986 Feb: 23(1): 14-8.
Analysis of beta globin gene haplotypes for prenatal diagnosis of beta
thalassaemia has revealed a recombination event within the beta globin gene
cluster. Both a change in the AvaII polymorphic site within the beta globin gene
and a change in the phenotype of the beta globin gene were observed. Paternity
was established by the pedigree analysis of hypervariable 'minisatellite' DNA
polymorphisms and the most probable explanation of the recombination event is a
crossover between the psi beta globin gene and the beta globin gene. The data
provide direct evidence in support of a DNA region 3' to the beta globin gene
with a recombination frequency much higher than expected, and have important
implications for the prenatal diagnosis of beta thalassaemia by linked
restriction fragment length polymorphisms.
------------------------------------------------------------------------------------------------------------------------------------------------
Olson M, Hood L, Cantor C, Botstein
D. Department of
Genetics, Washington University School of Medicine, St. Louis, MO 63110.
`
A common language for
physical mapping of the human genome.
Science. 1989
Sep 29: 245(4925): 1434-5. Comment in:
Science. 1990 Apr 6;248(4951):18.
------------------------------------------------------------------------------------------------------------------------------------------------
Orkin SH, Kazazian HH Jr,
Antonarakis SE, Goff SC, Boehm CD, Sexton JP, Waber PG, Giardina PJ.
Linkage of beta-thalassaemia
mutations and beta-globin gene polymorphisms with DNA polymorphisms in human
beta-globin gene cluster.
Nature. 1982 Apr 15: 296(5858):
627-31.
------------------------------------------------------------------------------------------------------------------------------------------------
Orkin SH, Kazazian HH Jr,
Antonarakis SE, Ostrer H, Goff SC, Sexton JP.
Abnormal RNA processing
due to the exon mutation of beta E-globin gene.
Nature. 1982 Dec 23: 300(5894):
768-9.
As is typical of all beta-thalassaemias, the erythroid cells of individuals with
the variant haemoglobin E (alpha 2 beta 2(26Glu leads to Lys)) exhibit a
quantitative deficiency in their content of beta-globin (in this case beta E-globin)
and its messenger RNA2,3. To determine the molecular basis of this phenotype, we
have investigated the structure and expression of cloned beta E-globin genes. We
report here that the complete nucleotide sequence of a beta E-gene revealed the
expected GAG leads to AAG change in codon 26 but no other mutations. Expression
of beta E-globin genes introduced into HeLa cells revealed two abnormalities of
RNA processing: slow excision of intervening sequence-1 (IVS-1) and alternative
splicing into exon-1 at a cryptic donor sequence within which the codon 26
nucleotide substitution resides. These results demonstrate a disturbance in the
expression of the beta E-gene attributable solely to the exon mutation-a novel
mechanism for gene dysfunction.
------------------------------------------------------------------------------------------------------------------------------------------------
Orkin SH, Cheng TC, Antonarakis SE,
Kazazian HH Jr.
Thalassemia due to a mutation in the
cleavage-polyadenylation signal of the human beta-globin gene.
EMBO J. 1985 Feb: 4(2): 453-6.
A beta-globin gene cloned from a person with beta-thalassemia contained a T----C
substitution within the conserved sequence AATAAA that forms a portion of the
recognition signal for endonucleolytic cleavage and polyadenylation of primary
mRNA transcripts. By Northern blot analysis a novel beta-globin RNA species,
1500 nucleotides in length, was detected in erythroid RNA. Nuclease protection
studies of erythroid RNA, as well as RNA generated upon transient expression of
the cloned mutant gene in HeLa cells, located the 3' terminus of this novel,
polyadenylated RNA 900 nucleotides downstream of the normal poly(A) addition
site, within 15 nucleotides of the first AATAAA in the 3'-flanking region of the
beta-globin gene. These findings define the in vivo terminus of an elongated RNA
and establish that human beta-globin transcription may extend at least 900
nucleotides 3' of the normal polyadenylation site.
------------------------------------------------------------------------------------------------------------------------------------------------
Palsdottir A, Fossdal R, Arnason A,
Edwards JH, Jensson O.
Heterogeneity of human C4
gene size. A large intron (6.5 kb) is present in all C4A genes and some C4B
genes.
Immunogenetics. 1987: 25(5):
299-304.
In this article we present a study showing that the human C4 genes differ in
length because of the presence or absence of a 6.5 kb intron near the 5' end of
the gene. DNA from individuals of known HLA, factor B, and C4 haplotypes was
analyzed for restriction fragment length polymorphism (RFLP) by Southern blot
analysis with C4-specific cDNA probes. The RFLP patterns obtained showed that
the C4 genes are either 22.5 kb or 16 kb in length. They are referred to as long
and short C4 genes, respectively. A population study was carried out to examine
the distribution of the gene size according to C4 allotypes and haplotypes. Long
C4 genes included all C4A genes studied and also some C4B allotypes, e.g., B1 on
most C4 A3B1 haplotypes. Similarly, C4B null genes were found to be of the long
form. Other C4B allotypes tested were found to be coded for by short C4 genes,
including B2, B1 in C4 A6B1 and C4 AQOB1 (with a single C4B gene haplotype).
------------------------------------------------------------------------------------------------------------------------------------------------
Paolella G, Santamaria R, Buono P,
Salvatore F. Istituto di
Scienze Biochimiche, II Facolta di Medicina e Chirurgia, Universita degli Studi
di Napoli, Italy.
Mapping of a restriction
fragment length polymorphism within the human aldolase B gene.
Hum Genet. 1987 Oct: 77(2): 115-7.
Peripheral blood DNA was hybridized to the full-length cDNA and the cloned
structural gene of human aldolase B. With PvuII endonuclease a restriction
fragment length polymorphism was detected that was present in the heterozygous
state in about 21% of the individuals tested. A map of the human aldolase gene
was constructed for the two groups of individuals found to produce different
fragments after PvuII digestion. This allowed the localization of the
polymorphic site within the gene, which was found to be due to the loss of a
PvuII site in the last intron upstream from the 3' end. This polymorphism may be
used as a genetic marker to study individuals affected by hereditary fructose
intolerance.
------------------------------------------------------------------------------------------------------------------------------------------------
Parker R, Siliciano PG, Guthrie C.
Recognition of the TACTAAC
box during mRNA splicing in yeast involves base pairing to the U2-like snRNA.
Cell. 1987 Apr 24: 49(2): 229-39.
The U2 snRNP binds to the site of branch formation during splicing of mammalian
pre-mRNA in vitro. In Saccharomyces cerevisiae the branch site is within the
so-called TACTAAC box (UACUAAC box), an absolutely conserved intron sequence
required for splicing. Based on the identification and sequence of a U2 analogue
in yeast, a specific base pairing interaction between the UACUAAC box and a
highly conserved region of this snRNA can be proposed. To test this hypothesis,
we have taken advantage of two mutations constructed previously in the UACUAAC
box of an actin-HIS4 fusion. These mutant strains were transformed with stable
plasmids bearing U2-like snRNAs into which changes predicted to restore base
pairing had been introduced. Allele-specific suppression of biological and
biochemical phenotypes was observed in both cases. Recognition of the UACUAAC
box thus relies, at least in part, on Watson-Crick base pairing with the yeast
U2 analogue.
------------------------------------------------------------------------------------------------------------------------------------------------
Patterson M, Gitschier J, Bloomfield
J, Bell M, Dorkins H, Froster-Iskenius U, Sommer S, Sobell J, Schaid D,
Thibodeau S, et al.
Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford,
England.
An intronic region within the human
factor VIII gene is duplicated within Xq28 and is homologous to the polymorphic
locus DXS115 (767).
Am J Hum Genet. 1989 May: 44(5): 679-85.
The genomic sequences recognized by the anonymous probe 767 (DXS115) are
localized to two sites within Xq28. One site lies within intron 22 of the factor
VIII gene (FBC). Physical mapping suggests that the second site lies within 1.2
megabases of the F8C gene. The RFLPs detected by 767 are located within the
second site. Genetic data suggest that F8C and DXS115 are tightly linked (theta
max = .04; Zmax = 8.30). Recombination events in meioses informative for DXS52
(St14), DXS115, and F8C suggest that DXS115 and F8C lie distal to DXS52.
------------------------------------------------------------------------------------------------------------------------------------------------
Paul H, Galton D, Stocks J.
DNA polymorphic patterns
and haplotype arrangements of the apo A-1, apo C-III, apo A-IV gene cluster in
different ethnic groups.
Hum Genet. 1987 Mar: 75(3): 264-8.
The allelic frequency of five different restriction fragment length
polymorphisms (RFLPs) in the A-1, C-III, A-IV gene region has been determined in
Caucasians, Negroes, Indian Asians, and Japanese. The polymorphic sites are with
Taq-1 at the 5' end of the A-1 gene, with Msp-1 in the third intron of the A-1
gene, with Pst-1 in the intergenic sequence between the A-1 and C-III genes,
with Sst-1 in the 3' non-coding region of the C-III gene, and with Pvu-II in the
third intron of the C-III gene. The alleles identified by three of the RFLPs
showed large differences in frequency amongst the races, especially between
Caucasians and non-Caucasians. Alleles of the Msp-1 polymorphism and Sst-1
polymorphism, which were rare in Caucasians (frequencies 0.03 and 0.01), were
more common in Japanese (frequencies 0.37 and 0.35), Indian Asians (frequencies
0.37 and 0.26), and Negroes (frequencies 0.31 and 0.31). In contrast with a Pvu-II
polymorphism one allele was rare in Japanese and in Indian Asians (frequency
0.01) but more common in Caucasians (frequency 0.11). Linkage disequilibrium was
evident between some of the alleles and a total of seven haplotypes were
identified among the different races.
------------------------------------------------------------------------------------------------------------------------------------------------
Peake IR, Bowen D, Bignell P,
Liddell MB, Sadler JE, Standen G, Bloom AL.
Department of Haematology, University of Wales College of Medicine, Cardiff, UK.
Family studies and
prenatal diagnosis in severe von Willebrand disease by polymerase chain reaction
amplification of a variable number tandem repeat region of the von Willebrand
factor gene.
Blood. 1990 Aug 1: 76(3): 555-61.
We have previously demonstrated within intron 40 of the von Willebrand factor (vWF)
gene a region of ATCT repeats that was shown to vary in length between two
different DNA clones from unrelated individuals. The polymerase chain reaction (PCR)
was used to examine the variability in length of this variable number tandem
repeat (VNTR) in 53 normal individuals, using primers to DNA sequence flanking
the repeat region. Overall, eight different length allelic bands were seen.
These were individually sequenced and shown to contain from 6 to 14 ATCT repeats
(a nine-repeat band was not seen). Seventy-five percent of individuals were
shown to be heterozygous for this vWF.VNTR, and family studies showed Mendelian
inheritance with allelic frequencies from 1% (vWF.VNTR [8] and vWF.VNTR [14]) to
39% (vWF.VNTR [7]). In the family of a patient with type III severe von
Willebrand disease (vWD), vWF.VNTR results mirrored the phenotypic data and
results with previously reported intragenic vWF restriction fragment length
polymorphisms (RFLP). The patient was shown to be a compound heterozygote. In a
family with a child with severe type III vWD, prenatal diagnosis by vWF.VNTR
analysis on DNA obtained by chorionic villus sampling at 10 weeks gestation
during a subsequent pregnancy indicated a severely affected fetus. This
diagnosis was confirmed by fetal blood sampling at 18 weeks.
------------------------------------------------------------------------------------------------------------------------------------------------
Petersen MB, Economou EP,
Slaugenhaupt SA, Chakravarti A, Antonarakis SE.
Center for Medical Genetics, Johns Hopkins University School of Medicine,
Baltimore, Maryland 21205.
Linkage analysis of the
human HMG14 gene on chromosome 21 using a GT dinucleotide repeat as polymorphic
marker.
Genomics. 1990 May: 7(1): 136-8.
A (GT)n repeat in intron 4 of the functional human HMG14 gene on chromosome 21
was used as polymorphic marker to map this gene relative to the genetic linkage
map of human chromosome 21. Variation in the length of the (GT)n repeat was
detected by electrophoresis on polyacrylamide gels of DNA amplified by the
polymerase chain reaction using primers flanking the repeat. The observed
heterozygosity of this polymorphism in 40 CEPH families was 58% with six
different alleles. Linkage analysis localized the HMG14 gene close to the ETS2
gene and locus D21S3 in chromosomal band 21q22.3.
------------------------------------------------------------------------------------------------------------------------------------------------
Phillips JA 3rd, Panny SR, Kazazian
HH Jr, Boehm CD, Scott AF, Smith KD.
Prenatal diagnosis of sickle cell
anemia by restriction and endonuclease analysis: HindIII polymorphisms in gamma-globin
genes extend test applicability.
Proc Natl Acad Sci U S A. 1980 May;77(5):2853-6.
Polymorphism for a Hpa I restriction endonuclease site associated with about 60%
of beta S genes in American Blacks allows exact prenatal diagnosis of sickle
cell anemia by amniocentesis in 36% of couples at risk. In three families in
whom exact diagnosis by Hpa I sites was impossible, we found analysis for the
presence of polymorphic HindIII sites in the G gamma and A gamma intervening
sequences would allow an exact prenatal diagnosis of sickle cell status in all
three. In one of these families, the presence of an A gamma HindIII site in
amniocyte DNA confirmed the diagnosis (sickle cell trait) made by synthetic
studies using fetal erythrocytes obtained at fetoscopy. Studies of other Black
families and individuals provide evidence for linkage disequilibrium in the G
gamma-A gamma-delta-beta gene complex involving the four sites, G gamma HindIII,
A gamma HindIII, beta S, and Hpa I, which span 33 kilobases (kb). Ten of 14
chromosomes bearing a beta S gene in a 7.6-kb Hpa I fragment contained a G gamma
but not an A gamma HindIII site, whereas 16 of 16 chromosomes bearing a beta S
gene in a 13-kb Hpa I fragment lacked both the G gamma and A gamma HindIII
sites. Two-thirds of beta A-bearing chromosomes lacked both G gamma and A gamma
sites, whereas one-third contained either the G gamma or both G gamma and A
gamma sites. These data demonstrate that combined analysis of both Hpa I and
HindIII polymorphisms and verification of their linkage phase should increase
the fraction of couples for whom amniocentesis can provide an exact diagnosis of
sickle cell status from 36% to greater than 80%.
------------------------------------------------------------------------------------------------------------------------------------
Philipsen JN, de Vries JE, Samallo
J, van Dijk C, Arnberg AC, AB G.
Laboratory of Biochemistry, Groningen, The Netherlands.
Characterization of a
polymorphism in the 3' part of the chicken vitellogenin gene.
J Mol Evol. 1989 Mar: 28(3): 185-90.
An allele giving rise to a polymorphism within the 3' part of the chicken
vitellogenin gene was cloned, sequenced, and compared to the previously cloned
allele. The polymorphism is formed by a perfect copy of 343 bp from intron 32 in
tandem array with a perfect copy of 244 bp from intron 33; this 587-bp element
is inserted in a head-to-tail arrangement in intron 33. We propose a mechanism
in which an unequal crossing-over resulted in a vitellogenin gene with two exons
33, one of which was subsequently deleted. Thus, intron 33 was enlarged by the
tandem repeats without affecting the protein-encoding sequence of the gene. At
the boundaries of the repeated elements, two short direct repeats are found that
resemble the recombination signals of immunoglobulin genes. They may have had a
key role in the formation of the new allele.
------------------------------------------------------------------------------------------------------------------------------------------------
Pietu G, Thomas-Maison N, Sie P,
Larrieu MJ, Meyer D.
INSERM U. 143, Hopital de Bicetre, Le Kremlin-Bicetre, France.
Haemophilia A in a female:
study of a family using intragenic and extragenic restriction site
polymorphisms.
Thromb Haemost. 1988 Aug 30: 60(1):
102-6.
Restriction fragment length polymorphisms (RFLPs) were studied in a large
Algerian family which includes 6 haemophiliacs and a previously described case
of female haemophilia A. The female propositus is 66 years old with a normal
karyotype. Her parents are first cousins. Her 3 sons are haemophiliacs and her 3
daughters with affected children are obligate carriers. The proband has an
excessive bleeding tendency and markedly reduced levels of F.VIII (VIII C 0.03
U/ml, VIII Ag 0.01 U/ml) with elevated vWF Ag (2.30 U/ml), similar to the levels
observed in affected males from the family. Four RFLPs can be identified by
Southern blotting after digesting genomic DNA with the restriction enzymes Bcl
I, Bgl I, Kpn I/Xba I and Taq I and hybridization with a 647 bp Stu I/Sca I
F.VIII genomic probe, a 1.8 Kb EcoRI F.VIII cDNA probe, a 1.0 Kb EcoRI/Sst I
fragment of intron 22 and the extragenic probe ST 14, respectively. With these
four RFLPs, the propositus was found to be homozygous for the alleles
segregating in this family with the abnormal X-chromosome. The carrier status
was proven in a granddaughter and excluded in another. In conclusion, this RFLP
linkage analysis is another argument to suggest that the propositus, a rare case
of female haemophilia, is homozygous for the abnormal gene.
------------------------------------------------------------------------------------------------------------------------------------------------
Poncz M, Schwartz E, Ballantine M,
Surrey S.
Nucleotide sequence
analysis of the delta beta-globin gene region in humans.
J Biol Chem. 1983 Oct 10: 258(19): 11599-609.
The continuous DNA sequence of a 16.5-kilobase pair region encompassing the
linked delta beta-globin gene cluster in humans is presented with a detailed
restriction endonuclease map. There are 38 differences (0.5%) in comparison with
published sequence data, corrected for errors in sequencing, resulting in
polymorphic rates of 0.2% in exons and 0.76% in 5'-gene flanking regions.
Fifteen changes result in the generation or elimination of restriction sites
which may be useful in linkage disequilibrium studies. Two pairs of inverted Alu
repeats, a pyrimidine-rich region 5' to delta, and (TG)n, (Pu/Py)n, and (ATTTT)n
tracts 5' to beta are described. Dinucleotide frequencies and deviation from
expected values approximated those found in total human genomic DNA. Regions of
less than 50% A + T content were found associated with Alu sequences, a 150-base
pair region immediately 5' to the beta gene, exon regions from both genes, and
an area 3' to the beta gene. These regions also contained significantly lower
than expected CpG levels compared to other regions, suggesting a possible
relationship between DNA organizational patterns and functionally important
regions. In addition, strand asymmetries in base composition in this region
differ from those associated with the fetal globin genes.
------------------------------------------------------------------------------------------------------------------------------------------------
Potter H, Dressler D.
A 'Southern Cross' method
for the analysis of genome organization and the localization of transcription
units.
Gene. 1986: 48(2-3): 229-39.
A 'Southern Cross' hybridization method is described which permits the rapid
restriction mapping of DNA molecules, up to 40 kb in size, for at least ten
enzymes in a single operation. The procedure allows the full set of
32P-end-labelled fragments derived from one restriction enzyme digest to
intersect and attempt to hybridize to the gel-separated fragments of as many as
ten unlabelled digests immobilized on parallel sheets of filter paper. A
two-dimensional array of hybridization spots is revealed on each recipient
paper, indicating which radioactive and non-radioactive DNA fragments have
sequences in common. A restriction map can then be directly and simply deduced
from the matrix of hybridization spots in each cross-blot. The method affords
advantages over other procedures for obtaining restriction maps in terms of the
time required, the number of restriction enzymes that can be mapped, and the
potential for eliminating ambiguity. It is also sufficiently sensitive to detect
DNA rearrangements and restriction-site polymorphisms in moderately complex
genomes. Furthermore, the procedure is applicable to other aspects of the study
of genome organization: for example, the exon and intron areas of a segment of
cloned genomic DNA can be identified by cross-hybridizing a set of radioactive
restriction fragments from the genomic clone against immobilized RNA from a cell
type of interest.
------------------------------------------------------------------------------------------------------------------------------------------------
Quirk SM, Bell-Pedersen D, Belfort
M. Wadsworth Center for
Laboratories and Research, New York State Department of Health, Albany
12201-0509.
Intron mobility in the
T-even phages: high frequency inheritance of group I introns promoted by intron
open reading frames.
Cell. 1989 Feb 10: 56(3): 455-65.
Intron mobility in the T-even phages has been demonstrated. Efficient
nonreciprocal conversion of intron minus (In-) alleles to intron plus (In+)
occurred for the td and sunY genes, but not for nrdB. Conversion to In+ was
absolutely dependent on expression of the respective intron open reading frame (ORF).
Introns were inserted at their cognate sites in an intronless phage genome via
an RNA-independent, DNA-based, duplicative recombination event that was
stimulated by exon homology. The td intron ORF product directs the
endonucleolytic cleavage of DNA, targeting the site of intron integration. A 21
nucleotide deletion of the integration site abolished high frequency intron
inheritance. These experiments provide a novel example of gene conversion in
prokaryotes, while suggesting a molecular rationale for the inconsistent
distribution of introns within highly conserved exon contexts of the T-even
phage genomes.
------------------------------------------------------------------------------------------------------------------------------------------------
Quirk SM, Bell-Pedersen D,
Tomaschewski J, Ruger W, Belfort M.
New York State Department of Health, Wadsworth Center for Laboratories and
Research, Albany 12201.
The inconsistent
distribution of introns in the T-even phages indicates recent genetic exchanges.
Nucleic Acids Res. 1989 Jan 11:
17(1): 301-15.
Group I self-splicing introns are present in the td, nrdB and sunY genes of
bacteriophage T4. We previously reported that whereas the td intron is present
in T2, T4 and T6, the nrdB intron is present in T4 only. These studies, which
argue in favor of introns as mobile genetic elements, have been extended by
defining the distribution of all three T4 introns in a more comprehensive
collection of T2, T4 and T6 isolates. The three major findings are as follows:
First, all three introns are inconsistently distributed throughout the T-even
phage family. Second, different T2 isolates have different intron complements,
with T2H and T2L having no detectable introns. Third, the intron open reading
frames are inherited or lost as a unit with their respective flanking intron
core elements. Furthermore, exon sequences flanking sites where introns are
inserted in the T4 td, sunY and nrdB genes were determined for all the different
T-even isolates studied. Six of eighteen residues surrounding the junction
sequences are identical. In contrast, a comprehensive comparison of exon
sequences in intron plus and intron minus variants of the sunY gene indicate
that sequence changes are concentrated around the site of intron occurrence.
This apparent paradox may be resolved by hypothesizing that the recombination
events responsible for intron acquisition or loss require a consensus sequence,
while these same events result in sequence heterogeneity around the site.
------------------------------------------------------------------------------------------------------------------------------------------------
Ragusa A, Lombardo M, Bouhassira E,
Beldjord C, Lombardo T, Nagel RL, Labie D, Krishnamoorthy R.
INSERM, Paris.
Nucleotide variations in
the 3' A gamma enhancer region are linked to beta-gene cluster haplotypes and
are unrelated to fetal hemoglobin expression.
Am J Hum Genet. 1989 Jul: 45(1):
106-11.
Molecular cloning and sequence analysis of a nondeletion form of Sicilian beta o
hereditary persistence of fetal hemoglobinemia (HPFH) (mutation in IVS2 nt1
position) homozygous for haplotype III revealed the presence of four sequence
variations: C----T at -158 5' to G gamma, T----C at +2285, C----A at +2476, and
A----G at +2676, all 3' to A gamma. The latter three variations in the putative
A gamma enhancer are identical to those observed in the case of Seattle HPFH.
However, a severe beta o-thalassemia case from Algeria (mutation in IVS1 nt1
position), also homozygous for haplotype III, revealed the same nucleotide
variation, albeit an inefficient HbF production. We conclude that the variations
in the A gamma enhancer element do not play a role in the regulation of HbF
production. To assess both the linkage of these sites with the beta-cluster
haplotype and the extent of the polymorphism, we examined several black and
Mediterranean chromosomes, by PCR amplification followed by both EspI digestion
and oligonucleotide hybridization. Our data indicate that these sequence
variations in the enhancer element are absent in Mediterranean haplotypes I, V,
and VII but are consistently associated with Mediterranean haplotypes II, III,
and IX, as well as with the black beta c-associated haplotype. The common
feature of all the latter haplotypes is the presence of a polymorphic PvuII site
between A gamma and psi beta, which is thus in linkage disequilibrium with the
variations in the A gamma enhancer.
------------------------------------------------------------------------------------------------------------------------------------------------
Rathbun GA, Born W, Kuziel WA,
Tucker PW. Department of
Microbiology, University of Texas Health Science Center, Dallas 75235.
Diversity of the mouse T
cell receptor C gamma 1 gene: structural analysis in C57BL/Ka.
Immunogenetics. 1988: 27(2): 121-6.
We have isolated an unusual T cell receptor gamma chain cDNA clone (gamma 7.1)
from a library made from RNA derived from adult thymus of C57BL/Ka mice. This
cDNA clone corresponds to the appropriately processed C gamma 1 constant region
exons preceded by 1.5 kb of J-C gamma 1 intron. The gamma 7.1 coding region is
extremely homologous to the C gamma 1 gene of BALB/c mice, differing at the
protein level by a single deletion (alanine 139) and a single substitution. This
latter change eliminates the sole N-linked sugar attachment site, providing a
basis for strain-specific glycosylation patterns. The J-C gamma 1 intronic
region contains two DNA segments (termed psi J gamma 1 and psi J gamma 2) that
are highly reminiscent of joining (J) segments; both have potentially functional
recombination and donor splice sequences flanking an open reading frame.
Northern analysis suggests that gamma 7.1 may be derived from a large, variable
region-containing precursor.
------------------------------------------------------------------------------------------------------------------------------------------------
Rathbun GA, Born W, Kuziel WA,
Tucker PW. Department of
Microbiology, University of Texas Health Science Center, Dallas 75235.
Diversity of the mouse T
cell receptor C gamma 1 gene: structural analysis in C57BL/Ka.
Immunogenetics. 1988: 27(2): 121-6.
We have isolated an unusual T cell receptor gamma chain cDNA clone (gamma 7.1)
from a library made from RNA derived from adult thymus of C57BL/Ka mice. This
cDNA clone corresponds to the appropriately processed C gamma 1 constant region
exons preceded by 1.5 kb of J-C gamma 1 intron. The gamma 7.1 coding region is
extremely homologous to the C gamma 1 gene of BALB/c mice, differing at the
protein level by a single deletion (alanine 139) and a single substitution. This
latter change eliminates the sole N-linked sugar attachment site, providing a
basis for strain-specific glycosylation patterns. The J-C gamma 1 intronic
region contains two DNA segments (termed psi J gamma 1 and psi J gamma 2) that
are highly reminiscent of joining (J) segments; both have potentially functional
recombination and donor splice sequences flanking an open reading frame.
Northern analysis suggests that gamma 7.1 may be derived from a large, variable
region-containing precursor.
------------------------------------------------------------------------------------------------------------------------------------------------
Raulf F, Robertson SM, Schartl M.
Genecenter, Max-Planck-Institute for Biochemistry, Munich-Martinsried, Federal
Republic of Germany.
Evolution of the
neuron-specific alternative splicing product of the c-src proto-oncogene.
J Neurosci Res. 1989 Sep: 24(1): 81-8.
The observation of a slower migrating form of pp60c-src in neural tissue of
chicken and mouse has recently been shown to be due to an alternative transcript
form of the c-src gene (Martinez et al.: Science 237:411-415, 1987; Levy et al.:
Mol Cell Biol 7:4142-4145, 1987). An insertion of 18 basepairs between exons 3
and 4, presumed to be due to alternative splicing of a mini-exon, gives rise to
six amino acid residues not found in the non-neuronal (termed fibroblastic) form
of pp60c-src. We have addressed the question of the evolutionary origin of the
c-src neuronal insert and its functional significance regarding neural-specific
expression of the c-src gene. To this end we have investigated whether the c-src
gene of a lower vertebrate (the teleost fish Xiphophorus) gives rise to a
neural-specific transcript in an analogous manner. We could show that the fish
c-src gene does encode for a "fibroblastic" and a "neuronal" form of transcript
and that the neuronal transcript does indeed arise by way of alternative
splicing of a mini-exon. The mini-exon is also 18 basepairs long and we could
demonstrate directly that this exon lies within the intron separating exons 3
and 4. For comparative purposes we have examined whether the fish c-yes gene,
the member of the src gene family most closely related to c-src, also encodes a
neural tissue-specific transcript. No evidence for a second transcript form in
brain was obtained.
------------------------------------------------------------------------------------------------------------------------------------------------
Rees A, Stocks J, Paul H, Ohuchi Y,
Galton D.
Haplotypes identified by
DNA polymorphisms at the apolipoprotein A-1 and C-III loci and
hypertriglyceridaemia. A study in a Japanese population.
Hum Genet. 1986 Feb: 72(2): 168-71.
A Japanese group comprising 40 hypertriglyceridaemic and 35 normolipidaemic
subjects were genotyped for two intragenic DNA restriction fragment length
polymorphisms (RFLPs) at the A-1 and C-III gene loci. An Sst-1 polymorphism is
located at the 3' end of the C-III gene and a Msp-1 polymorphism in the third
intron of the A-1 gene. The polymorphic restriction sites are 3.8kb apart. The
polymorphism with Sst-1 was present at allelic frequencies of 0.67 (S1 allele)
and 0.33 (S2 allele), and the polymorphism with Msp-1 was present at allelic
frequencies of 0.55 (M1 allele) and 0.45 (M2 allele). The alleles S1, S2, M1,
and M2 are in linkage disequilibrium and three haplotypes were identified S1-M1,
S1-M2, and S2-M2. Unlike the previously reported association of the S2 allele
with hypertriglyceridaemia found in Caucasians there was no difference in the
frequency of S2 allele between normolipidaemic and hyperlipidaemic Japanese.
However one of the haplotypes S1-M2 was significantly increased in the
hypertriglyceridaemic subjects (32% versus 11% P less than 0.025). Thu